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INTRODUCTION
Dengue virus infection has a large global burden
Dengue has become the most important arthropod-borne viral infection 
in the world. Dengue virus belongs to the Flaviviridae and 4 serotypes have 
been recognized so far. Dengue virus is transmitted by Aedes mosquitoes in 
(sub)tropical areas and infections are frequently asymptomatic. In those with 
symptomatic disease, the clinical course varies from a mild, self-limiting, febrile 
illness to a life-threatening condition with plasma leakage, hemorrhage and/ or 
organ failure. An estimated 390 million dengue infections occur globally each 
year, of which 96 million are symptomatic. Seventy percent of the symptomatic 
cases occur in Asia [1]. Despite substantial vector control efforts, the  global 
spread of dengue has not been halted. There are no licensed vaccines or 
specific therapeutics: intravenous rehydration is the current therapy of choice. 
This intervention can reduce the case fatality rate to less than 1% in severe 
dengue cases [2], but may also be complicated by respiratory failure due to 
pulmonary fluid overload. 
The clinical course of mild and severe dengue infections
Symptomatic dengue infection (dengue fever) is usually a mild, self-limiting 
disease characterized by a febrile phase which lasts 2-7 days. Symptoms are 
frequently non-specific and include headache, retro-orbital pain, nausea, 
vomiting, abdominal pain, diarrhea, rash, cough, sore throat, myalgia and/or 
arthralgia. An increased bleeding tendency may be present in the form of a 
positive tourniquet test, occurrence of spontaneous petechiae, ecchymosis 
or hemorrhage. Hepatomegaly with increased serum transaminase levels can 
occur, but jaundice is rarely seen. Although most patients recover rapidly and 
spontaneously, a small proportion develops severe dengue. The most common 
and feared complication seen in complicated dengue is severe plasma leakage, 
which is due to a sudden and transient increase in endothelial permeability 
leading to extravasation of fluid. This may lead to shock and/or respiratory 
distress. The early stages of shock can be recognized by a narrow pulse 
pressure (20 mmHg or less), with a relatively high diastolic blood pressure, 
before both systolic and diastolic blood pressure drop. Patients often appear 
deceivingly well and lucid until the end stages of shock. In the previous WHO 
guidelines of 1997, severe dengue with hemorrhage in absence of shock was 
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called Dengue Hemorrhagic Fever (DHF) and severe dengue with shock (with 
or without bleeding) was known as Dengue Shock Syndrome (DSS)  [3]. In the 
current WHO guidelines of 2009, severe dengue is defined as dengue with 
severe plasma leakage leading to shock and/or respiratory distress, dengue 
with severe organ failure or dengue with severe hemorrhage [2]. 
Thrombocytopenia is a hallmark of dengue infection and platelet counts are 
inversely associated with the severity of dengue infection. Daily full blood 
counts are recommended to monitor dengue patients. Other hematological 
laboratory characteristics of dengue infection are leukopenia and neutropenia 
with a relative lymphocytosis. Hemoconcentration (increase of hematocrit of 
20% or more) or a single high hematocrit value are also considered signs of 
severe plasma leakage. Notably, the platelet count nadir is reached around the 
time of defervescence, which is also the typical time point for complications 
to arise. This period around defervescence is therefore called the critical phase 
of dengue and lasts about 48-72 hours. The critical phase is usually followed 
by a rapid recovery of symptoms and normalization of the hematological 
parameters, but may be delayed or have a fatal outcome in severe dengue. The 
clinical phases in relation to platelet count kinetics are shown in figure 1.
Figure 1. Platelet count kinetics during the different phases of symptomatic dengue infection.
The febrile phase starts with a sudden onset of fever and is often accompanied 
by flu-like symptoms. Bleeding manifestations may also occur. The critical phase 
starts around the time of defervescence and marks the 48-72 hours period 
during which the platelet count nadir is reached. If severe plasma leakage and/
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or severe bleeding and/or severe organ failure occur, it is usually in the critical 
phase. In the absence of these severe complications the clinical symptoms and 
laboratory parameters usually recover rapidly.
Recognizing patients at risk for severe dengue infection is important but 
difficult
An important challenge for clinicians caring for dengue patients is to timely 
identify patients who will progress to severe disease. Dengue-associated 
shock develops rapidly and patients at risk therefore require hospitalization 
and intensive monitoring. Especially during outbreaks, health care facilities in 
resource poor countries are often overloaded with clinically suspected dengue 
patients. 
Currently, no accurate biomarkers for disease severity are available. Additionally, 
timely detection of significant plasma leakage is difficult in clinical practice. 
Serial hematocrit values are frequently used to detect hemoconcentration as 
a sign of plasma leakage, but are hard to interpret due to individual variation, 
absence of pre-illness values, and hematocrit changes due to intravenous 
fluid administration and/or bleeding. Monitoring the development of pleural 
effusion and/or ascites - both predilection sites of plasma leakage in dengue -  is 
an alternative. Ultrasonography of the chest and abdomen may be preferential 
as chest X-rays can only detect a significant amount of pleural effusion. The main 
advantages of ultrasonography are its high sensitivity to detect small amounts 
of pleural effusion and ascites and the possibility to visualize the gallbladder 
wall, which is frequently thickened in dengue due to edema. However, these 
techniques are hardly implemented in dengue-endemic areas due to financial 
and availability constraints. 
Difficulties in dengue differential diagnosis 
Dengue virus infection has become one of the most common causes of 
undifferentiated fever in tropical settings, particularly in areas where malaria 
transmission is decreasing [1, 4, 5]. This also applies for West-Java, Indonesia, 
where the studies described in this thesis were performed. Dengue shares 
clinical features with other endemic infections that are characterized by 
fever and thrombocytopenia, such as leptospirosis and enteric fever [6-8]. 
Timely differentiation between these specific infections is important as their 
management differs and early interventions may prevent severe illness and 
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death. Close observation and judicious use of fluids is important in severe 
dengue [9], while early antibiotics may be life saving in leptospirosis and 
enteric fever [10-15]. Rapid diagnostic tests have been developed for dengue, 
leptospirosis and enteric fever in recent years, but the diagnostic performance 
of these tests in highly endemic regions is suboptimal [16-19]. Dengue-
specific PCR and paired serology for dengue specific IgM and IgG are often not 
affordable or (timely) available to be of clinical benefit in dengue endemic areas. 
Interpretation of IgM serology of a single sample in dengue endemic areas is 
hampered by the low frequency of an IgM titre response during secondary 
infections and by possible false positivity due to dengue IgM cross-reactivity 
with other infections. Apart from these microbiological tests, a full blood count 
is often performed in these patients. Due to advances in hematology analyzers 
new parameters can be identified, including immature blood cells and the use 
of special dyes to measure the activation status of different types of leukocytes, 
allowing characterization of pathogen-specific immune responses. It is still 
unknown whether these parameters can be used to discriminate dengue from 
other febrile diseases. 
Pathogenesis of dengue-associated plasma leakage is still incompletely 
understood
The pathogenic mechanisms underlying the severe complications of dengue 
are complex and still incompletely understood due to several reasons. First, 
there is a lack of animal models for dengue virus infections that can induce the 
classic human pathology. Different murine models exists, each with their own 
(dis)advantages varying from a defective interferon response -which is crucial 
in human host defense against dengue-, to the incapability to induce severe 
dengue complications or requiring the use of modified dengue virus strains 
which may not be representative for human dengue infection [20]. Recent 
developments of an intravenous infection model with rhesus macaques are 
promising, but require further fine-tuning [21]. Second, although different cell 
lines permissive for dengue virus replication in vitro are available, in vitro studies 
produced conflicting results and interpretation of the data is complicated due 
to the lack of information regarding the actual phenotypes of these cells [22]. 
Third, available in vivo human studies often do not provide information about 
the early stages of dengue virus infection. Finally, dengue has a typical course 
over time, whereby it is sometimes difficult to identify the duration of the 
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subsequent phases, due to the lack of a uniform schedule for the timing of 
blood sampling. These factors complicate the comparison and interpretation 
of the various studies addressing dengue pathogenesis. 
Vascular leakage is due to endothelial dysfunction rather than destruction 
The endothelial hyperpermeability leading to dengue-associated plasma 
leakage is thought to result from endothelial barrier dysfunction rather than 
endothelial destruction. Supporting findings are the transient nature of 
plasma leakage with a rapid recovery of hyperpermeability and the limited 
morphological endothelial damage at autopsy [23-25]. Although many 
possible mechanisms have been reported, also from human studies, their 
actual contribution to dengue-associated plasma leakage remains unclear. The 
prevailing explanation is that a transient compromise of endothelial barrier 
function is induced by an exaggerated immune-response to dengue virus with 
a cytokine storm and immune cell activation that affects endothelial function. 
However, these processes are not unique to dengue and can also be observed 
in a range of infectious diseases in which endothelial hyperpermeability 
and bleeding are uncommon. Dengue-associated plasma leakage also 
predominantly occurs in the pulmonary and abdominal vascular bed, leading 
to pleural effusion, ascites and/or gallbladder wall edema, but not so much to 
the generalized peripheral edema as is seen in for example in bacterial septic 
shock.  Tissue/ organ specific components of the endothelium itself and the 
glycocalyx layer of the endothelium which regulates permeability of proteins 
based on their size and charge [26] may interact with dengue virus antigens 
[27] or dengue-specific antibodies [28, 29] and may contribute to the transient 
nature and the predilection sites of dengue-associated plasma leakage. 
Notwithstanding the role of the host immune response in the development of 
plasma leakage (as described further below), the present thesis attributes an 
important role to platelets in the pathophysiology of dengue complications. 
Platelets are now recognized to be crucial for maintaining endothelial vascular 
integrity [30] and complications of plasma leakage occur around the time of 
the platelet count nadir during dengue-induced thrombocytopenia.  
Role of platelets in dengue-associated endothelial hyperpermeability
Platelets were primarily known for their role in hemostasis, but these 
anucleated cells turned out to have many more functions. In recent years, the 
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role of platelets in regulating endothelial integrity and dengue-associated 
plasma leakage has gained increased interest [30-34]. In normal conditions, 
maintenance of the endothelial barrier is established by adherens junctions 
between endothelial cells, which can be compared to a zipper-like structure. 
The degree of closure of this zipper is an active process that involves many 
different pathways and each vascular bed has its own specific properties. 
Platelets constitutively release a broad panoply of endothelial trophogens 
-including angiopoietin-1 and sphingosine-1-phosphate-, which stabilize the 
endothelial adherens junctions and thereby promote endothelial integrity [30, 
35, 36]. In case the release of platelet-derived trophogens decreases below 
a critical point -which occurs in severe thrombocytopenia- these adherens 
junctions disassemble, resulting in increased endothelial permeability with 
consequently plasma leakage and/ or red blood cell extravasation. Sufficient 
numbers of functional platelets are especially required for preservation of 
endothelial integrity during inflammation [37-39]. 
Besides vasculoprotective trophogens, platelets release factors that promote 
plasma leakage such as vascular endothelial growth factor A (VEGF-A) and 
serotonin. Local release of platelet-stored serotonin was shown to enhance 
plasma leakage in an experimental arthritis model [40]. Another line of 
evidence linking platelets to plasma leakage was recently provided by Hottz et 
al [34], who showed that platelets contain functional inflammasome that can be 
activated by exposure to dengue virus resulting in shedding of interleukin(IL)-
1β rich micro particles, which in turn enhances endothelial permeability. 
Notably, petechiae and bleeding complications in dengue patients frequently 
occur with platelet counts well above the threshold for spontaneous bleeding. 
In addition, a hemorrhagic diathesis is very rare in other conditions associated 
with moderate thrombocytopenia, such as malaria. This suggests that dengue 
has the capacity to induce not only thrombocytopenia, but also platelet 
dysfunction. Previous studies indicated that platelet activation occurs during 
dengue infection [41, 42], but the mechanisms are largely unknown. Dengue 
virus may directly activate platelets by infection of platelets or megakaryocytes, 
since dengue virus has been detected in both cell types [43-47]. Possible 
indirect interactions of dengue and platelets can occur through virus-specific 
antigens, virus (antigen)-specific anti-platelet antibodies [48-50], interaction 
with immune cells and/or circulating soluble mediators with the potential to 
activate platelets.  The exact contribution of these factors to platelet activation 
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has not been elucidated yet in dengue. In this thesis, we hypothesized that 
dengue-induced thrombocytopenia in combination with ongoing platelet 
activation results in exhaustion of vasculoprotective trophogens, since platelets 
have only a limited capacity for de novo synthesis of proteins that are released 
upon platelet activation. This promotes endothelial hyperpermeability with 
plasma leakage and extravasation of erythrocytes. Additionally, during platelet 
activation factors are released that promote vascular permeability and/ or 
immune cell activation, which can further induce or prime the endothelium for 
increased permeability. 
Data concerning platelet function during human dengue infection are scarce. 
Early studies using platelet aggregometry indeed showed reduced aggregation 
in dengue patients [51-53] or decreased aggregation of platelets treated with 
dengue-antibody containing serum [48, 50], but because the reliability of 
aggregometry is compromised in conditions with thrombocytopenia, these 
findings should be interpreted with caution. In this thesis we studied platelet 
function by using flow cytometry, which can also be performed in conditions 
with thrombocytopenia. 
Another non-traditional role of platelets is that of an important mediator 
in immunity and inflammatory conditions [54-56]. Platelets can recognize 
and interact with (products of ) pathogens including viruses and can release 
a ranges of cytokines, chemokines and anti-microbiological peptides in 
response to microorganisms and mediators of inflammation [57]. Additionally, 
activated platelets bind to leukocytes through P-selectin expression on the 
platelet surface. Dengue virus infection elicits platelet-monocyte and platelet-
neutrophil complexes in a primate model of dengue infection and in human 
dengue infection [21, 58]. Activated and apoptotic platelets that aggregate with 
monocytes during dengue infection can alter the inflammatory response of 
monocytes [59]. Furthermore, platelets are phagocytosed [60] during dengue 
and expose monocytes/ macrophages to intra-platelet immune-modulating 
molecules. 
So, platelet function is affected by pathogens and host immune responses, 
but also vise versa: platelets play a role in the host immune response during 
infections. These processes may directly or indirectly affect endothelial 
permeability. 
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Adequate anti-dengue host immune response versus harmful effects on endothelial 
barrier
The role of host immune response against dengue infection has received most 
attention so far in deciphering the pathogenesis of plasma leakage. Complement 
activation and release of pro-inflammatory cytokines and chemokines by 
activated innate and adaptive immune cells such as monocytes/ macrophages, 
dendritic cells, mast cells, B-lymphocytes  and T-lymphocytes are thought 
to be crucial for the host defense against dengue, but may also lead to an 
exaggerated or imbalanced host immune response contributing to endothelial 
hyperpermeability and shock [20, 61-64]. Human monocytes are considered to 
be the main target of dengue virus infection [65, 66] and these cells produce 
vaso-active pro-inflammatory cytokines such as TNF-α [67, 68], which is a 
known inducer of vascular leakage in animal models [69]. Additionally, pro-
inflammatory cytokines produced by activated virus-specific T-lymphocytes 
are not only important for the clearance of dengue virus, but can also directly 
(IL-2) or indirectly (IFN-γ) induce vascular leakage as reviewed in Rothman et al. 
[63]. Opposite to the idea that a cytokine storm is underlying the pathogenesis 
of severe dengue virus infections is the observation that complications occur 
around the time of defervescence and not in the febrile phase of dengue. 
Possibly a imbalance in cytokines develops during defervescence. Most pro-
inflammatory cytokines induce fever, apart from interleukin-18, produced by 
macrophages. Furthermore, IL-18 is associated with macrophage activation 
syndrome and hyperferritinemia, as may be seen in severe dengue infections. 
In this thesis we therefore studied the levels of biologically active IL-18 levels 
and it’s naturally occurring antagonist IL-18 binding protein (IL-18BP) in relation 
to the timing of dengue-associated plasma leakage, as these data were not yet 
available. 
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OUTLINE OF THE THESIS
This thesis first addresses the issues of timely detection of plasma leakage 
during dengue and the differentiation of dengue from other febrile illnesses 
that are associated with thrombocytopenia, using  methods that have the 
potential to be implemented in resource poor countries. Subsequently, we 
focus on the pathogenesis of dengue-associated plasma leakage with special 
emphasis on the role of platelets and platelet-derived proteins.
The two studies described in this thesis were performed in Indonesian adults 
with severe and non-severe dengue virus infection (chapters 2-5 and 8) and 
in Indonesian children with severe dengue virus infection (chapters 6 and 7), 
both in Java, Indonesia, where dengue virus infection is hyperendemic. The 
objectives of the studies described in the following chapters were to determine:
• The predictive diagnostic value of serial, daily, bedside 
ultrasonography for detection of dengue-associated plasma 
leakage (chapter 2). 
• The diagnostic value of new hematological parameters available 
on a standard hematology analyzer in differentiating dengue 
from leptospirosis and enteric fever (chapter 3). 
• The occurrence of abnormalities in platelet function during 
dengue infection and the association with plasma leakage and 
bleeding (chapter 4).
• Changes in plasma concentrations of the endothelial protective 
molecule sphingosine-1-phosphate and its main carrier 
apolipoprotein M, and the association with plasma leakage 
(chapter 5).
• Changes in plasma concentrations in the anti- and pro-
permeability proteins angiopoietin-1 and angiopoietin-2, and 
their association with plasma leakage (chapter 6).
• Changes in concentrations of  mid-regional pro-adrenomedullin 
(MR-proADM) and copeptin and the association with plasma 
leakage (chapter 7).
• The IL-18/ IFN-γ axis during dengue infection and the association 
with plasma leakage (chapter 8).
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SUMMARY
Background.  Identification of dengue patients at risk for progressing to severe 
disease is difficult. Significant plasma leakage is a hallmark of severe dengue 
infection which can suddenly lead to hypovolemic shock around the time 
of defervescence. We hypothesized that the detection of subclinical plasma 
leakage may identify those at risk for severe dengue. The aim of the study 
was to determine the predictive diagnostic value of serial ultrasonography for 
severe dengue. 
Methodology/ Principal Findings. Daily bedside ultrasounds were performed 
with a handheld ultrasound device in a prospective cohort of adult Indonesians 
with dengue. Timing, localization and relation to dengue severity of the 
ultrasonography findings were determined, as well as the relation with serial 
hematocrit and albumin values. The severity of dengue was retrospectively 
determined by WHO 2009 criteria. A total of 66 patients with proven dengue 
infection were included in the study of whom 11 developed severe dengue. 
Presence of subclinical plasma leakage at enrollment had a positive predictive 
value of 35% and a negative predictive value of 90% for severe dengue. At 
enrollment, 55% of severe dengue cases already had subclinical plasma 
leakage, which increased to 91% during the subsequent days. Gallbladder wall 
edema was more pronounced in severe than in non-severe dengue patients 
and often preceded ascites/pleural effusion. Serial hematocrit and albumin 
measurements failed to identify plasma leakage and patients at risk for severe 
dengue. 
Conclusions/ Significance. Serial ultrasonography, in contrast to existing 
markers such as hematocrit, may better identify patients at risk for development 
of severe dengue. Patients with evidence of subclinical plasma leakage and/or 
an edematous gallbladder wall by ultrasonography merit intensive monitoring 
for development of complications. 
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INTRODUCTION
Dengue virus infection is the most rapidly spreading mosquito-borne viral 
disease in the world and has the highest burden in often resource poor (sub)
tropical countries. Symptomatic dengue patients usually present with a self-
limiting febrile illness, called dengue fever. However, a proportion of dengue 
patients develops severe complications around the time of defervescence. 
Transient plasma leakage into serosal cavities, which may progress to life-
threatening hypovolemic shock, is a hallmark of severe dengue [1,2]. In the 
former World Health Organization (WHO) classification (1997), severe dengue 
characterized by fever, thrombocytopenia, plasma leakage and hemorrhagic 
tendency, is referred to as dengue hemorrhagic fever (DHF) and, when 
accompanied by circulatory failure, as dengue shock syndrome (DSS) (table 1) 
[3]. The most recent WHO classification (2009) defines severe dengue infection 
in case plasma leakage leading to shock or respiratory failure, severe bleeding 
or severe organ failure is present [4] (table 1). However, in clinical practice severe 
bleeding and severe organ failure are relatively uncommon and rarely occur 
without plasma leakage [5,6]. Hence, plasma leakage is an essential element 
of severe dengue, regardless whether the WHO 1997 or 2009 classification is 
used.
One of the most important challenges for clinicians caring for dengue patients 
is to identify those patients who will progress to severe disease. Currently, 
no accurate biomarkers are available and prediction of significant plasma 
leakage is difficult in clinical practice. Serial hematocrit values are frequently 
used to detect hemoconcentration as a sign of plasma leakage, but are hard 
to interpreted due to individual variations, absence of baseline hematocrit 
values, intravenous fluid administration and bleeding. Monitoring for pleural 
effusion and/or ascites - both predilection sites of plasma leakage in dengue - 
is an alternative. Chest X-rays can only detect significant pleural effusions and, 
therefore, ultrasonography of the chest and abdomen may be preferential. 
The main advantages of ultrasonography are its high sensitivity to detect 
small amounts of pleural effusion and ascites [7-12] and the possibility to 
visualize the gallbladder wall, which is frequently thickened in dengue [13,14]. 
So far, most dengue ultrasonography studies are cross-sectional in nature, 
whereas significant changes in vascular permeability may occur after the 
initial presentation of the patient. Serial ultrasonography may therefore be 
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needed to detect the presence of plasma leakage. Despite the advantages of 
ultrasonography to detect plasma leakage in dengue, the clinical application is 
still limited in resource poor settings, because it requires sophisticated facilities 
and expertise. Lately, more affordable handheld ultrasound devices have 
become available, which can be used at the bedside.
The aim of our study was to determine the predictive diagnostic value of 
serial ultrasonography for severe dengue. Measurements were done using 
a handheld ultrasound device at the bedside. We compared the ability to 
detect plasma leakage by serial handheld ultrasonography with conventional 
ultrasonography performed by a radiologist. The presence of plasma leakage 
detected by handheld ultrasonography was compared with frequently used 
clinical and laboratory parameters for plasma leakage and related to severe 
dengue as a clinical outcome.
METHODS
Patients and study design
For this prospective observational study, we included patients with dengue 
infection, aged 14 years or above, who were admitted to Rumah Sakit Hasan 
Sadikin, an academic referral hospital in Bandung West Java, Indonesia, from 
March 2011 to January 2012. All patients had a clinically suspected dengue 
infection, which was retrospectively classified as non-severe or severe dengue 
according to WHO criteria from the guidelines edition 2009 (table 1) [4]. 
According to these guidelines a narrow pulse pressure (difference between 
systolic and diastolic blood pressure of 20 mmHg or less) is also a sign of shock. 
The presence of plasma leakage was confirmed by a significant hematocrit 
change (minimal 20%) and/or single high hematocrit values (> 50 and > 44 
% for men and women respectively), and/or by plasma leakage seen during 
ultrasonography. In case of a discrepancy in the presence or absence of plasma 
leakage between handheld or conventional ultrasonography, the latter was 
used as a golden standard. All patients had to be enrolled either in the febrile 
phase (defined as a temperature of 37.5 oC or more on that day) or in the critical 
phase (defined as the period within 48 hours after defervescence and before 
platelet counts increased again) of dengue infection. Patients with concurrent 
chronic disease and pregnant patients were excluded.
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Demographic, clinical, laboratory and ultrasonography data were collected 
using a standardized data collection form. Ultrasonography was not part of 
routine clinical care. A full blood count, including hematocrit measurements, 
was daily performed as part of routine clinical care, until platelet counts 
had shown a substantial increase and the patient had improved clinically. 
Patients were asked to return 2-3 weeks after discharge for follow up, which 
included clinical evaluation, blood drawing for full blood count including 
hematocrit for baseline values, serology and handheld ultrasonography. 
The degree of hemoconcentration was calculated according to the formula; 
% hemoconcentration = [(peak hematocrit surrounding defervescence)-
(convalescent hematocrit or minimum hematocrit during admission)]/ 
(convalescent hematocrit or minimum hematocrit during admission) x 100.
Table 1. Criteria for severe dengue according to World Health Organization guidelines 1997 and 2009. 
Criteria WHO 1997 Criteria WHO 2009
DHF
Dengue with all of the following 4 components: Dengue with any of the following:
1. Fever 1. Severe plasma leakage leading to shock 
2. Hemorrhagic tendency or respiratory distress
3. Thrombocytopenia (<100×10⁹cells/L) 2. Severe bleeding as evaluated by clinicians
4. Plasma leakage: 3. Severe organ failure
a. Pleural effusion or ascites and/or a. Liver (ASAT, ALAT >1000 U/L)
b. Minimum 20% hematocrit change and/or b. Central nervous system: impaired consciousness
c. High hematocrit for population/age/sex and/or c. Heart and other organs
d. Low serum protein 
DSS
DHF and circulatory failure  
Abbreviations: WHO: World Health Organization; DHF: dengue hemorrhagic fever; DSS: dengue shock 
syndrome; ALAT: alanine aminotransferase; ASAT: aspartate aminotransferase.
Laboratory diagnosis
Samples of dengue suspected cases were tested for presence of viral RNA by 
reverse-transcriptase PCR and samples were tested for dengue specific IgM and 
IgG  (Panbio, Windsor, Australia), interpreted according to the manufacturer’s 
instructions. Samples that were IgM positive, had an IgM or IgG conversion, 
a 4-fold titer increase in IgG and/or IgG levels comparable to a HI titer of at 
least 1:2560 (the IgG cut off point set by the manufacturer to detect secondary 
infection) were considered dengue positive. Patients with both negative PCR 
and dengue serology results were excluded.
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Ultrasonography procedures
Bedside ultrasound examinations were performed daily, using a handheld 
portable ultrasound device (Signos personal ultrasound) with a 3.5 MHz 
transducer. Measurements started on the day of study enrollment until the day 
of discharge. All handheld ultrasound examinations were carried out by study 
physicians, who first received a four-week practical training in systematically 
detecting ascites, pleural effusion and determining the gallbladder wall aspect 
and thickness. To validate the results of these portable ultrasonograms, one 
conventional ultrasound was made per patient by a radiologist. This was done 
in the critical phase, since the likelihood of finding plasma leakage is the 
highest at this time-point. Study physicians and radiologists were blinded for 
each other’s results. 
Ultrasonography was performed after a minimum of 6 hours of fasting, with 
the patient in supine position. The abdomen was screened for the presence 
or absence of ascites in the hepato-renal pouch and spleno-renal area (figure 
1 A-D). The conventional ultrasonography by the radiologist additionally 
screened for free fluid around the urine bladder, which was not feasible with 
the portable ultrasound device. Presence of multiple layers in the gallbladder 
wall and/or a gallbladder wall thickness of 0.3 cm or more were considered 
as a thickened gallbladder wall (figure 2 A and B). The presence or absence of 
pleural effusion was determined by visualizing bilateral costophrenic angles in 
supine position (figure 3 A and B).
Ethics
The Study Research Ethics Committee of the Faculty of Medicine of the 
Padjadjaran University, Bandung, Indonesia, approved all legal, ethical, 
radiological aspects of the study. Written informed consent was obtained from 
all patients or from their parents, in case the patient was below 17 years of age. 
All patients were able to provide informed consent.
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Figure 1. Ultrasonography findings showing presence or absence of ascites in dengue patients. 
Handheld ultrasonography performed at the bedside with the patient in supine position during 
examination. (A) Normal hepatic-renal area. (B) Minimal ascites in hepato-renal area (arrow). (C) Normal 
spleno-renal area. (D) Ascites in spleno-renal area (arrow). Abbreviations: L: liver; K: kidney, RLL: right 
lower lobe of lung; LLL: left lower lobe of lung; S: Spleen.
 
Figure 2. Ultrasonography findings showing a normal and thickened gallbladder wall in dengue 
patients. Handheld ultrasonography performed at the bedside with the patient in supine position 
during examination.  (A) normal gallbladder wall (< 0.30 cm) (B) and thickened gallbladder wall. The gall 
bladder wall is thickened with 0.90 cm and has a subserosal fluid layer, giving the gallbladder wall a 
multiple layer aspect. Abbreviations: L: liver; GB: gallbladder lumen.
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Figure 3. Ultrasonography findings showing presence or absence of pleural effusion in dengue patients. 
Handheld ultrasonography at the bedside with patient in supine position during examination. (A) 
Normal right costophrenic angle. (B) Pleural effusion in the right costophrenic angle (arrow). 
Abbreviations: L: liver; K: kidney, RLL: right lower lobe of lung.
Data presentation and statistical analysis
Data are expressed as medians with interquartile ranges (IQR) or numbers with 
percentages. Differences in non-continuous data of 2 groups were analyzed by 
Pearson’s Chi-square test or by Fisher’s exact test in case of expected counts < 
5. Continuous variables between 2 groups were analyzed by unpaired t-test in 
case of normally distributed data; and by Mann Whitney U test in case of non-
parametric data. Relationships between continuous data were examined by 
Pearson’s correlation for parametric data and Spearman’s correlation for non-
parametric data. A p-value < 0.05 was considered significant. All analysis were 
performed using SPSS (version 18.0) statistical program.   
RESULTS
Clinical characteristics
Among the 71 patients with clinically suspected dengue infection, 66 patients 
had a positive PCR and/or serology and were included. Fifty-five (83%) patients 
were retrospectively classified as non-severe dengue and 11 (17%) as severe 
dengue according to the 2009 WHO classification [4]. All patients with severe 
dengue had plasma leakage with vascular collapse; none of the patients had 
severe bleeding or organ failure. Patient characteristics and baseline data are 
presented in table 2. The first day of fever was defined as the first day of illness. 
All patients were discharged from the hospital in good health. 
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Table 2. Patient characteristics and baseline data for non-severe and severe dengue patients.
 
 
Non-severe dengue Severe dengue
n = 55 (83%) n= 11 (17%)
Age; years                           22 (19-30) 19 (15-29)
Male sex;  n (%) 32 (58) 6 (55)
Duration of illness; days 6 (5-7) 6 (5-7)
Phase of dengue 
     Febrile phase; n (%) 16 (29) 2 (18)
     Critical phase; n (%) 39 (71) 9 (82)
Abdominal pain; n (%) 21 (38) 6 (55)
Nausea; n (%) 35 (64) 5 (46)
Vomiting; n (%) 8 (15) 3 (27)
Blood pressure; mmHg
     Systolic 110 (100-120) 100 (90-100)**
     Diastolic 75 (70-80) 70 (60-80)
Pulse pressure; mmHg 40 (30-40) 20 (20-30)***
Pulse rate; per minute 84 (78-92) 92 (72-108)
Respiratory rate; per minute 22 (20-24) 20 (20-24)
Temperature; oC 36.6 (36.2-37.3) 36.1 (35.3-38.1)
Hemoglobin; g/dL 13.9 (13.0-15.5) 13.2 (11.1-16.2)
Hematocrit; % 41 (37-45) 39 (35-47)
Platelet count; x10⁹/L 60 (34-83) 31 (20-54)*
Leukocyte count; x10³/mL 3.6 (2.6-5.0) 3.8 (3.2-5.3)
Albumin; g/dL 3.8 (3.6-4.1) 3.7 (3.1-3.8) 
ALAT; U/dL 30 (18-77) 46 (35-69)
Creatinin; mg/dL 0.8 (0.6-0.8) 0.7 (0.6-0.8)
* p < 0.05
** p < 0.01
*** p < 0.001
Data are represented in medians (interquartile range) for continuous data or in numbers (percentage) 
(n (%)) for non-continuous data.  Comparisons of non-continuous and continuous data between non-
severe and severe dengue patients were analyzed by Pearson’s Chi Square test/ Fisher’s exact test and 
Mann-Whitney U test, respectively. P value < 0.05 was considered significant. Abbreviations: ALAT: 
alanine aminotransferase.
Subclinical plasma leakage detected by handheld ultrasonography
At enrollment, ascites and/or pleural effusion were found by handheld 
ultrasonography in 11/55 (20%) patients in the non-severe dengue group and 
in 6/11 (55%) patients of the severe dengue group (p = 0.03) (table 3). As 6 
of 17 patients with ascites or pleural effusion at enrollment developed severe 
dengue, the positive predictive value (PPV) of detection of plasma leakage 
by handheld ultrasonography for development of severe dengue was 35%. 
None of the patients had clinical signs or symptoms suggestive for plasma 
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leakage at enrollment, as determined by careful history taking and physical 
examination by the study clinicians. Four of the 11 patients eventually classified 
as having severe dengue, already fulfilled criteria for severe dengue at the 
time of enrollment due to subclinical plasma leakage combined with a narrow 
pulse pressure.  Five of the 49 patients without ultrasonographic evidence of 
plasma leakage at enrollment, eventually developed severe dengue, yielding 
a negative predictive value (NPV) of 90%. Two of these patients already had 
a narrow pulse pressure at enrollment without further clinical evidence for 
plasma leakage. 
After admission, another 10 patients developed ultrasonographic findings of 
plasma leakage, mainly  in the critical phase (80%). In total, 17/55 (31%) patients 
in the non-severe and 10/11 (91%) in the severe dengue group developed 
ultrasonographic evidence of plasma leakage (p < 0.001) (table 3). 
The diagnosis of plasma leakage in the patient with severe dengue without 
ultrasonographic evidence of plasma leakage was based on an >20% increase 
in hematocrit values. Moreover, three patients without evidence of plasma 
leakage during follow up developed hypotension and/or a narrow pulse 
pressure. In 9/11 (82%) severe dengue cases, shock developed without 
preceding clinical symptoms or signs of plasma leakage. The remaining two 
patients had symptomatic pleural effusions. Ascites was more frequently 
detected by ultrasonography than pleural effusion, which was found either 
right-sided or bilateral (table 3). 
Gallbladder wall thickening
A thickened gallbladder wall was found in 34/52 (65%) of non-severe and 9/10 
(90%) of severe dengue patients at enrollment (p = 0.15) (table 3). The median 
thickness of the gallbladder wall at enrollment was 0.36 cm (IQR, 0.27-0.50 
cm) in patients with non-severe dengue versus 0.54 cm (IQR, 0.34-0.75 cm) in 
those with severe dengue (p<0.01). Gallbladder wall thickness could not be 
determined in six patients at enrollment, because these patients had taken 
food. Eventually, a thickened gallbladder wall was detected in 37/55 (67%) of 
the non-severe dengue and 11/11 (100%) of the severe dengue patients (p = 
0.27). Detection of a thickened gallbladder wall at enrollment had a PPV of 
21% and a NPV of 91% for severe dengue. In patients who developed ascites 
or pleural effusion, thickening of the gallbladder preceded the detection of 
ascites or pleural effusion by 1 to 3 days in 6/10 (60%) of the non-severe and 
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in 6/9 (67%) of the severe patients. Multiple layers were frequently  visible in 
thickened gallbladder walls suggesting the presence of a sub-serosal fluid 
layer (figure 2 B).  
Table 3. Ultrasonography findings of plasma leakage and hemoconcentration in non-severe and severe 
dengue patients.
 
 
Non-severe dengue Severe dengue
n = 55 (83%) n= 11 (17%)
Portable ultrasonography enrollment
Pleural effusion only; n (%) 2 (4) 0 (0)
Ascites only; n (%) 6 (11) 5 (45)*
Pleural effusion and ascites; n (%) 3 (5) 1 (9)
Total: Plasma leakage at enrollment; n (%) 11 (20) 6 (55)*
Gallbladder wall thickened; n (%) 34 (65)³ 9 (90)¹ 
Gallbladder wall thickness; cm 0.36 (0.27-0.50)⁶ 0.54 (0.34-0.75)¹ ***
Portable ultrasonography follow up
New pleural effusion only; n (%) 1 (2) 0 (0)
New ascites only; n (%) 4 (7) 1 (9)
New pleural effusion and ascites; n (%) 1 (2) 3 (27)*
Total: New plasma leakage in follow up; n (%) 6 (11) 4 (36)
Total: Plasma leakage at any time; n (%) 17 (31) 10 (91)***
New gallbladder wall thickening in follow up; n (%) 3 (5) 2 (18)
Total: Gallbladder wall thickened at any time; n (%) 37 (67) 11 (100)
Hemoconcentration and bleeding follow up
Hemoconcentration minimal 20%; n (%) 12 (23)³ 9 (90)¹ ***
High hematocrit value; n (%) 3 (6)³ 1 (10)¹ 
Spontaneous bleeding; n (%) 
None 38 (69) 6 (55)
Epistaxis 10 (18) 3 (27)
Gingival bleeding 7 (13) 1 (9)
Menorrhaghia 0 (0) 1 (9)
¹ ² ³ or ⁶ = the number of observations missing
* p < 0.05
*** p < 0.001
Data are represented in medians (interquartile range) for continuous data or numbers (percentage) 
(n (%)) for non-continuous data. Comparisons of non-continuous and continuous data between non-
severe and severe dengue patients were analyzed by Fisher’s exact test and Mann-Whitney U test, 
respectively. P value < 0.05 was considered significant.
39796 Michels, Meta.indd   33 28-03-16   12:38
Chapter 2
34
Patients with subclinical plasma leakage at enrollment had a thicker gallbladder 
wall than those without plasma leakage with median values of 0.59 cm (IQR, 
0.38-0.79 cm) and 0.35 cm (IQR, 0.27-0.44 cm) respectively (p<0.01). There was 
an inverse correlation of gallbladder wall thickness with platelets counts at 
enrollment (r
s
= -0.53, p<0.001). In contrast, no significant correlation existed 
with clinical symptoms (nausea, vomiting or abdominal pain) and laboratory 
values (absolute value of hematocrit or its change in time, serum albumin, 
alanine aminotransferase (ALAT)) (data not shown).
Regarding the timing of the ultrasonographic abnormalities in relation to the 
day of illness, in patients developing pleural effusion or ascites and gallbladder 
wall thickening during the study, these findings were already detectable on 
the first ultrasonography performed at enrollment in 17/27 (63%) and 43/48 
(90%) of patients, respectively. The first ultrasonography was performed after 
a median duration of 6 days of illness (IQR, 5-7 days). The median day plasma 
leakage was first detected by ultrasound was day 7 of illness (IQR, 6-7 days). The 
maximum gallbladder wall thickness was also observed on this day (IQR, 6-8).
Comparing serial handheld ultrasonography with conventional 
ultrasonography
Fifty-five conventional ultrasound reports were available to serve as the 
golden standard for the detection of plasma leakage by serial handheld 
ultrasonography. In 48/55 patients (87%), the handheld ultrasound scored the 
same results for the presence or absence of plasma leakage as the conventional 
ultrasound on that same day. In an additional 4/55 patients (7%) portable 
ultrasonography missed the presence of plasma leakage on the same day, but 
still detected plasma leakage one day after the conventional ultrasound. In 
3/55 patients (5%), handheld ultrasonography failed to detect plasma leakage 
seen by conventional ultrasonography. This was partly because conventional 
ultrasonography also screened for ascites in the pelvis. Gallbladder wall 
thickness measurements were available for 45 patients using the conventional 
ultrasonography. For 37/45 (82%) of the handheld ultrasonography 
measurements, the presence or absence of gallbladder wall thickening was 
identical to the conventional ultrasonography. There were no cases in which 
conventional ultrasonography did not show plasma leakage while handheld 
ultrasonography on the same day did.   
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Hematocrit is a poor indicator of plasma leakage compared to handheld 
ultrasonography
An elevated hematocrit value was found in only 4/66 (6%) of patients at 
enrollment. Single hematocrit values at enrollment were not helpful in 
discriminating between patients with and without ultrasonographic plasma 
leakage and between patients classified as non-severe or severe dengue (figure 
4 A). The change in hematocrit values was also not helpful for this purpose 
(figure 4 B). In 13/21 (62%) of the patients in whom hemoconcentration was 
observed, this was only first detected after the critical phase when patients 
already started to recover. Other variables showed larger differences between 
patients with and without ultrasonographic plasma leakage. Patients with 
plasma leakage had lower median platelets counts (21 x109/L vs. 70 x109/L; 
p<0.001), serum albumin levels (36 g/L vs. 40 g/L; p<0.01) and higher ALAT 
levels (60 U/L vs. 26 U/L; p<0.05). 
Figure 4. Hematocrit values in dengue patients with and without subclinical plasma leakage detected 
by handheld ultrasonography. (A) Absolute hematocrit values (%) (Normal maximum hematocrit value 
50 % and 44 % for men and women, respectively) related to the presence or absence of plasma leakage 
detected by handheld ultrasonography on the day of enrollment. (B) Changes in hematocrit (%) related 
to the presence or absence of plasma leakage during the follow up of adult Indonesian dengue patients. 
Plasma leakage was detected in the form of ascites or pleural effusion by daily handheld ultrasonography 
at the bedside performed by a clinician and by conventional ultrasonography. 
The black dots indicate patients who developed severe dengue characterized by shock. The horizontal 
continuous lines represent median values. The horizontal interrupted line represents the reference 
value for hematocrit change (normally < 20 % change) P-values were determined by unpaired t-test 
for hematocrit values and by Mann Whitney U test for hematocrit changes. * p value < 0.05; ** p value 
< 0.01.
39796 Michels, Meta.indd   35 28-03-16   12:38
Chapter 2
36
DISCUSSION
This study shows that serial handheld ultrasonography at the bedside may 
be useful to identify patients at risk for severe dengue. More than 1 out of 3 
patients (35%) with ultrasonographic evidence of subclinical plasma leakage 
at enrollment developed shock, in contrast to only 1 out of 10 patients (10%) 
without subclinical plasma leakage. Dengue-related shock is known to develop 
rapidly and it is currently not possible to identify those at risk for shock at an 
early stage of illness. Our findings suggest that careful monitoring of circulatory 
status is merited in those patients with ultrasonographic evidence of subclinical 
plasma leakage since there is a significant risk for progressing to shock. Despite 
much research effort, reliable biomarkers for predicting severe dengue have 
not yet been identified. Therefore, even though the positive predictive value 
of ultrasonography for predicting severe dengue in our study was still far from 
optimal (35%), serial ultrasonography may be a considerable advance in the 
clinical management of dengue patients. 
The high sensitivity of handheld ultrasonography to detect plasma leakage 
has implications for the interpretation of WHO classification of dengue severity 
from 1997, which continues to be used frequently in research settings [6]. 
Ultrasonography findings of subclinical plasma leakage changed the diagnosis 
from non-severe dengue (dengue fever) to severe dengue (dengue hemorrhagic 
fever) in 9 cases of our study population if WHO 1997 guidelines had been 
applied. This is in line with recent studies that report subclinical plasma leakage 
in patients with clinically mild dengue infection [15,16]. Moreover, it contradicts 
the long-existing dichotomous view of dengue severity that is reflected in WHO 
classifications, in which plasma leakage is a hallmark of severe dengue infection 
only [8,9]. Also in the WHO 2009 guidelines, plasma leakage remains the main 
criteria for severe dengue, since the other two criteria – severe bleeding and 
severe organ failure- are relatively rare. 
Handheld abdominal ultrasonography showed a thickened gallbladder wall 
in 65% of the dengue cases at enrollment, and the degree of thickening was 
associated with dengue severity. Gallbladder wall thickening often preceded 
the first detection of pleural effusion or ascites and may therefore be an useful 
early warning sign for plasma leakage, as has also been suggested by others 
[7,8,13,17]. Several case reports have described the occurrence of acalculous 
cholecystitis in dengue patients. In most of these cases, the diagnosis was 
based on an ultrasonographic demonstration of a thickened gallbladder 
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wall. Some of these patients underwent cholecystectomy whereby histology 
showed congestion of the serosa with presence of mononuclear cell infiltrates 
and lymphocyte follicle formation [18,19]. We speculate that plasma leakage 
plays an important role in the pathogenesis of gallbladder wall thickening 
in dengue. Both ascites and gallbladder wall thickening appear and resolve 
around the same time and within a short time span [9,14]. In those gallbladders 
with the most outspoken wall thickening, multiple layers were visible due to 
sub-serosal edema, suggesting plasma leakage inside the gallbladder wall. 
Finally, gallbladder wall thickening was not associated with abdominal pain in 
our patients, which makes inflammation less likely. 
We demonstrated that the sensitivity for detecting plasma leakage and a 
thickened gallbladder wall of handheld ultrasonography performed by a non-
radiologist, was comparable to conventional ultrasonography by a radiologist. 
Compared to ultrasonography, hematocrit proved to be a poor indicator of 
subclinical plasma leakage and changes in the hematocrit often occurred too 
late to be of clinical benefit. 
There are only few prospective ultrasonography studies in dengue [9,16,17] 
and our study is, to our knowledge, the first to employ a handheld ultrasound 
device operated by clinicians instead of radiologists. Heterogeneity in 
study populations, dengue classification, timing of ultrasonography and 
used definitions of gallbladder wall thickening and dengue classifications 
complicate a proper comparison between results of previous ultrasonography 
studies and ours. The reported proportion of dengue patients with gallbladder 
thickening in earlier studies varied from 28% to 100%, while pleural effusion 
and ascites was found in 32% to 100% and 15% to 96%, respectively [7-
9,11,12,17]. So far, the clinical application of ultrasonography in dengue was 
hampered by financial and logistic constraints, but the recent availability of 
more affordable handheld ultrasound devices may help to overcome these 
restrictions. Serial bedside ultrasonography by clinicians may not only have a 
prognostic value by identifying dengue patients at risk for disease, but also a 
diagnostic value. The clinical features of dengue overlap with other endemic 
febrile illnesses, such as rickettsiosis and typhoid fever. The ultrasonographic 
detection of ascites, pleural effusion or gallbladder edema in a patient with 
a clinical picture of dengue supports the diagnosis of dengue [20]. Moreover, 
handheld ultrasonography might especially proof useful for triage during 
dengue outbreaks when health care facilities are overloaded.
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Our study has several limitations. First, our study population consisted of 
patients admitted to an academic referral hospital in whom severe disease 
was common. This explains why plasma leakage was already visible by 
ultrasonography in many patients at the time of enrollment. Moreover, it makes 
it impossible to determine the day of illness at which plasma leakage could 
have been detected initially. Studies in patients presenting at an earlier stage 
of dengue are required to answer this question. Second, adiposity was rare in 
our Indonesian study population and the diagnostic performance of handheld 
ultrasonography in populations with more overweight may be lower. Finally, 
despite the fasting instructions before ultrasonography, we cannot exclude 
that some patients had eaten before the examination which may have resulted 
in an over-estimation of gallbladder wall thickness.   
In conclusion, serial handheld ultrasonography holds promise as a diagnostic 
and prognostic tool in dengue. Compared to serial hematocrit values, serial 
ultrasonography had a better predictive value in identification of those patients 
at risk for severe dengue. Moreover, it may improve monitoring of circulatory 
status and enable timely adjustments in fluid balance to avoid hypovolemic 
shock or iatrogenic fluid overload.
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SUMMARY
Introduction. Distinguishing dengue virus infection from other febrile 
thrombocytopenic illnesses such as leptospirosis or enteric fever is important 
but difficult, due to unavailability of reliable diagnostic tests. Sysmex XE-5000 
hematology analyzers use  fluorescence flow cytometry  to quantify new 
parameters including cells in the atypical lymphocyte area (AL), high fluorescent 
lymphocyte counts (HFLC), immature granulocytes (IG) and immature platelets 
(IPF). The present study aimed to investigate whether these parameters can 
help to discriminate between the diseases.
Material and methods. We compared hematocytometry performed by a 
Sysmex XE-5000 analyzer in Indonesian adults with dengue (n=93), leptospirosis 
(n=11) and enteric fever (n=6) infection, and in healthy controls (n=28). 
Results. Receiver operating characteristic  curves comparing dengue and 
leptospirosis showed that dengue was characterized by increased %AL (AUC 
0.87; 95%CI 0.70-1.03), %HFLC (AUC 0.89; 95%CI 0.78-0.99) and %IPF (AUC 0.81; 
95%CI 0.65-0.97), while leptospirosis patients had increased %IG (AUC 0.86; 
95%CI 0.71-1.02). Low %AL, %HFLC and %IG supported a diagnosis of enteric 
fever.
Conclusions. Detection of AL, HFLC, IG and IPF by Sysmex XE-5000 hematology 
analyzers  can help to differentiate between common causes of febrile illnesses 
with thrombocytopenia in dengue endemic areas. We recommend further 
investigating the discriminatory value of these parameters in clinical practice.
39796 Michels, Meta.indd   42 28-03-16   12:38
Hematocytometry in dengue differential diagnosis
43
3
INTRODUCTION
Dengue virus infection has become one of the most common causes of 
undifferentiated fever in tropical settings, particularly in areas where malaria 
transmission is decreasing [1, 2]. The diagnosis is often complicated by the 
fact that dengue shares many clinical features with the common co-occurring 
bacterial infections leptospirosis and enteric fever [3, 4]. Timely differentiation 
between these specific infections is important as their management differs and 
early interventions may prevent severe illness and death. Close observation 
and judicious use of fluids is important in complicated dengue [5], while early 
antibiotics may be life saving in leptospirosis [6] and enteric fever [7]. In recent 
years, rapid diagnostic tests have been developed for dengue, leptospirosis 
and enteric fever, however, these tests suffer from a limited sensitivity in highly 
endemic regions [8]. Apart from these microbiological tests, a complete blood 
count is also often requested in these patients. In the first place, a complete 
blood count may help to differentiate the different diseases as the white blood 
cell (WBC) count is usually low in dengue [9] and low or normal in enteric fever 
[10] and high or normal in leptospirosis [6, 11]. Secondly, thrombocytopenia 
is commonly found in the three diseases [10, 12, 13], but the prevalence and 
cause of severe thrombocytopenia might be different. Nonetheless, the platelet 
and WBC count cannot distinguish dengue from leptospirosis and enteric fever 
reliably enough to guide clinical decision making [4, 14-16]. 
Recent advances in automated blood cell counting offered new possibilities 
to further analyze leukocyte differential by fluorescence RNA/DNA staining 
combined with scattered light intensity. For instance, Sysmex XE-5000 
hematology analyzers can flag for cells in the atypical lymphocyte (AL) area 
[17], which are lymphocytes suspected for being reactive [18]. Increased 
atypical lymphocyte counts have been observed during dengue as reviewed 
by Chuansumrit et al [19], and may reflect activated lymphocyte populations. 
Additionally, the XE-5000 features the count of high fluorescent lymphocytes 
(HFLC) as a research parameter. Since the fluorescence intensity depends on 
membrane composition as well as nucleic acid content, the HFLC indicates the 
presence of highly activated lymphocytes, such as activated B cells or plasma 
cells [20], which are also present during dengue infection [21]. Furthermore, the 
presence of immature blood cells including immature platelets and immature 
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granulocytes (IG) can be determined at the same time using the new analyzers. 
The immature platelet fraction (IPF) is routinely reported as percentage of the 
total platelet count (%IPF) or for research purpose also as absolute numbers 
(a-IPF), indicating the degree of destruction respectively production of 
platelets [22]. Alterations in %IPF or a-IPF have been reported in bacterial and 
viral infections [23, 24]. In contrast, increments in IG have only been reported in 
bacterial infections and has to the best of our knowledge, has not been studied 
in viral infections, and as such also not in studies comparing viral and bacterial 
infections. The same holds true for AL and HFLC.
The aim of the present study is to explore our hypothesis that the differences 
in the pathophysiology of dengue, leptospirosis and enteric fever may lead to 
different changes of IPF, IG, AL and HFLC in the various diseases. This study 
reports that automated blood cell counting of these hematological parameters 
can help to differentiate between common causes of febrile illnesses with 
thrombocytopenia in dengue endemic areas. 
METHODS
Patients and study design
For this prospective observational study, we included consecutive patients, 
aged 14 years and above who were admitted to Rumah Sakit Hasan Sadikin, 
an academic referral hospital in Bandung, West Java, Indonesia, from March 
2011 to March 2012 with a history of fever and thrombocytopenia (< 150 x109 
cells/L) and with a clinical suspicion of dengue, leptospirosis or enteric fever 
infection. A group of healthy controls was also enrolled. Exclusion criteria 
were presence of a concurrent chronic disease, pregnancy and the inability to 
retrospectively obtain a laboratory confirmation of either dengue, leptospirosis 
or enteric fever. Bandung is a malaria free area and patients were not routinely 
tested for malaria. Demographic, clinical, laboratory and ultrasonography data 
were collected using a standardized data collection form. Ultrasonography 
was daily performed at the bedside of dengue patients to detect plasma 
leakage as a complication of dengue as described before [25]. Hemocytometry 
was performed at the day of study enrolment in all patients by the XE-5000 
hematology analyzer (Sysmex Corporation, Kobe, Japan). In patients suspected 
for dengue, hemocytometry was repeated in the critical and recovery phase 
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of the infection, defined as the period within 48 hours after defervescence 
before platelet counts started to rise and as the period in which platelet counts 
started rising again, respectively. In patients in whom a clinical suspicion for 
one or more of these diseases existed, blood was collected at admission for 
blood cultures for the diagnosis of enteric fever, serology and rapid testing 
for leptospirosis and/or molecular diagnostics and serology for dengue. All 
patients were asked to return for follow up in the convalescent phase 2-4 weeks 
after discharge, which included clinical evaluation and convalescent dengue or 
leptospirosis serology. 
The Study Research Ethics Committee of the Faculty of Medicine of the 
Padjadjaran University, Bandung, Indonesia, approved all legal, ethical, 
radiological aspects of the study. Written informed consent was obtained from 
all patients or from their parents, in case the patient was below 17 years of age. 
All patients provided informed consent.
Laboratory procedures
Hemocytometry was performed on venous blood collected in EDTA vacutainers 
(Becton Dickinson Vacutainers Systems Europe, Meylan, France) and analyzed 
by the XE-5000 automated hematology analyzer. As described in the 
introduction, the XE-5000 can distinguish WBC subpopulations by fluorescence 
flow cytometry and side scatter properties, including ALand HFLC, which are 
reported as absolute numbers or percentages of the total leukocyte count. An 
example of the gates for total lymphocytes, AL and HFLC in a representative 
dengue patient is shown in Fig 1. Furthermore, %IPF and a-IPF are identified 
using a dye containing polymethine and oxazine and a gating system in the 
fluorescent platelet channel to measure intra-cellular RNA contents that is 
found in immature platelets. For IG measurements - reported as percentage 
of total leukocyte count or as absolute numbers -  the membranes of mature 
WBC are first partly lyzed before analyzing light scatter properties and the 
nucleic acid content of the cells in the leukocyte differentiation channel. The 
laboratory confirmation of dengue, leptospirosis and enteric fever diagnosis 
was performed as previously described for this cohort [26].
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Figure 1. Fluorescence flow cytometry of lymphocytes in a dengue patient. Example of fluorescence 
flow cytometry, showing the critical phase (left panel) and the convalescence phase (right panel) in a 
representative dengue patient in this study, made by XE-5000 hematology analyzer. Side fluorescence 
(Y-axis) is plotted against the side scatter (X-axis). Gates 1, 2 + 3 together indicate the total lymphocyte 
count; gate 2 + 3 together the lymphocytes in the atypical lymphocyte area and gate 3 the high 
fluorescence lymphocyte counts. 
Data presentation and statistical analysis
Data are expressed as medians with interquartile ranges (IQR) or as numbers 
with percentages. Non-paired non-parametric data of continuous variables of 
2 groups were compared with Mann-Whitney U test, and more than 2 groups 
were analyzed by Kruskall-Wallis test with Dunn’s multiple comparison’s post-
test. Relationships between non-parametric continuous data were examined 
by Spearman’s correlation. Areas under receiver operating characteristic  curves 
are presented with 95% confidence intervals. A p-value < 0.05 was considered 
significant. All analysis were performed using SPSS (version 18.0) statistical 
program.   
RESULTS
Clinical characteristics
A total number of 93 patients with confirmed dengue, 11 with leptospirosis 
and 6 with blood culture positive enteric fever were enrolled after a median 
(interquartile range) duration of illness of 5 days (4-6 days), 7 days (5-9 days) 
and 9 days (7-15 days), respectively. Fifty-two out of 93 (56%) of the dengue 
patients, 8/11 (72%) of the leptospirosis and 2/6 (33%) of the enteric fever 
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patients were male. According to WHO 2009 guidelines, 78/93 (84%) of the 
dengue patients were classified as non-severe dengue and 15/93 (16%) as 
severe dengue [27]. A total number of 28 healthy controls with a median age 
of 25 years (22-31 years) and of whom 10 (36%) were male, were included as 
controls. 
Increased percentage of cells in the atypical lymphocyte area and increased 
percentage of high fluorescence lymphocyte counts differentiate dengue 
from leptospirosis and enteric fever
The total lymphocyte counts between patients with dengue, leptospirosis 
and enteric fever showed significant overlap (Fig 2A). However, in the dengue 
patients, a high percentage of AL (%AL) and HFLC (%HFLC) were present, while 
this was not the case for leptospirosis and enteric fever (Fig 2B and C). These 
parameters did not correlate with the severity of dengue infection. 
Figure 2. Dengue is associated with increased percentage of cells in the atypical lymphocyte area and 
high fluorescence lymphocyte counts. Total lymphocyte counts were significantly lower in leptospirosis 
(n=11) and enteric fever (n=6) compared to the febrile (n=15), critical (n=82), early recovery (n=80) and 
convalescence phase (n=57) of dengue (total patients n=93) (A), but shared a substantial overlap in 
values. In contrast, the percentage of cells in the atypical lymphocyte flagging area (%AL) (B) and high 
fluorescent lymphocyte counts (%HFLC) (C) were clearly increased during dengue virus infection 
compared to leptospirosis and enteric fever. Healthy control values (n=28) were included as a reference. 
Data are represented as scatter plots. The horizontal lines represent medians and the whiskers 
interquartile ranges. Differences between the diseases leptospirosis, enteric fever and each phase of 
dengue were compared with the Mann- Whitney U test. A p value < 0.05 was considered significant; *** 
denotes p < 0.001; ** p < 0.01 and * p < 0.05.
Immature granulocytes are increased in leptospirosis and immature platelet 
fraction is most increased in dengue.
Patients with leptospirosis had a significantly higher absolute IG count (a-IG) 
and percentage (%IG) than patients with enteric fever or with dengue infection 
39796 Michels, Meta.indd   47 28-03-16   12:38
Chapter 3
48
(Fig 3A and B). The a-IG and %IG values in the latter groups were similar to 
values in the control group.   
The %IPF was increased in all three patient groups compared to the controls, 
indicating increased platelet destruction (Fig 4A). The highest %IPF was found 
in the dengue patients, who also had the lowest platelet counts. There was 
an inverse correlation of platelet counts with the %IPF in the dengue patients 
(R
s
 = -0.69 p < 0.001), but not in the leptospirosis group (R
s
 = -0.06 p = 0.87) 
at admission (data not shown).  The a-IPF count was similar in the admission 
samples across the patients groups (Fig 4B). In dengue patients, the a-IPF 
increased in the recovery and convalescence phases of the illness, when 
platelet counts started to recover (Fig 4B and C).
Figure 3. Leptospirosis is characterized by increased count and percentage of immature granulocytes. 
The immature granulocyte count (a-IG) is increased in leptospirosis (n=11), compared to enteric fever 
(n=6) and to the different phases of dengue virus infection (total patients n=93; febrile n=15; critical 
n=82; early recovery n=80; convalescence phase n=57) (A). Also the %IG in leptospirosis was significantly 
increased compared to enteric fever and dengue virus infection (B).  Healthy control values (n=28) were 
included as a reference. Data are represented as scatter plots. The horizontal lines represent medians 
and the whiskers interquartile ranges. Differences between the diseases leptospirosis, enteric fever and 
each phase of dengue were compared with the Mann- Whitney U test.  A p value < 0.05 was considered 
significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
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3Figure 4. The percentage immature platelets is most increased during dengue infection, while absolute immature platelet counts are similar in leptospirosis, enteric fever and acute dengue phases. The 
percentage of immature platelets (%IPF) were most increased during the critical (n= 82) and early 
recovery phase (n=80) of dengue as compared to leptospirosis (n=11) indicating that a higher 
proportion of circulating platelets consisted of young platelets during dengue (A). The absolute IPF 
count (a-IPF) was similar in the admission samples across the patients groups (Figure 4 B). Total platelet 
counts were decreased in all patient groups (C). Data are represented as scatter plots. Healthy control 
values (n=28) were included as a reference. The horizontal lines represent medians and the whiskers 
interquartile ranges. Differences between leptospirosis, enteric fever and each phase of dengue were 
compared with the Mann- Whitney U test. A p value < 0.05 was considered significant; *** denotes p < 
0.001; ** p < 0.01 and * p < 0.05.
Receiver operating characteristic curves. 
The diagnostic value of %AL, %HFLC, %IG and %IPF for differentiating dengue 
and leptospirosis were further studied using ROC curves. ROC analysis was not 
performed for enteric fever due to the small sample size. Only data from the 
first sampling at admission were used. The %AL and %HFLC had an area under 
the curve (AUC) of 0.87 (95% confidence interval [CI] 0.70-1.03) and 0.89 (0.78-
0.99), respectively, for distinguishing dengue from leptospirosis.  The AUC of 
the a-IG was 0.86 (0.71-1.02) and the AUC of the %IG was 0.77 (0.57 – 0.96). The 
%IPF had a higher area under the curve (AUC) of 0.81 (95% confidence interval 
[CI] 0.65 – 0.97) than the platelet count (AUC 0.71; 95% CI 0.49 – 0.93) and a-IPF 
numbers (AUC 0.61; 0.36-0.86). 
DISCUSSION
Our findings indicate that new fluorescence flow cytometry based 
hematological parameters determined by automated hematology analyzers 
such as XE-5000 can help to differentiate dengue from leptospirosis and 
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enteric fever in patients with undifferentiated fever and thrombocytopenia. 
Patients with dengue were characterized by the most pronounced increase of 
the percentage of cells in the atypical lymphocyte flagging area (%AL) and in 
the high fluorescent lymphocyte count (%HFLC) area, while only the patients 
with leptospirosis had increased absolute numbers (a-IG) and percentage 
(%IG) of immature granulocytes. Our findings suggest that low %AL, %HFLC 
and %IG support a diagnosis of enteric fever. However, the group of patients 
with blood culture proven enteric fever was too small to draw any firm 
conclusions. Whether these differences will also be present in clinical practice, 
in which enteric fever diagnosis is often not confirmed at the time of clinical 
decision making, remains to be investigated. The same holds true for the ROC 
data showing the discriminating value between dengue and leptospirosis of 
the different parameters.
The presence of metamyelocytes, myelocytes and promyelocytes , as suggested 
by the increased a-IG, was limited to leptospirosis patients and could not be 
found in dengue and enteric fever. Indeed, an increased number of IG is widely 
thought to be indicative for bacterial infections and even has been reported 
as a useful parameter to predict the presence of a bacterial infection or sepsis, 
although their presence in the form of band cells in the peripheral blood smear 
of young children with viral infections have been documented as well [28]. It 
should be noted however that young granulocytes in the form of band cells are 
excluded from the IG count. To the best of our knowledge, our study is the first 
to indicate that IG may be a useful parameter to distinguish certain bacterial 
and viral infections. 
Increased numbers of atypical lymphocytes and B lymphocytes have also been 
reported before in dengue infection by blood smears of isolated peripheral 
blood cells and several flow cytometry studies [29-31]. Similar changes have 
been found in other viral infections [32], while data in bacterial infections, apart 
from mycobacteria, are more scant.  However, the presence of lymphocytosis 
and atypical lymphocytes has indeed been demonstrated to be more prevalent 
in viral than bacterial infections [33]. Few data are also available concerning 
lymphocyte subsets in leptospirosis. Leptospirosis has been associated 
with normal total lymphocytes counts, decreased T- lymphocyte counts and 
increased B-lymphocyte counts [34]. Atypical lymphocytes were found by flow 
cytometry in 15/27 patients with leptospirosis [35]. Our data indicate indeed 
that %AL and %HFLC are increased in all three diseases, but most markedly in 
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dengue. Most data concerning lymphocyte subsets in enteric fever are derived 
from vaccination trials instead of natural infection [36]. 
Thrombocytopenia is common in dengue [12], leptospirosis [13] and enteric 
fever [10] and was an inclusion criteria of the present study. We found that 
the %IPF was increased in the three diseases compared to controls, indicating 
platelet consumption/ destruction. The %IPF was highest however in dengue. 
A-IPF was not clearly increased in the admission samples and suggested 
relatively impaired thrombopoiesis, although clearance of immature platelets 
cannot be excluded and could underestimate thrombopoiesis. 
To our knowledge, this study is the first to report the automated hematology 
parameters AL, HFLC, and IG to help differentiating between dengue, 
leptospirosis and enteric fever. The use of hemocytometry as a diagnostic aid 
has obvious advantages, of which the direct availability of results is probably 
the most important to timely initiate appropriate treatment.  Dengue is a viral 
infection requiring adequate fluid administration to prevent shock, while the 
bacterial infections leptospirosis and enteric fever need to be treated promptly 
by antibiotics and early differentiation between these diseases is still difficult. 
We found no association between any of these new hematology parameters 
and the severity of dengue infection.
Our study has several limitations. First, patients came relatively late to our 
referral hospital and no  data from the first days of illness were therefore 
available. Second, the group of patients with proven, i.e. blood culture positive, 
enteric fever was small. Blood cultures have only a moderate sensitivity in 
enteric fever and this was further reduced by the fact that patients frequently 
presented late in illness and were already treated with antibiotics. Third, the 
value of these new hematological parameters to distinguish dengue form 
leptospirosis and enteric fever need to be validated in other areas where the 
incidence of these infections and other infections, such as malaria, may be 
different. Furthermore, confirmation of these findings in a larger study that 
includes the development of an algorithm how to use the various parameters 
and determining the optimal cut-off point is recommended.
In conclusion, cells in the atypical lymphocyte flagging area, the high 
fluorescence lymphocyte count, immature platelets and immature granulocytes 
are new hematological parameters that may help to differentiate between 
common causes of febrile illnesses with thrombocytopenia in dengue endemic 
areas. 
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SUMMARY
Severe dengue is characterized by thrombocytopenia, plasma leakage and 
bleeding. Platelets are important for preservation of endothelial integrity. 
We hypothesized that platelet activation with secondary platelet dysfunction 
contribute to plasma leakage. In adult Indonesian patients with acute dengue, 
we measured platelet activation status and the response to the platelet agonist 
TRAP using flow cytometer-based assays. Patients were monitored daily 
for plasma leakage by ultrasonography. Acute dengue was associated with 
platelet activation with an increased expression of the activated fibrinogen 
receptor (αIIbβ3), the lysosomal marker CD63 and the alpha-granule marker 
CD62P (P-selectin). Upon maximal platelet activation by TRAP, platelet function 
defects were observed with a significantly reduced maximal activated α
IIb
β
3
 
and CD63 expression and reduced platelet-monocyte and platelet-neutrophil 
complexes. Patients in the lowest tertile of activated α
IIb
β
3 
and CD63 expression 
had an odds ratio for plasma leakage of 5.2 (95% CI 1.3-22.7) and 3.9 (95% CI 1.1-
13.7), respectively, compared to the highest tertile. Platelet-derived serotonin 
has previously been related to plasma leakage and we found increased intra-
platelet serotonin concentrations in our patients. In conclusion, platelet 
activation with platelet function alterations can be found in patients with acute 
dengue and this may contribute to dengue-associated plasma leakage.
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INTRODUCTION
Dengue has become the most important arthropod-borne viral infection in 
the world [1]. Severe dengue is characterized by thrombocytopenia, vascular 
leakage and hemorrhage. The pathogenic mechanisms underlying these 
complications, which typically occur during or shortly after defervescence 
and are not associated with morphological endothelial damage, are still 
incompletely understood [2-4]. In recent years, the role of platelets in regulating 
endothelial integrity and dengue-associated plasma leakage has gained 
increased interest [5-9]. 
Sufficient numbers of functional platelets are required for preservation of 
endothelial integrity during inflammation [10]. The observation that petechiae 
and bleeding complications in dengue patients frequently occur with platelet 
counts well above the threshold for spontaneous bleeding, suggests that 
dengue is not only associated with thrombocytopenia, but also with functional 
platelet defects. Studies using platelet aggregometry indeed showed reduced 
aggregation in dengue patients [11-13], but because the reliability of 
aggregometry is compromised in conditions with thrombocytopenia, these 
findings should be interpreted with caution. We have developed a novel flow 
cytometer-based platelet function test using anti-coagulated unprocessed 
blood that is well suited for use in thrombocytopenia [14]. In this test, expression 
of the alpha-granule marker CD62 (P-selectin), the lysosomal marker CD63 and 
binding of the monoclonal antibody PAC-1 to the activated αIIBβ3 (the GPIIbIIIa 
complex, CD41/ CD61) receptors are used as markers for platelet activation [15-
17]. Reduced expression of these markers upon addition of a platelet agonist 
suggests the presence of thrombocytopathy [18]. Activated platelets form 
complexes with monocytes and neutrophils by binding of platelet CD62P to 
its counter-ligand on leukocytes, P-selectin  glycoprotein ligand-1 (PSGL-1) 
[19]. These complexes can also be quantified using flow cytometry and it has 
frequently been used as a sensitive marker of platelet activation.  
The hypothesis which formed the basis of this study was that dengue is not 
only associated with thrombocytopenia, but also with functional platelets 
alterations due to excessive platelet activation and that these functional 
alterations are associated with plasma leakage. We therefore determined 
platelet activation status, platelet-monocyte (PMC) and platelet-neutrophil 
complexes (PNC) and the functional response to platelet stimulation by a 
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platelet agonist in adult Indonesian patients with dengue. In addition, we 
determined soluble platelet activation markers as a measure of recent platelet 
degranulation and intra-platelet serotonin concentrations. Plasma leakage 
in dengue occurs at predilection locations and can be easily detected by 
ultrasonography as gallbladder wall edema, ascites and/ or pleural effusion. We 
compared results of the platelets assays with daily ultrasonography as previous 
reported [20].
METHODS
Patients and study design
This study was performed from March 2011 – March 2012 in Hasan Sadikin 
General Hospital, an academic referral hospital in Bandung, Indonesia. Febrile 
patients clinically suspected for dengue infection were eligible for inclusion in 
the study. Patients with chronic diseases, use of platelet function inhibitors and 
pregnant patients were excluded. Patients were systematically followed by daily 
history, physical examination, laboratory tests and by daily ultrasonography 
for detection of plasma leakage. Special attention was paid to bleeding 
manifestations. Demographic, clinical, laboratory and ultrasonography data 
were collected using a standardized data collection form. Blood was drawn 
at admission and in each clinical phase of dengue infection: the febrile phase 
(temperature of 37.5oC or higher), the critical phase (period within 48 hours 
after defervescence when complications usually occur and before platelet 
counts start to recover), early recovery phase (recovering platelet counts 
together with clinical improvement) and convalescence phase (> 2 weeks after 
discharge). Plasma leakage was defined as an increase in hematocrit of ≥ 20%, 
a single high hematocrit value (> 50% for men and > 44 % for women), and/or 
by plasma leakage in the form of ascites and/or pleural effusion detected by 
ultrasonography, according to WHO guidelines [21]. A thickened gall bladder 
wall was not used as a criteria for plasma leakage. Handheld ultrasonography 
were performed by three study physicians who had received a 4-week 
training to examine patients for presence of ascites, pleural effusion and 
measurement of gallbladder wall thickness. All all images were daily reviewed 
by the coordinating physician. Results of the handheld ultrasonography 
were also compared with results obtained by conventional ultrasonography 
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performed by a trained radiologist. Details on the methods and findings of the 
ultrasonography in our cohort have previously been reported. Patients were 
retrospectively classified as non-severe or severe dengue according to the 
2009 WHO guidelines [21]. A group of healthy volunteers was recruited among 
hospital staff to serve as controls. None of the controls had had fever or other 
complaints in the past two weeks and all had a normal complete blood count. 
The study was approved by the local Medical Ethical Committee of the Medical 
Faculty of Padjadjaran University, Hasan Sadikin General Hospital and written 
informed consent was obtained before enrolment from all patients and healthy 
controls.
Laboratory diagnosis
Samples of clinically dengue suspected cases were tested for the presence 
of viral RNA by reverse-transcriptase PCR and for dengue specific IgM and 
IgG (Panbio, Windsor, Australia). A proven dengue infection was defined as a 
positive RT-PCR result, a ≥ 4-fold increase in dengue IgG titre and/or IgM or 
IgG seroconversion. Patients with a positive IgM titre in at least one sample 
and/or IgG levels comparable to a HI titre of at least 1:2560 (the IgG cut off 
point set by the manufacturer to detect secondary infection) were diagnosed 
with acute dengue infection. The remaining patients with clinically suspected 
dengue who failed to fulfil the diagnostic laboratory criteria outlined above 
were excluded.
Flow cytometer-based platelet activation and platelet function assays
Venous blood was collected using a 21-gauge needle in 3.2% citrate anti-
coagulated vacutainers (BD Biosciences) after a light tourniquet application, 
which was released as soon as a good blood flow was established. The first 
2 mL of blood were used for other purposes. The blood was kept at room 
temperature and processed immediately. 
For the platelet activation assay, 5 µL whole blood was added to a mixture 
of monoclonal antibodies (MoAb), fixed after 20 minutes incubation with 0.2 
% formyl saline (0.2 % formaldehyde in 0.9 % NaCl) and analyzed within 3 
hours on a Guava® EasyCyteTM 6-2L flow cytometer (Merck KGaA, Darmstadt, 
Germany). The following MoAb were used: fluorescein isothiocyanate (FITC)-
labelled or phycoerythrin (PE)-labelled anti-CD42b (anti-GP1b, a platelet 
identification marker abundantly present on platelets), PE-labelled anti-CD62P 
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(anti-P-selectin, an alpha granule marker), allophycocyanin (APC)-labelled anti-
CD63 (dense-body/ lysosomal marker; all from Biolegend, San Diego, USA), and 
FITC-labelled PAC-1 MoAb which recognize the activated fibrinogen binding 
conformation of α
IIB
β
3
 (BD Biosciences, Franklin Lakes, NJ, USA). Platelets were 
gated based on their forward- and sideward-scatter (FSC/SSC) properties and 
positivity for CD42b. CD42b positivity was defined as a mean fluorescence 
intensity (MFI) exceeding the MFI of the matched isotype control.  Next, all 
CD42b positive events were gated for the platelet activation markers CD62P, 
CD63 and activated α
IIB
β
3
. 
Platelet-monocyte complexes (PMC) and platelet-neutrophil complexes (PNC) 
were measured by incubating 50 µL of citrate anti-coagulated whole blood 
with anti-CD14 and with anti-CD42b MoAb (both Biolegend, San Diego, USA) 
for 15 minutes. Erythrocytes were lyzed using lyzing solution (OptiLyse B, 
Beckman Coulter, France). Monocytes and neutrophils were identified based 
on their FSC/SSC and CD14 staining as has been described before [22]. PMC and 
PNC were determined by using the proportion of monocytes and neutrophils, 
respectively, which were positive for the platelet identification marker CD42b.
Platelet responsiveness to stimulation by the PAR-1 agonist thrombin receptor 
activating peptide (TRAP) (Bachem, Bubendorf, Switzerland) and the formation 
of PMC and PNC were measured after 20 minutes of incubation with 625 µM of 
TRAP before fixation. In addition, a dose response curve using 8 serial dilutions 
of TRAP, ranging from 0.038 to 625 µM, was made using CD62P as readout for 
platelet activation. 
Soluble platelet activation markers
Concentrations of the soluble platelet activation markers platelet factor 4 
(PF4), P-selectin (sCD62P) and RANTES were determined in plasma derived 
from venous blood collected in CTAD tubes (BD Biosciences). These tubes 
contain citrate and the platelet stabilizing agents theophylline, adenosine 
and dipyridamole, preventing in vitro platelet activation. Plasma was obtained 
by centrifugation the tubes at 1700g for 15 minutes followed by immediate 
storage at -80oC until further analysis. Concentrations of the platelet activation 
markers were measured using a semi-automated ELISA on a TECAN Freedom 
Evo robot in the Department of Clinical Chemistry and Hematology of the 
University Medical Center Utrecht as described in detail earlier [23].
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Intra-platelet and plasma serotonin levels
Blood was drawn into CTAD containing vacutainers and centrifuged at 150g for 
10 minutes without brake to obtain platelet rich plasma which was pipetted 
off and further processed by centrifuging at 1350g for 15 minutes to a platelet 
pellet with a known number of platelets. This platelet pellet was subsequently 
resuspended and lyzed by perchloric acid. Platelet poor plasma was obtained 
from the sample that remained after pipetting off the platelet rich plasma, 
by centrifuging at 1700g for 15 minutes. Lyzed platelet pellets and platelet 
poor plasma were stored at -80oC until analysis. Plasma serotonin levels were 
determined by commercially available ELISA (Genway Biotec, San Diego, USA), 
which had a lower detection limit of 0.3 ng/mL, according the manufacturer’s 
instructions. Intra-platelet serotonin levels were determined in the supernatant 
of the platelet pellets, which was obtained after centrifuging the thawed 
samples for 10 minutes at 2000g. The supernatant was aspired and hydrochloric 
acid was added before reading the fluorescence of serotonin after exciting at 
310 nm and registering at 510 nm by a Fluorescence Spectrophotometer (F-
7000, Hitachi High Technologies, USA). 
Data presentation and statistical analysis
Data are expressed as medians with interquartile ranges (IQR) or numbers with 
percentages, unless otherwise specified. Differences in non-continuous data 
of 2 groups were analyzed by Pearson’s Chi-square test or by Fisher’s exact 
test in case of expected counts less than five. Continuous variables between 
2 groups were analyzed by unpaired t-test in case of normally distributed 
data and by Mann Whitney U test in case of non-parametric data. Continuous 
variables with repeated measurements in the different phases of dengue 
infection were analyzed by a linear mixed model with repeated measurements 
after log transformation in case of non-parametric data. Relationships between 
continuous data were examined by Spearman’s correlation for non-parametric 
data. TRAP-CD62P expression dose-response graphs were produced with 
Prism 5.02 software (Graphpad Software, La Jolla, CA, USA). A p-value < 0.05 
was considered significant. All analysis were performed using SPSS (version 
18.0).  Binding of PAC-1 was considered the primary outcome. Assuming that 
an increase in PAC-1 positive platelets from 25% in the convalescent phase to 
50% in the critical phase of dengue would be relevant, a total number of 74 
patients had to be included. 
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RESULTS
Clinical characteristics and baseline data
A total number of 77 patients with a dengue infection and 30 healthy controls 
were included. Demographics and clinical and laboratory characteristics at 
baseline are summarized in table 1. Twenty nine (38%) of the dengue patients 
had a positive RT-PCR with DENV-2 being the most common serotype (n=13), 
followed by DENV-3 (n=7), DENV-1 (n=5) and DENV-4 (n=4). The 48/77 (62%) 
PCR negative patients in this study were included based on a positive dengue-
specific serology.  Most patients were admitted in the critical phase around 
defervescence (n=62; 81%), the others in the febrile (n=11; 14%) or the early 
recovery phase (n=4; 5%). Based on serology results, 58 (75%) had a secondary 
infection (n=58; 75%), two (3%) a primary infection and the remainder was 
inconclusive. Thrombocytopenia (platelet count < 150 * 109/L) was present in 
all dengue patients at enrolment with a median platelet count of 44 * 109/L. 
Seventy five percent of patients had some form of bleeding manifestation, of 
which skin and gingival bleeding and epistaxis were the most common. Plasma 
leakage was confirmed in 39 (51%) of patients during hospitalization. Ascites 
and/or pleural effusion were demonstrated by ultrasonography in 18/74 (24%) 
patients at enrolment and developed in an additional 15/77 (19%) patients. 
In the remaining six patients, the diagnosis of plasma leakage was based on 
their hematocrit values, which is defined by WHO criteria [21] as a significant 
hematocrit change (minimal 20%) and/or single high hematocrit values (> 50 
and > 44 % for men and women respectively) . Thickening of the gallbladder 
wall is a common event in dengue, 
which is also thought to result from plasma leakage [24]. Thickening of the 
gallbladder wall to more than 0.5 cm was found in 15 patients (20%) during 
hospitalization. All patients were discharged from hospital in good health. 
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Table 1. Characteristics of dengue patients and healthy controls. 
 
 
Dengue Healthy controls
n = 77 n= 30
Age; years                           23 (19-32) 25 (24-31)
Male sex;  n (%) 41 (53) 11 (37)
Duration of illness; days 5 (4-6) -
Plasma leakage at enrolment; n (%) 18 (24) -
        Ascites; n (%) 17 (23) -
        Pleural effusion; n (%) 6 (8) -
Plasma leakage during study; n (%) 39 (51) -
        Ascites or pleural effusion; n (%) 33 (43) -
        Hematocrit criteria for plasma leakage ; n (%) 21 (27) -
Bleeding manifestations at enrolment; n (%) 58 (75) -
        Spontaneous petechiae; n (%) 25 (33) -
        Tourniquet test positive; n (%)¹⁶ 44 (72) -
        Hematoma after venapuncture; n (%) 8 (10) -
        Ecchymosis; n (%) 2 (3) -
        Gingival bleeding; n (%) 11 (14) -
        Epistaxis; n (%) 17 (22) -
        Vaginal bleeding; n (%) 2 (3) -
        Hematemesis; n (%) 1 (1) -
        Melena; n (%) 0 (0) -
Systolic blood pressure; mmHg 110 (100-113) -
Diastolic blood pressure; mmHg 70 (60-80) -
Pulse pressure; mmHg 40 (30-40) -
Pulse rate; per minute 80 (74-88) -
Respiratory rate; per minute 20 (20-24) -
Temperature; oC 36.4 (35.8-37.2) -
Hemoglobin; g/dL 14.3 (13.0-15.7) 13.8 (12.3-15.5)
Hematocrit; % 42.0 (39.0-45.0) 41.2 (37.7-45.7)
Platelet count; * 10⁹/L 44 (24-68)*** 289 (249-317)
Platelet count < 150 * 10⁹/L; n (%) 77 (100)*** 0 (0)
Leukocyte count; * 10³/mL 3.8 (2.9-4,8)*** 7.6 (6.8-10.2)
Albumin; g/dL 3.7 (3.5-3.9) -
The first day of fever was defined as the first day of illness. Data are presented as medians (interquartile 
range) or numbers (n) with percentage (%).  Mann-Whitney U tests or Chi-Square tests were performed 
whenever appropriate. A  p-value < 0.05 was considered significant and was indicated as *** (p<0.001); 
** (p<0.01); or * (p<0.05).
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Dengue is associated with platelet function alterations.
The course of platelet number and platelet activation markers is shown in figure 
1 and 2A, respectively. The most striking finding was a strong increase in the 
binding of PAC-1 antibodies, indicating that the integrin α
IIB
β
3
 had undergone 
a conformational change to a fibrinogen binding state. The median expression 
of CD63 and CD62P, signifying degranulation of lysosomes and α-granules 
respectively, were also significantly higher in the dengue patients. 
Subsequently, the capacity of platelets to be maximally activated was tested 
by adding a high concentration of the platelet agonist TRAP. Platelets of 
patients in the febrile and critical phase of dengue had a reduced expression 
of activated α
IIb
β
3 
and
 
CD63, implying a reduced hemostatic function (figure 
2B). In some patients, CD63 expression to high dose TRAP remained low up 
to the convalescent phase, while expression of CD62P and activated α
IIb
β
3
 had 
recovered. The difference in CD62P expression between groups after high dose 
TRAP was only modest, but a clear difference in the dose-response curve with a 
downward and vertical shift of the curve, suggesting impaired CD62P secretion 
from α-granules, was seen in the dengue patients when eight concentrations 
of TRAP were used (figure 3). 
Figure 1. Course of platelet counts during dengue. Platelet counts were determined in dengue patients 
(n=77) and in healthy controls (n=30). The boxes indicate the median and interquartile ranges and the 
whiskers indicate 10th to 90th percentile. Differences between each phase of dengue were compared 
to healthy controls values with the Mann- Whitney U test. A p value < 0.05 was considered significant; 
*** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
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Figure 2. Dengue is associated with baseline platelet activation and a decreased expression of platelet 
activation markers after TRAP-stimulation.
The binding of the platelet activation markers was determined in citrate anti-coagulated whole blood 
by flow cytometry before and after addition of the PAR-1 agonist thrombin receptor activating peptide 
(TRAP) in patients with dengue infection (n=77) and in healthy controls (n=30). The proportion of 
platelets positive for the platelet activation markers PAC-1, CD63 and P-selectin (CD62P) was increased 
during dengue (A), while expression of these markers was decreased upon incubation with a high 
concentration of TRAP (B). Expression of PAC-1, CD63P and CD62P indicate platelet activation with a 
conformational change of activated α
IIb
β
3
 to a fibrinogen binding state, degranulation of α-granules 
and degranulation of lysosomes and dense granules, respectively. The boxes indicate the median and 
interquartile ranges and the whiskers indicate 10th to 90th percentile. Differences between each phase 
of dengue were compared to healthy controls values with the Mann- Whitney U test. A p value < 0.05 
was considered significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
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Figure 3. P-selectin expression is decreased at sub-maximal TRAP stimulation during dengue. The dose-
response curve of platelets expressing the platelet activation markers P-selectin (CD62P) after 
stimulation with 8 serial dilution ranging from 0.038 to 625 µM of the PAR-1 agonist thrombin receptor 
activating peptide (TRAP) was assessed in dengue patients (n=77) and in healthy controls (n=30) in 
citrate anti-coagulated whole blood by flow cytometry. Data are presented as medians of the TRAP 
dose-response curves for each group. Differences in CD62P expression at each dilution between each 
phase of dengue were compared to healthy controls values with the Mann- Whitney U test. A p value < 
0.05 was considered significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05. In addition, CD62P 
levels for each TRAP dose were compared to dengue convalescence levels, by a mixed linear model 
analysis for repeated measurements; + denotes p < 0.05.
Functional platelet defects are associated with plasma leakage.  
Patients who developed plasma leakage had a significantly lower expression 
of activated α
IIb
β
3 
and CD63 in TRAP-stimulated samples at enrolment 
compared to patients without plasma leakage (figure 4). When these results 
were stratified in tertiles, the patients in the lowest tertile of activated α
IIb
β
3 
and CD63 expression had an odds ratio for plasma leakage of 5.2 (95% CI 1.3-
22.7) and 3.9 (95% CI 1.1-13.7) compared to the highest tertile, respectively. 
Thickening of the gallbladder wall was also associated with a reduced activated 
α
IIb
β
3
 expression upon TRAP stimulation (Figure 4). There was no association 
between either plasma leakage or gallbladder wall thickening and CD62P 
expression in TRAP-stimulated samples, nor with the expression of activated 
α
IIb
β
3, 
CD63 and CD62P in baseline samples. Bleeding manifestations were also 
not associated with expression of these platelet markers in non-stimulated 
and TRAP-stimulated samples (data not shown). Finally, patients with plasma 
leakage had significantly lower platelet counts with median value of 28 *109/L 
(16-51 *109/L) versus 63 *109/L (40-83 *109/L).
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Figure 4. Platelet dysfunction is associated with plasma leakage and gallbladder wall thickening during 
dengue. The percentage of platelets showing PAC-1 binding and CD63P expression after stimulation 
with 625 µM of the PAR-1 agonist thrombin receptor activating peptide (TRAP) is lower in dengue 
patients with (n=39) plasma leakage than in dengue patients without (n=38) plasma leakage. The PAC-1 
expression was also lower in patients with a maximal gallbladder wall thickness (GBWT) of more than 
0.50 cm (n=15) compared to a maximal GBWT of less than 0.50 cm (n=39) during the study. Activation 
markers were determined in citrate anti-coagulated whole blood by flow cytometry. The boxes indicate 
the median and interquartile ranges and the whiskers indicate 10th to 90th percentile. Differences 
between each phase of dengue were compared to healthy controls values with the Mann- Whitney U 
test. A p value < 0.05 was considered significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05. 
Reduced PMC and PNC in plasma leakage.
In dengue patients, the proportion PMC and PNC were decreased at baseline 
(Figure 5A) and after stimulation with TRAP (figure 5B). This decrease was 
especially outspoken in those with plasma leakage, in whom PMC and PNC at 
enrolment were significantly lower at baseline and in TRAP-stimulated samples 
compared to those without plasma leakage. 
 
Figure 5. Decreased platelet monocyte and platelet neutrophil complexes during dengue are associated 
with plasma leakage. Platelet-monocyte (PMC) and platelet-neutrophil complexes (PNC) were 
determined in baseline (A) and TRAP stimulated (B) citrate anti-coagulated whole blood of dengue 
patients (n=77) and healthy controls (n=30) as the % of CD42b positive cells within de monocyte and 
neutrophil population respectively. Enrolment PMC and PNC values were lower for patients with plasma 
leakage (n=39) than for patients without plasma leakage (n=38). The boxes indicate the median and 
interquartile ranges and the whiskers indicate 10th to 90th percentile. Differences between each phase 
of dengue were compared to healthy controls values and differences between patients with and 
without plasma leakage were determined by the Mann- Whitney U test. A p value < 0.05 was considered 
significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
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Concentrations of soluble platelet markers. 
We found that serotonin concentrations within platelets were higher in platelets 
from dengue patients (figure 6). This was not associated with a detectable 
increase in plasma serotonin concentrations, as 70% (n=39/56) of the tested 
dengue samples and 100% (n=15/15) of the control plasma samples had levels 
below the detection limit of the assay (data not shown). Intra-platelet serotonin 
concentrations correlated inversely with platelet number in the critical phase 
of dengue (R
s
= - 0.75; p<0.0001). Intra-platelet serotonin levels were not 
significantly different between patients with and without plasma leakage with 
median values of 5824 nmol/ 1011 platelets (4373-9850) versus 4795 nmol/ 1011 
platelets, (3903-5484 nmol/ 1011 platelets), respectively (p = 0.07). 
Figure 6. Intra-platelet serotonin levels are increased during dengue. Intra-platelet serotonin levels 
were determined in dengue patients (n=46) and in healthy controls (n=12). The boxes indicate the 
median and interquartile ranges and the whiskers indicate 10 to 90 percentile. Differences between 
each phase of dengue were compared to healthy controls values with the Mann- Whitney U test. A p 
value < 0.05 was considered significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
The soluble platelet activation markers soluble CD62P (sCD62P), PF4 
and RANTES were subsequently measured to determine recent platelet 
degranulation (figure 7). Plasma levels of sCD62P were lowest in the febrile 
and critical phases of dengue and recovered in the convalescent phase. In 
contrast, levels of PF4 and RANTES were high in the febrile phase of dengue 
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but relatively stable in the further course of the infection. None of these soluble 
markers were different significantly between patient with and patients without 
plasma leakage (data not shown). 
Figure 7. Course of soluble platelet activation markers during dengue. Citrate, theophylline, adenosine 
and dipyridamole (CTAD) anti-coagulated plasma levels of soluble P-selectin (sCD62P), platelet factor 4 
(PF4), and Regulated on Activation, Normal T cell Expressed and Secreted (RANTES) which are present in 
and released from platelet α-granules upon activation, were collected in dengue patients (n=77) and in 
healthy controls (n=30). Levels of sCD62P and PF4 were decreased during the critical phase of dengue, 
whereas RANTES levels remained unchanged. The boxes indicate the median and interquartile ranges 
and the whiskers indicate 10th to 90th percentile. Differences between each phase of dengue were 
compared to healthy controls values with the Mann- Whitney U test. A p value < 0.05 was considered 
significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
DISCUSSION
Our study shows that dengue is associated with platelet activation and multiple 
platelet function alterations, of which the reduced expression of the activated 
fibrinogen receptor (α
IIb
β
3
) and the lysosomal marker CD63 following TRAP 
stimulation were the most striking. These platelet function defects correlated 
with plasma leakage, which is a cardinal feature of severe dengue. The 
pathogenesis of plasma leakage in dengue is multifactorial, but inflammatory 
cytokines are thought to play an important role. Increasing evidence supports 
the notion that sufficient numbers of functioning platelets are required to 
maintain vascular integrity during inflammation [5, 6, 10]. Platelets have a 
dual role in endothelial integrity and can have both vascular protective and 
permeability-enhancing effects. Different mechanisms may therefore have 
contributed to the correlation between platelet function alterations and plasma 
leakage in our study. First, platelet granules contain multiple vasculoprotective 
proteins, including angiopoietin-1 and sphingosine-1 phosphate. The reduced 
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expression of CD63 and CD62P following TRAP stimulation and the lower plasma 
concentrations of soluble platelet granule proteins suggests that platelets in 
our patients were degranulated and in a sort of ‘exhausted’ state. This may result 
in a local shortage of such vascular protective proteins as we have previously 
shown for angiopoietin-1 [8]. Second, release of CD62P from platelet granules 
and the change in the conformation in α
IIb
β
3 
allowing fibrinogen to bind are 
critical steps in thrombus formation [25-28]. Platelet function defects may 
impair platelet adhesion and aggregation on inflamed endothelium, promoting 
inflammatory bleeding. Infusion of thrombin-degranulated platelets indeed 
did not prevent intra-tumour bleeding in thrombocytopenic mice in contrast 
to normal resting platelets [29]. Moreover, mice lacking integrin β
3 
were prone 
for severe bleeding during infection with lymphocytic choriomeningitis virus 
[30]. Third, platelet activation itself may promote vascular leakage by local 
release of pro-permeability mediators, such as serotonin and VEGF. Platelets are 
the most important vehicle for serotonin in the blood and uptake of serotonin 
by platelets through their serotonin transporter (SERT) [31] was a prerequisite 
for the enhancement of microvascular permeability in a murine experimental 
inflammatory arthritis model, while either pharmacologic blockage of SERT 
or the use of SERT-deficient mice reduced leakage [32]. Platelet serotonin 
concentrations were increased in our study patients, which may have been 
due to the effects of thrombocytopenia itself and the upregulation of SERT, 
as has been described previously in association with activation of the αIIbβ3 
integrin [33]. Fourth, DENV-induced platelet activation may promote leakage 
by activation of the NLRP3 inflammasome inside platelets leading to shedding 
of IL-β rich micro particles, as recently shown by Hottz et al. [9]. Finally, 
platelets interact with inflammatory cells and endothelial cells and as such 
promote immune responses and leukocyte infiltration in inflamed tissues [34, 
35]. Multiple platelet receptors are involved in platelet leukocyte interaction 
and leukocyte infiltration, including CD62P, GP1b and α
IIb
β
3 
[36, 37]. Platelet 
activation is likely to enhance infiltration of inflammatory cells, while platelet 
dysfunction may eventually impair clearing of DENV.  
Bleeding in dengue usually manifests as skin bleeding, epistaxis and mucosal 
bleeding [38, 39]. The majority of dengue patients in our study had some 
manifestation of hemorrhagic tendency, but clinically important bleeding 
was rare. This may explain the absence of an association between the degree 
of platelet hypo-responsiveness and bleeding complications in our study. In 
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other studies, similar platelet function defects such as reduced expression of 
activated α
IIb
β
3 
and CD62P were associated with a higher bleeding risk in ITP 
[40] and in acute myeloid leukaemia [41]. Pharmacological inhibition of α
IIb
β
3 
by 
drugs such as abciximab are also associated with an increased risk for bleeding 
and CD62P deficient mice have a prolonged bleeding time [42]. 
Our findings are in line with the few studies which have reported data on 
platelet activation and function in dengue [11-13]. These studies used platelet 
aggregometry which is a less reliable method in thrombocytopenia. Reduced 
aggregation was found in these studies, which is explained by the finding 
of reduced expression of activated α
IIb
β
3 
in our study since this receptor is 
critical for platelet aggregation. Hottz et al.  recently reported increased 
CD62P expression in isolated platelets of dengue patients [43] supporting our 
observations of platelet activation in dengue. None of these studies, however, 
related platelet dysfunction to plasma leakage. 
The finding that PMC and PNC were lower in dengue was unexpected and is in 
contrast to findings by Tsai et al. [44] and Onlamoon et al. [45] who found an 
increase in platelet-leukocyte aggregates in humans and macaques infected 
with dengue, respectively. One possible explanation is that Tsai et al. used the 
platelet activation marker CD62P to identify PMC and PNC, whereas we used 
the platelet identification marker CD42b which is the abundantly present  on 
platelets. In our study, platelet function defects and thrombocytopenia may 
have resulted in decreased complex formation. Another explanation may be 
the shedding of PSGL-1 from monocytes and neutrophils which is known to 
occur when these cells are activated [46]. Platelet-leukocyte complexes are 
generally considered a sensitive marker for platelet activation, since a small 
increase in CD62P expression already promotes complex formation via PSGL-
1. Our present data however suggest that quantification of platelet-leukocyte 
complexes may not always be a reliable marker of platelet activation, especially 
in conditions with thrombocytopenia. Moreover, platelet-leukocyte interaction 
is important in enhancement of innate immunity [47] and removal of micro-
organisms form the circulation by formation of neutrophil extracellular traps 
(NETs) [48].  
Our study has several limitations. First, our study is observational and the 
association between platelet function abnormalities and plasma leakage does 
not does not necessarily imply causation. Second, our patients presented 
relatively late in our referral hospital, which limited the number of patients that 
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could be included early in dengue infection. Third, we used only TRAP as platelet 
agonist. Additional platelet agonists, such as ADP and collagen-related peptide 
would have given a broader insight in dengue-associated platelet function 
abnormalities. Moreover, inclusion of samples using other anticoagulants not 
chelating calcium, such as direct thrombin inhibitors, and estimation of the 
numbers of molecules per platelet may be considered for future studies [49, 
50]. A particular strength of our study is the use of daily ultrasonography to 
reliably diagnose plasma leakage. 
In conclusion, platelet activation with secondary platelet function alterations 
were detected in patients with dengue and these alterations correlated 
with plasma leakage. In case our findings are confirmed in other studies, 
interventions aimed at reversal of platelet activation and platelet dysfunction 
may be explored as new means of preventing the severe complications of 
dengue.  
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SUMMARY
Background. A transient endothelial hyperpermeability is a hallmark of 
severe dengue infections. Sphingosine-1-phosphate (S1P) maintains vascular 
integrity and protects against plasma leakage. We related plasma S1P levels to 
dengue-induced plasma leakage and studied mechanisms that may underlie 
the decrease in S1P levels in dengue. 
Methods. We determined circulating levels of S1P in 44 Indonesian adults 
with acute dengue and related levels to plasma leakage, as determined by 
daily ultrasonography, and to levels of its chaperone apolipoprotein M, other 
lipoproteins and platelets.  
Results. Plasma S1P levels were decreased during dengue and patients with 
plasma leakage had lower median levels compared to those without (638 
vs 745 nM; p <0.01). ApoM and other lipoprotein levels were also decreased 
during dengue, but did not correlate to S1P levels. Platelet counts correlated 
positively with S1P levels, but S1P levels were not higher in frozen-thawed 
platelet rich plasma, arguing against platelets as an important cellular source 
of S1P in dengue.
Conclusions. Decreased plasma S1P levels during dengue are associated with 
plasma leakage. We speculate that decreased levels of ApoM underlies the 
lower S1P levels. Modulation of S1P levels and its receptors may be a novel 
therapeutic intervention to prevent plasma leakage in dengue.
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INTRODUCTION
Dengue is a systemic mosquito-borne viral infection for which no vaccine or 
specific treatment exists. This disease is endemic to tropical and subtropical 
areas of the world causing a fundamental public health problem [1]. Clinical 
manifestations vary from a mild self-limiting febrile illness to a severe life-
threatening condition. Complications of dengue usually arise around the time 
of defervescence and include bleeding manifestations, thrombocytopenia and 
plasma leakage [2]. The latter is due to a transient endothelial hyperpermeability, 
of which the pathogenesis is still incompletely understood [3].
Several studies implicate that the bioactive sphingolipid sphingosine 
1-phosphate (S1P) is a crucial signaling molecule that modulates a variety 
of physiological functions. Some of the pleiotropic actions of S1P are highly 
relevant for dengue infection, including the regulation of cell death and the 
modulation of immune cell trafficking, but especially the maintenance of the 
endothelial integrity [4, 5]. The multiplicity of S1P-mediated actions can be 
explained by the fact that the sphingolipid on the one hand exhibits intracellular 
targets and on the other hand is able to stimulate G protein-coupled receptors 
(GPCR) after release into the extracellular environment. Until now five high-
affinity receptors for S1P, designated S1P1-S1P5, have been discovered. The 
S1P1 has been identified as the central receptor subtype involved in the robust 
barrier enhancing action of S1P [6]. 
In mammalians high levels of S1P are mainly present in the circulatory system 
such as blood and lymph and its cellular source has only recently begun to be 
characterized. Erythrocytes contain large amounts of S1P [7, 8] and are together 
with vascular endothelial cells [9] a main source for blood S1P. Additionally, 
platelets are an important storage site for S1P [10] which can be released 
upon platelet activation [11, 12]. In the circulation, S1P is largely chaperoned 
by apolipoprotein M (ApoM), which is a plasma apolipoprotein that associates 
with different lipoproteins, but particularly with high-density lipoproteins 
(HDL) [13]. Hepatocytes can generate and release ApoM-lipoprotein and its 
overexpression is associated with increased plasma S1P concentrations [14] 
and larger ApoM-S1P enriched HDL particles in mice [15]. ApoM concentrations 
correlate to lipoprotein concentrations, above all to total cholesterol levels 
[16]. A reduction in plasma cholesterol concentrations is commonly observed 
during dengue and is related to severity of illness and mortality [17]. 
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Recently, Gomes et al. reported decreased S1P serum levels during dengue 
infection with the lowest levels in those with severe dengue infection [18]. To 
investigate the role of reduced S1P levels in plasma leakage in dengue as well 
as mechanisms involved in the reported low S1P levels in dengue, we measured 
plasma S1P levels in a cohort of adult Indonesian dengue patients and related 
these levels to plasma leakage, as determined by daily ultrasonography, serum 
lipoprotein and ApoM levels as well as platelet counts. 
METHODS
Patients and study design 
This prospective observational study was part of a larger study in which we 
included patients aged 14 years and above who were admitted to Rumah Sakit 
Hasan Sadikin, an academic referral hospital in Bandung, West Java, Indonesia, 
from March 2011 to March 2012 [19]. Patients with a history of fever and 
thrombocytopenia (< 150 x109 cells/L) and with clinical suspicion of dengue 
infection were included. Exclusion criteria were presence of a concurrent 
chronic disease, pregnancy, the inability to retrospectively obtain a laboratory 
confirmation of dengue diagnosis. Patients from whom no platelet rich plasma 
(PRP) was obtained were also excluded from the current study. Demographic, 
clinical, laboratory and ultrasonography data were collected using a 
standardized data collection form. Ultrasonography was daily performed at the 
bedside to detect plasma leakage as a complication of dengue as described in 
detail before [20]. Routine complete blood count was determined every day. 
Additionally, blood was drawn at enrollment of the study and in each clinical 
phase of dengue infection; the febrile phase (temperature of 37.5°C or higher); 
the critical phase (period within 48 hours of defervescence when complications 
usually occur and before platelet count recover); the early recovery phase 
(increasing  platelet counts with a minimum increase of 10 * 109/ L, which 
further increases in the days thereafter until normal platelet counts are reached) 
and the convalescence phase (> 2 weeks after discharge). Plasma leakage was 
defined as an increase in hematocrit of ≥ 20%, a single high hematocrit value 
(> 50% for men and > 44 % for women), and/or by plasma leakage in the form 
of ascites and/or pleural effusion detected by ultrasonography, according to 
WHO guidelines [21]. Plasma leakage within the gallbladder wall is an early 
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sign of plasma leakage and can be observed by ultrasonography as a thickened 
gallbladder wall, but it is not part of the WHO criteria for plasma leakage 
[21]. Gallbladder wall thickness (GBWT) was therefore not used as a criteria 
for plasma leakage in this study. Circulatory failure was defined as a narrow 
pulse pressure (a difference between systolic and diastolic blood pressure of 
20 mmHg or less), and/or hypotension (decrease in systolic blood pressure 
of 20 mmHg or more compared to the normal blood pressure, if this known 
for a specific patient), and/or a systolic blood pressure below 100 mmHg in 
combination with clinical signs of hypoperfusion. All patients were asked to 
return for follow up in the convalescent phase 2-4 weeks after discharge, which 
included clinical evaluation and convalescent dengue serology. A group of 
healthy controls was recruited among hospital staff to serve as controls. None 
of the healthy controls had had fever or other physical complaints in the past 2 
weeks and all had a normal complete blood count.
The Study Research Ethics Committee of the Faculty of Medicine of the 
Padjadjaran University, Bandung, Indonesia, approved all legal, ethical, 
radiological aspects of the study. Written informed consent was obtained from 
all patients or from their parents, in case the patient was below 17 years of age. 
All patients provided informed consent.
Laboratory procedures
Concentrations of plasma and intra-platelet S1P were determined in plasma and 
platelet rich plasma (PRP), respectively, derived from venous blood collected 
in CTAD tubes (BD Biosciences). These tubes contain citrate and the platelet 
stabilizing agents theophylline, adenosine and dipyridamole, preventing in 
vitro platelet activation. For PRP, CTAD anti-coagulated blood was centrifuged 
at 150g for 10 minutes without brake to obtain platelet rich plasma which 
was pipetted off and stored as PRP with a known number of platelets to later 
calculate S1P levels per platelet. Before measuring S1P, PRP underwent an extra 
freeze-thaw cycle to optimize platelet lyses. Normal (platelet poor) plasma 
was obtained from the sample that remained after pipetting off the PRP, by 
centrifuging at 1700g for 15 minutes. Plasma and PRP were stored at -80oC until 
analysis. S1P  was extracted and quantified as recently described [22] allowing 
determination of total S1P level in plasma samples. Lipid extraction of plasma 
was performed using C17-S1P as internal standard. Sample analysis was carried 
out by rapid-resolution liquid chromatography-MS/MS using a Q-TOF 6530 
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mass spectrometer (Agilent Technologies, Waldbronn, Germany) operating in 
the positive ESI mode. The precursor ions of S1P (m/z 380.256) and C17-S1P (m/z 
366.240) were cleaved into the fragment ions of m/z 264.270 and m/z 250.252 
respectively. Quantification was performed with Mass Hunter Software (Agilent 
Technologies). Total cholesterol, LDL, HDL, triglyceride and albumin levels were 
determined in serum samples of dengue patients, who had been fasting for 
at least 6 hours. Serum levels of ApoM were determined by a commercially 
available ELISA (Cloud-Clone corporation, Houston, USA), which had a lower 
detection limit of 0.14 ng/mL, according to the manufacturer’s instructions.
Samples of dengue suspected cases were tested for presence of dengue specific 
viral RNA by reverse-transcriptase PCR and for dengue specific IgM and IgG 
(Panbio, Windsor, Australia) and interpreted according to the manufacturer’s 
instructions. Samples that were IgM positive, had an IgG conversion, a 4-fold 
titer increase in IgG and/or IgG levels comparable to a HI titer of at least 1:2560 
(the IgG cut off point set by the manufacturer to detect secondary infection) 
were dengue positive. 
Data presentation and statistical analysis
Data are expressed as medians with interquartile ranges (IQR) or as numbers 
with percentages. Non-paired non-parametric data of continuous variables 
of 2 groups were compared with Mann-Whitney U test. Continuous variables 
with repeated measurements in the different phases of dengue infection 
were analyzed by a linear mixed model with repeated measurements after log 
transformation in case of non-parametric data. Relationships between non-
parametric continuous data were examined by Spearman’s correlation. All 
analysis were performed using SPSS (version 18.0) statistical program.   
RESULTS
Clinical characteristics
A total number of 44 patients with confirmed dengue were enrolled after a 
median (interquartile range) duration of illness of 5 days (4-6 days). Patients 
were either in the febrile phase (n=9) or in the critical phase (n=35) at the 
time of enrollment. Three (7%) of the patients had primary dengue infection 
versus 34 (77%) patients with a secondary infection. Four (9%) samples had 
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no conclusive results regarding primary of secondary dengue infection. Six 
(14%) patients fulfilled the criteria for severe dengue according to WHO 2009 
guidelines [21]. Twenty-three (52%) patients were male. Twenty-three (52%) 
patients developed plasma leakage in the form of ascites (n=16), pleural 
effusion (n=12) and/or significant hematocrit changes (n=12). Sixteen patients 
(36%) developed mild bleeding in the form of epistaxis (n=11) and/or bleeding 
of the gums (n=11). Circulatory failure was present in 9 (21%) patients during 
the course of disease. Median platelet counts at enrollment were 64 (31-97) 
*109/L and 42 (24-68) *109/L in the febrile and critical phase, respectively, versus 
259 (193-288) *109/L in the convalescence phase. A total number of 19 healthy 
individuals with a median age of 24 years (22-30 years) and of whom 4 (21%) 
were male, were included as controls for S1P levels and had platelet counts of 
294 (274-318) *109/L.
Sphingosine-1-phosphate plasma levels are reduced and associated with 
plasma leakage during dengue
Patients with dengue had reduced plasma S1P concentrations, particularly in 
the febrile (n=9) and critical phase (n=38). Concentrations in the convalescence 
phase (n=25) had increased, but were still lower than those in healthy controls 
(n=17) (figure 1A). The patients with plasma leakage (n=18) had lower median 
S1P concentrations in the critical phase compared to those without (n=20) 
(median 638 versus 745 nM; p<0.01) (figure 1B). Patients with a maximal 
gallbladder wall thickness (GBWT) of 0.5 cm or more (n=17) also had lower 
S1P concentrations in the critical phase than patients with a GBWT of < 0.5 
cm (n=21) (median 624 versus 746 nM; p<0.05) (figure 1C). There were no 
significant differences in plasma S1P concentrations in the critical phase 
between patients with (n=8) and without circulatory failure (n=30) or between 
patients with (n=14) and without (n=24) bleeding (data not shown). 
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Figure 1. Decreased plasma sphingosine-1-phosphate concentrations during dengue were associated 
with plasma leakage.
Plasma sphingosine-1-phosphate (S1P) concentrations were  decreased during the febrile (n=9) and 
critical phase (n=38) and to a lesser extend during the early recovery (n=34) and convalescence (n=25) 
phase of dengue virus infection in Indonesian patients (n=44) (A). S1P concentrations were lower in 
patients with plasma leakage (n=20) than in those without plasma leakage (n=18) during the critical 
phase of dengue (B), which was defined as the presence of pleural effusion, ascites and/ or significant 
hematocrit changes according to WHO guidelines as measured by daily ultrasonography and daily 
hematocrit measurements, respectively. Thickening of the gallbladder wall due to edema is an early 
sign of plasma leakage during dengue which can be easily detected by ultrasonography as well. Patients 
with a gallbladder wall thickness (GBWT) of 0.5 cm or more (n=17) also had significantly lower plasma 
S1P levels than those with a GBWT below 0.5 cm ( n=21) (C). Data are represented as scatterplots. The 
horizontal lines represent medians and the whiskers interquartile ranges. Differences between each 
phase of dengue were compared to healthy controls (A)  or differences were compared between 
patients with or without plasma leakage  (B) or between patients with or without  a GBWT of 0.5 cm or 
more (C) were determined by Mann- Whitney U test.  A p value < 0.05 was considered significant; *** 
denotes p < 0.001; ** p < 0.01 and * p < 0.05. 
Apolipoprotein M concentrations and other lipoproteins are decreased 
during dengue
Apolipoprotein M preferentially associates with HDL and binds plasma S1P [13]. 
The kinetics of serum Apo M and total cholesterol, LDL and HDL concentrations 
were comparable to kinetics of S1P with decreased concentrations during 
the febrile (n=9), critical (n=36) and early recovery phase (n=34) of dengue 
compared to the convalescence phase (n=24) (figure 2A-D). Nonetheless, 
plasma S1P concentrations did not correlate significantly with either ApoM, total 
cholesterol, LDL, HDL or albumin concentrations (data not shown). In contrast, 
ApoM concentrations did correlate with total cholesterol concentrations (Rs= 
0.36, p =0.03) (Figure 2E) and to LDL concentrations (R
s
= 0.45, p =0.006) (Figure 
2F), but not with HDL concentrations (R
s
= 0.26, p =0.78) in the critical phase of 
dengue infection. 
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Figure 2. Decreased  apolipoprotein M, total cholesterol, LDL cholesterol and HDL cholesterol during 
dengue. Serum apolipoprotein M (ApoM) concentrations were decreased during the febrile (n=9), 
critical (n=36) and early recovery phase (n=34) of dengue infection (total n=44 patients) compared to 
healthy control concentrations (n=16) (A). Serum total cholesterol (B), LDL (C) and HDL (D) were 
decreased in the febrile, critical and early recovery phase of dengue patients, compared to convalescence 
(n=24). Patients were fasting for at least  6 hours before blood drawing. ApoM  was correlated with total 
cholesterol (E) and LDL levels (F) during the critical phase of dengue. Data are represented as scatterplots. 
The horizontal lines in A-D represent medians and the whiskers interquartile ranges. Differences 
between each phase of dengue were compared to healthy controls values with the Mann- Whitney U 
test (A) or analyzed by a linear mixed model with repeated measurements after log transformation in 
case of non-parametric data (B-D).  Spearman correlation (Rs) was determined (E and F). A p value < 0.05 
was considered significant; *** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
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Plasma S1P concentrations correlate to platelet counts during dengue
Sphingosine 1-phosphate is predominantly stored in erythrocytes [7, 8] and 
platelets [10]. Thrombocytopenia, but not anemia, is a key feature of dengue, 
suggesting that thrombocytopenia may contribute to the low S1P plasma 
levels. Thrombocytopenia was present in all patients of our cohort (figure 3A) 
and there was a strong correlation between platelets counts and plasma S1P 
concentrations in the critical phase of dengue (R
s
= 0.59, p=0.0001) (figure 3B). 
However, S1P concentrations of the lyzed platelets in PRP (figure 3C) were 
comparable to the corresponding S1P concentrations in PPP as shown in the 
S1P concentration in PRP/ the S1P concentration in PPP (figure 3C), suggesting 
that the contribution of released intra-platelet S1P of lyzed platelets to the 
S1P concentrations in PRP was not substantial. There was also no association 
between S1P concentrations in PPP and markers of platelet activation such as 
P-selectin expression on the platelet surface and soluble P-selectin or platelet 
factor 4 levels, which we reported previously in the same patients (data not 
shown) [19]. 
Figure 3. Platelets counts were related to S1P concentrations during dengue.  The course of platelet 
counts in whole blood is shown during dengue (total n=44 patients) and in healthy controls (n=19) (A), 
as well as the positive correlation of S1P in plasma with the platelet count during the critical phase of 
dengue infection (n=38) (B). Platelet rich plasma (PRP) with a known number of platelets was obtained 
and lyzed by repeated freeze-thawing to determine the maximal release of S1P by platelets in plasma. 
The S1P concentrations in platelet poor plasma (PPP) were similar in the different phases of dengue and 
healthy control samples compared to the corresponding PRP concentrations, as shown by the 
concentration of S1P in PRP divided by the concentration in PPP (C). One outlier was left out in figure 1B, 
but not out of the analysis (S1P 1289 nM; platelet count 37*109/L). Data are represented as scatterplots. 
The horizontal lines in A and C represent medians and the whiskers interquartile ranges. Differences 
between each phase of dengue were compared to healthy controls values with the Mann- Whitney U 
test.  Spearman correlation (Rs) was determined (E and F). A p value < 0.05 was considered significant; 
*** denotes p < 0.001; ** p < 0.01 and * p < 0.05.
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DISCUSSION
The main finding of our study is that during the different stages of dengue 
a significant decrease of plasma S1P-levels occurs, which is associated with 
the main feature of severe dengue, namely plasma leakage. This is consistent 
with the fact that S1P is an important molecule involved in promoting the 
endothelial barrier function directly via the S1P
1
-receptor on endothelial cells 
[4, 5]. This has been clearly demonstrated in an animal model of mutant mice 
transformed to selectively lack S1P in plasma [6]. These mice displayed an 
increased vascular leak with depletion of intravascular volume after exposure 
to inflammatory challenges. The increased leakage could be reversed by the 
transfusion of wild-type erythrocytes as a physiological source of S1P as well 
as by the treatment with a S1P1 selective receptor agonist. The mechanism 
by which S1P maintains vascular integrity is still a matter of debate. It has 
been discussed that the constitutive activation of the S1P1 receptor subtype 
on the luminal side of the endothelium is responsible for the modulation of 
barrier integrity. Nevertheless, high S1P levels in the plasma are recognized 
to desensitize S1P1 receptor signaling. Thus, an alternative model postulates 
that small amounts of plasma S1P are locally translocated through the vascular 
barrier and act via the apical side on the S1P1 of the endothelium. Owing the 
small amount of plasma S1P that get access to the apical side of vessels it is not 
surprising that slight changes of plasma S1P levels could be associated with 
substantial alterations in barrier integrity [23]. This is consistent with our data 
indicating that an approximately 20 % reduction of plasma S1P in the critical 
phase of dengue was associated with a sustained plasma leakage. 
Several processes may contribute to the reduced plasma S1P concentrations 
during dengue. As S1P levels are tightly regulated by the balance between 
its synthesis and degradation, changes of enzyme activities which play a 
role in sphingolipid metabolism, such as sphingosine-kinase-1 (SphK1) or 
S1P lyase, may occur during dengue. SphK1 is a highly regulated enzyme 
that catalyzes the phosphorylation of sphingosine to the bioactive S1P, and 
S1P is in turn rapidly degraded by the enzyme S1P lyase. Indeed, in vitro 
studies indicate that different dengue-exposed cell types had reduced SphK1 
activity [24, 25]. Moreover, endothelial cells contribute to plasma S1P levels 
[9] and the endothelial activation and dysfunction that occur in dengue 
infection [3] may therefore affect extracellular S1P concentrations by altering 
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intracellular sphingolipid metabolism. While in vivo data of SphK1 or S1P 
lyase during human dengue infection have not yet been reported to the 
best of our knowledge, adult dengue patients from Singapore had increased 
sphingomyelin concentrations early in dengue infection [26]. As degradation 
of sphingomyelin is a major pathway involved in the formation of S1P, it can be 
speculated that a dysregulation of S1P metabolism may occur during dengue. 
Secondly, dengue is associated with a transient decrease in lipoproteins [17] 
which may also reduce S1P concentrations. The majority of plasma S1P is 
bound to HDL (60 %), whereas 30 % is bound to albumin and a minor fraction to 
VLDL and LDL. It was unknown how S1P binds to HDL until ApoM as a specific 
protein of HDL particles was identified to chaperone S1P. Indeed, a linkage of 
ApoM/HDL-bound S1P has been explored for the protection of the endothelial 
barrier [5]. Nevertheless, we did not find a significant correlation between S1P 
levels on one hand and levels of ApoM, other lipoproteins or albumin on the 
other hand. This is consistent with a previous study in healthy volunteers which 
also failed to demonstrate a significant correlation between ApoM and S1P 
concentrations [27]. Possible explanations for this discrepancy are the fact that 
only a part of all HDL carries ApoM [28] and that plasma ApoM may not be fully 
saturated with S1P due to the moderate affinity of ApoM for S1P [27]. 
Thirdly, platelets [10] and erythrocytes [7, 8] are major storage sites for S1P, due 
to the absence of intracellular S1P lyase or other enzymes that convert S1P to 
inactive metabolites. Thrombocytopenia is a key feature of dengue and may 
contribute to low S1P plasma concentrations, but anemia or other erythrocyte 
abnormalities are rare in dengue. We found a significant positive correlation 
between platelet counts and plasma S1P in our cohort, whereby we purposely 
used CTAD anticoagulated plasma to prevent ex vivo platelet activation. On 
the other hand, our findings that S1P concentrations in supernatant from 
platelet rich plasma was not higher than in platelet poor plasma and the 
absent correlation of plasma S1P with soluble and membrane markers of 
platelet activation argue against an important role for platelets in plasma S1P 
concentrations in dengue. This is consistent with a recent study in mice, in 
which platelet depletion did not result in lower plasma S1P concentrations [9]. 
Vice versa, S1P is also important for thrombopoiesis [29], which may explain the 
positive correlation of S1P with platelet counts. Sufficient numbers of platelets 
are important in maintaining the endothelial barrier, especially in conditions of 
inflammation [30]. Besides S1P, platelets also release other endothelial barrier 
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stabilizing factors such as angiopoietin-1 (Ang-1). We previously reported that 
Ang-1 levels are also lower in dengue infection [31]. Plasma Ang-1 acts through 
the Tie-2 receptor, which is not expressed on post-capillary venules [32]. These 
venules are an important site for plasma leakage. In this context, it should be 
mentioned that the anti-permeability effect of Ang-1 can be mimicked by S1P 
via activation of the S1P-producing enzyme SphK1 and that the endothelial 
barrier stabilizing effect of S1P is thus not restricted to the occurrence of Tie-2, 
suggesting a more universal function of S1P on endothelial barrier integrity 
compared to Ang-1 [33]. 
S1P may also influence dengue pathogenesis in other ways. S1P has important 
effects on immune cell migration, release of inflammatory mediators, 
phagocytosis and cell death, as reviewed by Carr et al. [34] and Maceyka et 
al. [35]. Specific data concerning alterations in sphingolipid metabolism in 
dengue infection are scarce. In vitro, reduced SphK1 in dengue-infected cells 
showed enhanced TNF-α induced apoptosis [24], which could limit severe 
complications induced by pro-inflammatory cytokines and limit ongoing viral 
replication within infected cells. SphK1 was also suggested to block type 1 IFN 
signaling as reviewed by Seo et al. [36], which plays a central role in anti-viral 
host defense. 
 In the light of these facts, therapeutics that interfere with S1P metabolism 
and/or its S1P1-receptor offer hope for development of a specific treatment 
for dengue. Indeed, the sphingosine analog FTY720 (Fingolimod), which is a 
prodrug that is phosphorylated in vivo to FTY720-phosphate, binds as active 
compound to all S1P receptors except the S1P2. FTY720 has been approved by 
the United States Food and Drug Administration in 2010 for the treatment of 
multiple sclerosis. The clinical accessibility of FTY720 provides the opportunity 
to examine its role as a potential therapeutic for patients with vascular barrier 
dysfunction. Animal models already have shown a divergent role of FTY720 
on vascular permeability. Thus, a single intraperitoneal injection of FTY720 
significantly decreased murine pulmonary injury in response to a LPS treatment 
[37, 38]. In analogy, low doses of FTY720 diminished lung permeability in 
artificially ventilated mice [13, 39]. On the contrary, it has been shown, that 
a prolonged exposure to FTY720 is associated with a down regulation of the 
S1P1 receptor subtype on endothelial cells resulting in an insufficient response 
to S1P [40]. Moreover, the use of FTY720 at high doses in mice resulted in a 
S1P1 degradation and a subsequent enhancement of vascular permeability 
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[41]. Therefore, an increased knowledge of S1P and its receptors to predict 
the beneficial and adverse effects of drugs targeting S1P receptors could lead 
to possible candidates for dengue treatment. Notably, future intervention 
studies should not only consider the vascular protective, but also the immune-
modulatory effects of S1P and the other components of S1P metabolism, 
which are likely to affect the host response against dengue virus infection as 
they usually possess an immunosuppressive effect.
Taken together, we demonstrated that decreased plasma S1P levels during 
dengue virus infection are associated with dengue-induced plasma leakage. 
Additionally, we speculate that decreased levels of its main chaperone ApoM as 
well as thrombocytopenia could underlie the decreased S1P levels. Although 
the study does not allow deducing a causal relationship between the reduced 
S1P levels and plasma leakage, animal models clearly indicate the functional 
role of S1P in pathological conditions in which vascular barrier function is 
dysregulated. Strengths of the study are the follow up in each phase of dengue, 
the serial determination of development of plasma leakage by ultrasonography 
and the use of CTAD anticoagulant to limit in vitro platelet activation which 
could increase plasma S1P concentrations. As no specific treatment for dengue 
is available, this study indicates that the modulation of S1P/S1P1 axis may be 
a novel therapeutic intervention to prevent plasma leakage during critical 
phases of dengue infection.
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SUMMARY
The pathogenesis of plasma leakage during dengue hemorrhagic fever/dengue 
shock syndrome (DHF/DSS) is largely unknown. Angiopoietins (Ang) are key 
regulators of vascular integrity: Ang-1 is stored in platelets and maintains 
vascular integrity, while the endothelium-derived Ang-2 promotes vascular 
leakage. We determined Ang-1 and Ang-2 levels in a cohort of Indonesian 
children with DHF/DSS and related them to plasma leakage markers. Patients 
with DHF/DSS had reduced Ang-1 and increased Ang-2 plasma levels on the 
day of admission, as compared to levels at discharge and in healthy controls. 
There was an inverse correlation of Ang-1 and a positive correlation of Ang-2 
with the markers of plasma leakage. Ang-1 levels followed the same trend as 
the soluble platelet activation marker P-selectin and correlated with platelet 
counts. In conclusion, dengue-associated thrombocytopenia and endothelial 
activation are associated with an imbalance in Ang-2/Ang-1 plasma levels. This 
imbalance may contribute to the transient plasma leakage in DHF/DSS. 
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INTRODUCTION
The clinical course of dengue virus infection ranges from asymptomatic 
infection to severe disease, known as dengue hemorrhagic fever/dengue shock 
syndrome (DHF/DSS). The latter is characterized by a transient endothelial 
hyperpermeability of which the pathogenesis is still incompletely understood 
[1, 2].
Inflammatory cytokines and angiogenic proteins are important mediators 
of vascular integrity [3]. The angiogenic protein vascular endothelial growth 
factor (VEGF) is a strong inducer of vascular permeability and several studies 
have reported circulating VEGF levels in dengue patients with contradicting 
results [4-8]. However, the role of another class of angiogenic proteins, called 
angiopoietins, has been neglected in dengue so far. 
Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) and their endothelial 
tyrosine kinase receptor Tie-2 form a central signaling system in endothelial 
permeability [9]. Ang-1-mediated Tie2 activation maintains the quiescent 
state of the endothelium by stabilizing endothelial cell-cell junctions and by 
countering the permeabilizing effects of VEGF [10]. Ang-2 antagonizes the 
effects of Ang-1: it destabilizes the endothelium by disrupting cell-cell adhesion 
and primes the endothelial cells to the effects of pro-inflammatory cytokines 
and VEGF [11]. Ang-2 is almost exclusively produced in endothelial cells and 
stored in Weibel-Palade bodies (WPBs) from which it can be rapidly released 
upon activation of the endothelium [12]. Ang-1 is produced in pericytes 
and smooth muscle cells, but platelets also contain high quantities of Ang-
1 [13]. Hence, both the number and activation status of circulating platelets 
may influence plasma Ang-1 levels. Evidence is mounting that platelets are 
important cells for maintaining vascular stability and platelet-derived Ang-1 
may be one of the factors involved [14].
DHF/DSS is associated with thrombocytopenia, inflammation and endothelial 
cell activation and these processes might lead to significant alterations in the 
balance between Ang-1 and Ang-2, favoring plasma leakage and hemorrhage 
[15]. We therefore studied Ang-1 and Ang-2 levels children with DHF/DSS and 
related these levels to markers of plasma leakage. 
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METHODS 
This study was part of a larger cohort study aiming to investigate 
pathophysiological mechanisms of severe dengue. Consecutive children with 
DHF/DSS, aged 15 years or below, admitted to the pediatric ward or intensive 
care unit of the Dr. Kariadi University Hospital in Semarang, Indonesia, from 
2005--2006, were enrolled; study details and clinical characteristics were 
published previously [16]. All patients had a positive dengue specific IgM, 
determined by ELISA (Focus Technologies). The Ethics Committee of the 
Diponegoro University in Indonesia, approved the study. Written informed 
consent was obtained from the parents or legal guardians of the children.
Forty-nine children of whom sufficient blood sample volume was available, 
were randomly selected from this larger cohort and classified as DHF or DSS 
according to WHO criteria [17]. Twenty-five healthy Indonesian children served 
as controls. Table 1 summarizes demographic and clinical characteristics. Fluid 
resuscitation was performed in all patients according to WHO-based protocols. 
Blood was drawn the days of enrollment and of discharge using a syringe and 
directly transferred to vacutainers containing sodium citrate as anticoagulant. 
Citrate was deliberately chosen as other anticoagulants or serum result in 
platelet activation with release of  platelet-derived molecules such as Ang-1. 
Short application of tourniquet for blood drawing was often inevitable. Blood 
samples were processed as soon as possible and handled with care to avoid 
in vitro platelet activation. Blood was centrifuged for 20 minutes at 1600g 
without brake and plasma was stored at -80 ºC. Plasma levels of Ang-1, Ang-2 
and P-selectin were measured by commercial ELISA-kits (R&D systems).
RESULTS
Patients with DHF/DSS had lower Ang-1 levels at enrollment compared to 
corresponding discharge levels and to levels in controls, with the lowest median 
level in children with DSS (Figure 1A). Nineteen patients had a Ang-1 level below 
the detection limit of 0.1 ng/mL at enrollment. In contrast, children with DHF/
DSS had higher Ang-2 levels at enrollment than at discharge and compared to 
healthy controls (Figure 1B). Taken together, DHF/DSS was associated with an 
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Table 1. Demographic and clinical characteristics of the patients studied.
Characteristic 
 
DHF (DHF I and II) DSS (DHF III and IV)
n = 26 (53%) n = 23 (47%)
Male sex; n (%) 12 (46) 7 (30)
Age; years 8 (6--10) 8 (6--10)
Body weight; kg 20 (17--28) 24 (18--30)
Body height; cm 125 (111--135) 120 (113--140)
Body temperature; ºC 37.6 (37.0--38.4) 38.0 (37.0--38.5)
Duration fever until admission; days 4.0 (3.0--5.0) 4.0  (4.0--5.0)
Tourniquet test positive; n (%) 17/23 (74) 10/16 (63)
Petechiae; n (%) 1/17 (6) 1/15 (7)
Epistaxis; n (%) 3 (12) 0 (0)
Gum bleeding; n (%) 0 (0) 0 (0)
Hematemesis; n (%) 2 (8) 0 (0)
Melena; n (%) 0 (0) 1 (4)
Hemoglobin; g/dL 13.1  (12.7--14.0) 13.5 (12.3--14.2)
Hematocrit; % 38.0 (37.9--41.3) 40.0 (36.0--43.5)
Platelet count; x 109/L 62 (39--88) 39 (26--68)
Leukocyte count;  x 10³ cells/ml 5.0 (3.1--7.8) 5.0 (3.0--9.5)
Albumin serum; g/dL, 3.3 (2.9--3.8) 2.8 (2.5--3.4)*
Alanine transaminase; U/dL 48 (31--82) 46 (32--71)
Pleural effusion index 8 (0--22) 18 (11--28)*
Data represent medians with interquartile ranges or numbers with percentages. All data represent 
data at enrollment, except for bleeding manifestations, which are presented for the whole duration 
of admission. DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; n (%), absolute numbers 
(percentage) within DHF or DSS group. * P value < 0.05; calculated by Mann-Whitney U test.
clear increase in Ang-2/Ang-1 ratios and those with DSS had the highest ratios 
(Figure 1C). Five children died and while their Ang-1 levels were in the lowest 
range, their corresponding Ang-2 levels were more evenly distributed over the 
range (Figure 1, black dots). There was no difference in Ang-1 and Ang-2 levels 
between children with and without bleeding (data not shown). 
Figure 1. Plasma levels of (A) angiopoietin-1 and (B) angiopoietin-2 and corresponding angiopoietin-2/ 
angiopoietin-1 ratios (C) in Indonesian children with DHF (n = 26) and DSS (n = 23) on day 0 (day of 
admission), the day of discharge (n = 44) and in a control group of healthy Indonesian children (n = 25). 
The minimum detection limit of angiopoietin-1 was 0.1 ng/mL. Black points indicate non-survivors. 
Horizontal lines represent median values. P values were determined by Wilcoxon signed-rank test for 
data in time and Mann-Whitney U test for comparison with the control group. *P value < 0.05.
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The association of Ang-1 and Ang-2 levels with plasma leakage was determined 
using serum albumin level and the pleural effusion index (PEI). The latter was 
defined as 100x the maximum width of the (right or left) pleural effusion on a 
chest X-ray (right lateral decubitus position), divided by the maximum width of 
the ipsilateral hemi-thorax. Ang-1 levels at enrollment correlated positively with 
albumin levels (Spearman R (R
s
)= 0.55; p < 0.0001) and negatively with the PEI 
(R
s 
= -0.39, p = 0.005). Ang-2 levels correlated inversely with serum albumin (R
s 
= -0.38; p = 0.009), but not with the PEI. The Ang-2/Ang-1 ratio was related with 
both the PEI (R
s
= 0.43; p = 0.002) and albumin levels (R
s 
= -0.60; p < 0.0001). Ang-
1 or Ang-2 levels did not correlate significantly with hematocrit values (data not 
shown). Finally, while platelet numbers correlated with serum albumin (R
s 
= 0.44; 
p < 0.05), there was no significant correlation with the PEI (R
s 
= -0.26; p = 0.07). 
As mentioned previously, platelets contain high quantities of Ang-1 and 
release Ang-1 during platelet activation [13]. Ang-1 levels correlated with the 
platelet count (R
s 
= 0.44, p < 0.002). Plasma levels of the platelet activation 
marker P-selectin followed the trend of Ang-1 levels with a low median level 
at admission (45.3 ng/mL, IQR 29.4--66.3 ng/ml) that had increased by the day 
of discharge (120.7 ng/mL, IQR 91.6--187.5 ng/mL). Nonetheless, Ang-1 levels 
only weakly correlated with P-selectin levels (R
s
 = 0.30, p <  0.04) at enrollment, 
but when the 19 samples with Ang-1 levels below the detection limit were 
ignored, this correlation improved considerably (R
s 
= 0.69, p < 0.0001). 
DISCUSSION
The present study shows for the first time that DHF/DSS is associated with 
reduced Ang-1 plasma levels and increased Ang-2 levels. These proteins and 
their endothelial receptor are important mediators of vascular integrity and 
we speculate that this imbalance in the Ang/Tie system contributes to the 
transient increase in vascular permeability. Platelets contain Ang-1 and we 
hypothesize that dengue-associated thrombocytopenia explains the low 
Ang-1 levels. Increasing evidence suggests a role for platelets in regulation of 
vascular integrity with Ang-1 and other platelet-derived angiogenic proteins 
as central mediators [14]. As suggested by others, both platelet count and 
activation status should therefore be taken into account when plasma levels of 
platelet-derived proteins are measured [18, 19]. 
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In turn, Ang-2 is produced in endothelial cells and stored in WPBs [12]. The finding 
of high levels of von Willebrand factor, the most abundant WPB constituent, 
in dengue patients, supports the notion that endothelial cell activation with 
WPB exocytosis is an important feature of dengue infection [15, 20]. Although 
the exact mechanisms of increased WPB exocytosis with subsequent Ang-2 
release in dengue are unknown, we hypothesize that endothelial activation 
due to increased pro-inflammatory cytokines is centrally involved [21]. Besides 
the effect of inflammatory cytokines, other mechanisms may also contribute, 
including direct interaction of dengue virus with endothelial cells, release of 
mast cell products and pro-coagulant factors like thrombin [21-25].
Clearly, no definite conclusion on a causal relationship of Ang-1 and Ang-2 
levels and plasma leakage can be made in this observational study. Similar 
trends in Ang-1 and Ang-2 levels have been found in severe malaria and 
sepsis [26, 27], but in contrast to DHF/DSS and sepsis, plasma leakage is not a 
prominent feature of malaria. Possibly, differences in other mediators of vascular 
permeability - such as pro-inflammatory cytokines, angiogenic proteins and 
their soluble receptors - account for these differences in vascular permeability. 
Our study has some limitations. First, no values for the platelet count at 
discharge and in the control group were available. Second, despite our efforts 
to limit ex vivo platelet activation, some degree of activation is often inevitable 
and this should be taken into account when interpreting plasma Ang-1 and 
P-selectin levels. In fact, Ang-1 levels across different studies seem to vary more 
than Ang-2 levels in controls [28-31]. Ang-1 levels in the controls of our study 
were comparable with other studies which also found relatively higher Ang-
1 levels [29-30]. Therefore, we suggest that relative changes in Ang-1 levels 
within one study may be more informative than comparing absolute Ang-1 
levels between studies. Third, the dengue diagnosis was based on the presence 
of a positive dengue specific IgM in a single sample. False-positive IgM results 
due to cross-reactivity may occur in patients with other infectious diseases 
than dengue, although the fact that all children in our study population had 
proven plasma leakage (pleural effusion on chest X-ray) around defervescence, 
a finding specific for dengue, makes alternative diagnoses unlikely. 
In conclusion, DHF/DSS is associated with an imbalance in the Ang/Tie system 
favoring plasma leakage. Dengue-associated thrombocytopenia may play a so 
far overlooked role in the transient plasma leakage seen in DHF/DSS. No specific 
treatment for dengue is yet available. Interventions aimed at the prevention of 
thrombocytopenia or the correction of the imbalance in the Ang/Tie system might 
offer a valuable adjunctive treatment for this devastating disease.
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SUMMARY
Introduction. Dengue hemorrhagic fever/ dengue shock syndrome (DHF/DSS) 
is characterized by hemorrhage, plasma leakage and shock. Adrenomedullin 
and vasopressin are vaso-active hormones that mediate endothelial 
permeability, vascular tone and water balance and may therefore play a role 
during DHF/DSS. Adrenomedullin reduces endothelial permeability and has 
vasodilatory properties, while vasopressin is a potent vasoconstrictor with 
anti-diuretic effects.
Objectives. To determine mid-regional pro-adrenomedullin (MR-proADM) 
and copeptin, which are reliable and stable markers for adrenomedullin and 
vasopressin response, respectively, and relate their plasma concentrations to 
outcome and markers of plasma leakage in Indonesian children with DHF and 
DSS. 
Study design.  In this observational cohort study Indonesian children with DHF/
DSS were enrolled. On study day 0 and 2, plasma MR-proADM and copeptin 
levels as well as parameters of plasma leakage were determined. Plasma MR-
proADM and copeptin concentrations were compared to values of healthy 
controls. 
Results. MR-proADM was increased in both DHF (n=43) and DSS (n=28) vs. 
controls (n=17), with median (IQR) values of 0.47 (0.40-0.68), 0.56 (0.44-1.00) vs. 
0.22 (0.19-0.29) nmol/L, respectively. Additionally, MR-proADM correlated with 
signs of increased vascular leakage such as low albumin and increased pleural 
effusion. Copeptin concentrations showed no significant changes as compared 
to controls.
Conclusions. MR-proADM concentrations are elevated in children with DHF 
and DSS and correlate with the severity of plasma leakage, in contrast to 
copeptin concentrations. We speculate that adrenomedullin has a functional 
role in limiting endothelial hyperpermeability during DHF/DSS. Finally, MR-
proADM may be a candidate biomarker to predict development of DHF/DSS.
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INTRODUCTION
The past decades have seen a remarkable increase in the incidence and global 
expansion of dengue virus infections. Dengue virus infection usually manifests 
as a non-severe febrile illness, called dengue fever (DF). However, each year 
250.000- 500.000 of the estimated 100 million patients with dengue virus 
infection develop more severe disease: dengue hemorrhagic fever/ dengue 
shock syndrome (DHF/DSS) [1]. A central phenomenon of DHF/DSS is a transient 
dysfunction of the endothelial barrier, which results in plasma leakage, shock 
and hemorrhage. The pathogenesis of this vascular hyperpermeability is still 
largely unknown, although the excessive release of pro-inflammatory cytokines 
and vaso-active mediators is generally assumed a central process [2]. 
Adrenomedullin and vasopressin are vaso-active hormones that exert specific 
hemodynamic effects and have received attention in recent years as biomarkers 
for sepsis. Adrenomedullin is predominantly released by the endothelium, 
acts as a potent vasodilator and has natriuretic effects [3]. Other properties 
of adrenomedullin include a reduction in endothelial permeability [4, 5], 
bactericidal effects [6] and down-regulation of pro-inflammatory cytokines 
[7]. Administration of exogenous adrenomedullin in animal models of sepsis 
results in reduced mortality [5]. Vasopressin (also known as the antidiuretic 
hormone) is released from the hypothalamus and has potent antidiuretic and 
vasoconstrictive effects [8]. The hemodynamic effects of adrenomedullin and 
vasopressin are thus partly opposite.  
Recently, assays have become available to determine circulating mid-regional 
pro-adrenomedullin (MR-proADM) and copeptin concentrations [9, 10]. 
These peptides are co-synthesized with adrenomedullin and vasopressin, 
respectively, and have the advantage of a longer half-life, lack of bioactivity 
and lack of protein binding, which makes them more suitable for daily practice 
[11, 12]. Patients with septic shock have elevated plasma concentrations of 
both MR-proADM and copeptin, which correlate with prognosis  [13, 14]. 
Vasopressin and adrenomedullin may play a pathogenic role in DHF/DSS 
through maintaining vascular tone and via regulating vascular endothelial 
integrity. Moreover, copeptin and MR-proADM may be valuable biomarkers to 
predict those patients at risk for developing DHF/ DSS. No data are yet available 
on copeptin and MR-proADM during dengue virus infection. 
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Objectives
To determine plasma MR-proADM and copeptin concentrations in a cohort of 
children with DHF or DSS and relate their plasma concentrations to outcome 
and markers of plasma leakage. 
METHODS
Study design
This study was designed as an observational cohort study and was conducted 
in the Dr. Kariadi University Hospital in Semarang, Indonesia. Children, aged 
below 15 years, admitted to the pediatric ward or intensive care unit with a 
clinical diagnosis of suspected DHF or DSS were included from July 2005 until 
May 2006; 17 healthy children, age 6-14 years, were included as controls. 
Demographic, clinical and laboratory data were collected using a standardized 
data collection form. A chest X-ray was performed with the patient lying in right 
lateral decubitus position to detect pleural effusion and a tourniquet test was 
performed to detect bleeding tendency. In children with pleural effusion, the 
pleural effusion index (PEI) was calculated. The PEI was defined as 100 times the 
maximum width of the (right or left) pleural effusion, divided by the maximum 
width of the hemi-thorax on that side. 
Children were classified as having suspected DHF or DSS according to WHO 
criteria [15]. In summary, suspected DHF was defined as presence of fever, a 
hemorrhagic tendency, thrombocytopenia (<100×109/L), evidence of pleural 
effusion and/ or a >20% rise or drop in hematocrit after volume replacement 
therapy. DSS was defined as DHF with evidence of circulatory failure. All 
patients had a positive dengue specific IgM, determined by ELISA. Blood was 
collected in EDTA and citrate blood tubes on day 0 (day of admission), day 2 
and the day of discharge. 
Laboratory procedures
EDTA blood was centrifuged at 15ºC for 20 minutes at 1600g and plasma 
was stored at -80ºC until further analysis. MR-proADM and copeptin were 
measured in 50 µl of plasma by a Time-Resolved Amplified Cryptate Emission 
(TRACE) technology assay [16], using kits designed for automated sandwich 
immunofluorescent assay of MR-proADM and copeptin, respectively (KRYPTOR; 
39796 Michels, Meta.indd   108 28-03-16   12:38
MR-proADM and copeptin in severe dengue
109
7
BRAHMS AG). The KRYPTOR MR-proADM and copeptin assays have a detection 
range of 0.05 - 100 nmol/l and 4.8 - 1200 pmol/l, respectively. 
A full blood count was performed daily by a standard hematology analyzer. 
Serum total protein and albumin concentrations were measured by Biuret and 
Bromocresol–Green method respectively, as described before [17, 18]. Presence 
of dengue specific IgM and IgG antibodies was determined by capture and 
indirect ELISA (Focus Technologies, Cypress, Calif., USA).
Statistical analyses
Data are expressed as medians with corresponding interquartile range (IQR) 
unless stated otherwise. Levels of MR-proADM and copeptin below the 
detection limit were assigned a value equal to the lower detection limit of 
the assay. Frequency comparison of categorical data was done by chi-square 
test. Mann-Whitney U test was used for statistical evaluation of continuous 
variables between 2 independent groups; Kruskal-Wallis test with Dunn’s 
multiple comparison test was used for evaluation between 3 or more groups. 
Wilcoxon matched pairs test was used to evaluate changes in variables in time 
within groups.  Relationships between continuous variables were examined 
by Spearman correlation analysis. A p-value of <0.05 indicated a significant 
difference. Statistical analyses were performed with SPSS version 16.0. 
RESULTS
Clinical characteristics
Seventy-one children with severe dengue virus infection were included in this 
study. According to WHO criteria, 43 (61%) were categorized as suspected DHF 
and 28 (39%) as suspected DSS. Patient characteristics and relevant baseline 
data are shown in table 1. Children with DHF/DSS were generally young with 
a median age of 8 and 7 years for the DHF and DSS group, respectively. There 
were no significant differences in demographic characteristics between both 
groups. Except for a significantly lower platelet count in the DSS group, there 
were also no significant differences in hematological values. As expected, 
parameters for plasma leakage were consistent with more severe plasma 
leakage in the DSS group; children with DSS had a significantly higher PEI values 
and lower concentrations of serum albumin and serum protein. The median 
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duration of hospital admission was 4 days (IQR 3-5). Six patients, all with DSS 
grade IV, died in hospital despite treatment. Treatment included intravenous 
fluid replacement (n=65/71), fresh frozen plasma (n=11/71), fresh plasma 
transfusion (n=1/71), platelet transfusion (n=6/71) and dopamine (n=7/71).
Table 1. Patient characteristics and baseline data.
Characteristic DHF (DHF I and II) DSS (DHF III and IV)
 n= 43 n= 28
Male sex; n (%) 15 (35) 9 (32)
Age; years 8 (6-9) 7 (6-9)
Body weight; kg 20 (18-28) 22 (17-30)
Body height; cm 120 (111-133) 120 (112-137)
Body temperature; ºC 37.6 (37.0-38.4) 38.0 (37.1-38.5)
Duration fever untill admission; days 4.0 (3.0-5.0) 4.0  (4.0-5.0)
Pulse rate; rate per minute 100 (90-110) NA
Systolic blood pressure; mmHg 100 (100-110) NA
Diastolic blood pressure; mmHg 70 (60-70) NA
Mean arterial pressure; mmHg 80 (73-85) NA
Respiratory rate; rate per minute 28 (24-29) 28 (24-30)
Tourniquet test positive; n (%) 29 (67) 14 (50)
Petechiae; n (%) 13 (30) 7 (25)
Epistaxis; n (%) 6 (14) 0 (0)
Gum bleeding; n (%) 1 (2) 0 (0)
Hematemesis; n (%) 2 (5) 1 (4)
Melena; n (%) 0 (0) 1 (4)
Hemoglobin; g/dL 13.1  (12.4-14.0)  13.3 (11.9-14.2)
Hematocrite; % 38.2 (36.4-41.7) 39.8 (35.6-43.3)
Platelet count; x 109/L 63 (40-85) 38 (26-67)
White blood cell count;  x 10³ cells/ml 4.4 (3.1-6.3) 5.0 (3.0-9.5)
Albumin serum; g/dL, 3.5 (2.9-3.8) 2.8 (2.5-3.3)**
Total protein serum; g/dL 5.9 (4.9-6.5) 4.8 (3.8-5.7)**
Pleural effusion index at day 0 14 (0-22) 18 (12-29)*
Data represent medians with interquartile ranges or numbers with percentages. No data are given for 
pulse rate and blood pressure in the DSS group as all children received immediate intravenous fluid 
therapy at the time of presentation.
DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; NA, not applicable; n (%), absolute 
numbers (percentage) within DHF or DSS group. * p < 0.05; ** p < 0.01; calculated by Mann-Whitney 
U test.
MR-proADM and copeptin concentrations during dengue
Plasma MR-proADM concentrations were significantly higher in the DHF and 
DSS groups at enrollment than in the healthy controls with median (IQR) values 
of 0.47 nmol/L (0.39-0.68) and 0.56 nmol/L (0.44-1.00) vs. 0.22 nmol/L (0.19-
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0.29), respectively (figure 1A). While MR-proADM concentrations in the DHF 
group had decreased by day 2 to 0.41 nmol/L (0.34-0.54 nmol/L), MR-proADM 
concentrations remained elevated with 0.57 nmol/L (0.44-1.07 nmol/L) in the 
DSS group. All 6 patients who died of DSS had MR-proADM concentrations that 
were around or above the highest concentration found in the healthy controls.
Copeptin concentrations were not significantly higher in either of the patient 
groups as compared to the healthy controls on any day (figure 1B). Copeptin 
concentrations in the control group showed a larger variation and a broader 
overlap with the DHF and DSS concentrations than MR-proADM concentrations. 
Of the 6 patients that died, 3 patients had concentrations above the maximum 
concentration of the control group and 3 patients had copeptin concentrations 
within the range of the control group. Of the 4 highest copeptin concentrations 
on admission, 3 patients died. 
Figure 1. Plasma mid-regional pro-adrenomedullin and copeptin concentrations in Indonesian children 
with DHF/DSS and in healthy controls.
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Plasma mid-regional pro-adrenomedullin (MR-proADM) (A) and copeptin (B) concentrations in 
Indonesian children with DHF and DSS vs. healthy controls. Data are depicted at the day 0 (day of 
study enrollment), day 2, and the day of discharge. The line represents the median value. P values 
are determined by Mann-Whitney U test for non-paired data and Kruskal Wallis test for paired data. * 
represents a p value < 0.05; ** p value < 0.01.
MR-proADM is associated with increased plasma leakage
In both groups, protein and plasma leakage was already present at enrollment, 
indicated by the low serum concentrations of albumin and total protein 
(normal minimum values of 3.3 and 6.0 g/dL respectively) and the presence of 
pleural effusion (table 1). The pleural effusion index increased from enrollment 
to day 2 in both groups, suggesting ongoing plasma leakage (figure 2A). 
There was an inverse correlation of MR-proADM with serum albumin 
concentrations at enrollment (Spearman r= -0.45, p= 0.0001) (figure 2B). MR-
proADM concentrations were positively associated with the pleural effusion 
index at day 2 (Spearman r= 0.51, p= 0.0001) (figure 2C). In contrast, there was 
no significant correlation of copeptin concentrations with either PEI or albumin 
concentrations (data not shown). There was also no significant correlation of 
blood pressure, which was corrected by intravenous fluids whenever necessary, 
with either MR-proADM or copeptin concentrations (data not shown).
Figure 2. Correlation of parameters plasma leakage parameters with mid-regional pro-adrenomedullin 
concentrations in Indonesian children with DHF/DSS.
(A) Pleural effusion index (PEI) in Indonesian children with DHF and DSS on day 0 (day of study 
enrollment) and day 2 respectively. P values are determined by Mann-Whitney U test for non-paired 
data and Kruskal Wallis test for paired data. P value < 0.05 is considered significant. * represents a p value 
< 0.05; ** p value < 0.01.
Correlation between plasma mid-regional pro-adrenomedullin (MR-proADM) and serum albumin 
concentrations (B) on the day 0 (n=69, 2 outliers are not represented in the figure). Correlation between 
MR-proADM and the PEI (C) at day 2 (n=52, 1 outlier is not represented in the figure). Correlations are 
determined by Spearman correlation analysis (r).  
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DISCUSSION
In the present study, we show that DHF/DSS is associated with elevations of 
plasma concentrations of MR-proADM. MR-proADM concentrations reflect the 
production of the vaso-active hormone adrenomedullin, which is considered 
to play an important role in the initiation of the early hyperdynamic response of 
septic shock [19]. Various studies have indeed reported elevated MR-proADM 
in patients with septic shock [13, 14]. Among its diverse properties, the ability 
of adrenomedullin to reduce endothelial permeability is of particular interest 
in DHF/DSS, because this condition is characterized by a transient dysfunction 
in the endothelial cell barrier resulting in plasma leakage in predominantly the 
pleural and peritoneal cavities. Disintegration of the endothelial cell barrier may 
also contribute to the bleeding complications of DHF/DSS. Thus, although the 
vasodilatory effects of adrenomedullin may potentially have detrimental effects 
in DSS, our findings of elevated MR-proADM concentrations being associated 
with low serum albumin concentrations and with an increased pleural effusion 
index, may support the hypothesis that an increased adrenomedullin response 
is beneficial during DHF/DSS by counter-regulating the endothelial vascular 
hyperpermeability. MR-proADM levels gradually decreased over time but were 
not normalized at the time of discharge from the hospital. It should be noted 
however that improvement of the clinical condition together with elevation of 
platelets numbers are reason for discharge, which occurred after an average of 
4 days in hospital. No follow-up samples were available after discharge.  
Copeptin, a marker for vasopressin concentrations, has shown to be elevated 
during sepsis and septic shock as well [20]. We found no significant differences 
in copeptin concentrations between DHF and DSS patients and healthy 
controls. Notably, as has been observed for other stress-hormones like cortisol, 
the vasopressin response during human septic shock occurs in a biphasic 
manner, with initially high vasopressin concentrations, followed by a relative 
vasopressin deficiency. This phenomenon may also explain the rather large 
variation in copeptin concentrations in our patients. In addition, being a 
major regulator of water balance, factors such as water intake may also have 
a strong impact on vasopressin secretion. The observed variation in copeptin 
concentrations in the healthy controls may be attributed to such factors as well.
There is an urgent need for biomarkers in dengue virus infection to select those 
patients that are at risk for developing DHF/DSS. Presently, such biomarkers 
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are lacking and this results in many more admissions of patients with dengue 
virus infection than the eventual number of DHF/DSS cases warrant, thereby 
seriously overloading the health care facilities in resource poor endemic 
countries. MR-proADM might be a potential biomarker to stratify patients with 
dengue infection for the risk of DHF/DSS. Prospective studies evaluating the 
predictive value of MR-proADM are needed, which should also include patients 
with uncomplicated dengue.
In conclusion, MR-proADM concentrations are elevated in children with DHF 
and especially with DSS. We hypothesize that adrenomedullin has a functional 
role in DHF/DSS by limiting endothelial hyperpermeability.
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SUMMARY
Background. Activated monocytes/macrophages and T-lymphocytes that 
produce a cytokine storm are assumed to play a pivotal role in the pathogenesis 
dengue. Interleukin(IL)-18 is a pro-inflammatory cytokine that is increased 
during dengue and known to induce interferon(IFN)-γ, which is crucial for 
dengue-immune response. No data are available regarding the balance 
between IL-18 and its natural inhibitor IL-18 binding protein (IL-18BP), and 
how they interact within the inflammatory reaction of patients with dengue 
infections.
Methods. Circulating levels of IL-18, IL-18BP, free biologically active IL-18, the IL-
18-dependent pro-inflammatory cytokine IFN-γ, monocyte-derived cytokines, 
and ferritin were assessed in adult Indonesian dengue patients (n=95). Healthy 
individuals (n=22), leptospirosis (n=19) and enteric fever patients (n=6) served 
as controls. 
Results. Total IL-18 levels were increased during dengue, leptospirosis and 
enteric fever compared to healthy controls. However, due to a concurrent 
increase in IL-18BP levels, biologically active IL-18 levels remained similar in the 
different phases of dengue and in patients with leptospirosis. Biologically active 
IL-18 levels were also similar in patients with severe and non-severe dengue.
Discussion. High total IL-18 and IL-18BP levels concur in dengue virus 
infections, leptospirosis and enteric fever. This resulted in unchanged levels of 
free, biologically active IL-18 in dengue and leptospirosis, which underlines the 
importance to measure both IL-18 and IL-18BP when studying the role of IL-18 
in diseases. 
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INTRODUCTION
Dengue has become one of the most important arboviral infections in the 
world [1]. Dengue virus infection usually manifest as a self-limiting febrile 
illness. A subset of patients, however, develops life-threatening complications, 
which include plasma leakage, bleeding and/or severe organ failure [2, 3]. 
These complications usually occur during or shortly after defervescence in 
the so-called critical phase. The precise pathogenesis of these complications 
is not yet fully understood, but a massive secretion of cytokines by activated 
monocytes/macrophages and T-lymphocytes is assumed to play a pivotal role 
[3-6]. 
Interleukin-18 (IL-18) is a member of the IL-1 family of cytokines. It is 
synthesized as an inactive precursor requiring processing by caspase-1 into 
an active cytokine. The precursor is constitutively expressed by nearly all cells 
in humans. Dengue virus has been shown to activate the inflammasome and 
induce the production of IL-18 by human macrophages [7]. IL-18, together with 
IL-12, plays a major role in the production of interferon-γ (IFN-γ). This was also 
shown in a murine dengue model, in which IL-18 acted in synergism with IL-12 
to induce IFN-γ and other T-helper 1 cytokines, which are considered central 
mediators in dengue host defense [8, 9].  
Previous studies in patients with acute dengue have reported high serum IL-18 
levels, which correlated with disease severity [10-12]. However, the activity of 
IL-18 is balanced by a naturally occurring IL-18 binding protein (IL-18BP). IFN-γ 
stimulates the production of IL-18BP [13] prompting a classical feedback loop 
whereby IL-18BP neutralizes excessive IL-18 and attenuates the IFN-γ response. 
Hyperferritinemia has recently been reported to be a common feature of 
dengue [14]. Hyperferritinemia is also commonly observed in conditions with 
macrophage activation such as adult onset Still’s disease and IL-18 has been 
implicated in the pathogenesis of these conditions [15]. To gain a better insight 
in the biological activity of IL-18 during dengue, we determined plasma levels 
of IL-18, together with levels of IL-18BP, IFN-γ and other pro-inflammatory 
cytokines in a cohort of Indonesian dengue patients. We also determined the 
association with ferritin levels and included a group of healthy individuals and 
patients suffering from leptospirosis and enteric fever as controls. 
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METHODS
Study design
This study was part of a prospective study performed between March 2011 
– March 2012 in Rumah Sakit Hasan Sadikin, an academic referral hospital in 
Bandung, Indonesia. Patients clinically suspected for dengue, leptospirosis or 
Salmonella typhi/ Salmonella paratyphi infection were eligible to be included in 
the study. Blood was drawn at admission for routine laboratory investigations 
and diagnosis. Samples of clinically dengue suspected cases were tested for 
the presence of viral RNA by reverse-transcriptase (RT) PCR and for dengue 
specific IgM and IgG (Panbio, Windsor, Australia). A positive RT-PCR, minimum 
4-fold IgM and/or IgG titer increase and/or an IgM and/or IgG conversion, was 
considered a proven dengue infection. Samples that were IgM positive in at 
least one sample and/or with IgG levels comparable to a HI titer of at least 1:2560 
(the IgG cut off point set by the manufacturer to detect secondary infection) 
were considered highly suggestive dengue cases [2].  Patients with a proven 
or highly suggestive dengue infection were included and retrospectively 
classified as non-severe or severe dengue according to WHO 2009 criteria 
[2]. Dengue patients were systematically evaluated by daily history, physical 
examination, laboratory investigation and ultrasonography to detect plasma 
leakage. Additional blood sampling was scheduled once in each clinical phase 
of dengue infection: the febrile phase (temperature of 37.5 oC or more on that 
day), the critical phase (period within 48 hours after defervescence and before 
platelet counts increased again), early recovery phase (increasing platelet 
counts and clinical improvement) and convalescence phase (> 2 weeks after 
discharge).  
Patients with a clinical leptospirosis diagnosis in combination with both a 
positive IgM rapid test [16] and ELISA IgM (Panbio Windsor, Australia) were 
included, as well as patients with a clinical diagnosis of enteric fever who had 
a positive blood culture (Bactec Blood Culture System; BD diagnostics, Sparks, 
MD, USA) for Salmonella typhi or Salmonella paratyphi. Furthermore, a group of 
healthy volunteers, recruited among hospital staff, served as healthy controls. 
The study was approved by the local Medical Ethical Committee and written 
informed consent was obtained before enrollment from all patients and 
healthy controls.
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Cytokines, IL-18 binding protein and ferritin measurements
Plasma was obtained from citrate anti-coagulated whole blood, which was 
immediately centrifuged at 1700g for 15 minutes and stored at -80oC until 
further analysis. IL-18, IFN-α, IFN-γ, TNF-α, IL-6, IL-1 receptor agonist (IL-Ra) and 
ferritin levels were determined using commercially available MagPix Milliplex 
kits (Merck Millipore). A minimum of 50 beads was acquired with a Luminex 
Magpix instrument (Luminex Corporation, Austin, USA).  The minimum 
detectable concentration was 9.8 pg/mL for IL-18; 2.4 pg/mL for IFN-α, IFN-γ, 
TNF-α, IL-6, IL-1Ra and 0.03 ng/mL for ferritin, respectively. Plasma IL-1α 
(Genprobe Dioclone) and IL-18BP (IL-18BP-α, R&D Systems) were determined by 
commercially available ELISA kits according to the manufacturer’s instructions 
and had minimum detection limits of 0.03 ng/mL and 0.1 ng/mL respectively. 
The level of free, bio-active IL-18 was calculated based on the mass-action law, 
using a dissociation constant of 400 pM and a stoichiometric ratio of 1:1 [17]. 
Statistical analysis
Data are expressed as medians with interquartile ranges (IQR) or numbers with 
percentages. Differences in non-continuous data of 2 groups were analyzed by 
Pearson’s Chi-square test or by Fisher’s exact test in case of expected counts < 
5. Continuous variables between 2 groups were analyzed by unpaired t-test 
in case of normally distributed data; and by Mann Whitney U test in case of 
non-parametric data. Relationships between continuous data were examined 
by Spearman’s correlation for non-parametric data. P < 0.05 was considered 
statistically significant. 
RESULTS
Clinical characteristics
A total number of 95 patients with acute dengue, 19 patients with acute 
leptospirosis, 6 patients with enteric fever and 22 healthy controls were enrolled. 
Of the dengue patients, 80 (84%) were retrospectively classified as having non-
severe dengue and 15 (16%) as severe dengue [2]. All patients with severe dengue 
had plasma leakage in combination with shock; two patients with severe dengue 
also had respiratory distress accompanied by pleural effusion. None of the severe 
dengue cases had severe bleeding or organ failure. Characteristics and baseline 
data of the enrolled subjects are presented in table 1. 
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The RT-PCR for dengue was positive in 33 (35%) patients with dengue virus 
(DENV)-2 being the most common serotype (n=16), followed by DENV-3 (n=8), 
DENV-1 (n=5) and DENV-4 (n=4). In the remainder of the dengue patients, the 
diagnosis was based on results of the serological tests. Most dengue patients 
were admitted in the critical phase (n=76; 80%), the others in the febrile (n=15; 
16%) phase and the early recovery phase (n=4; 4%). Plasma leakage in the form 
of ascites, pleural effusion and/ or significant hematocrit changes occurred in 
51 (54%) of the patients. Ferritin levels were most increased in dengue and 
enteric fever patients and to a lesser extent increased in leptospirosis patients, 
compared to healthy controls.
IL-18BP neutralizes increased IL-18 levels in early dengue and in leptospirosis
Patients with acute dengue, leptospirosis and enteric fever all had significantly 
higher total median IL-18 plasma levels compared with levels in healthy 
controls (Figure 1A). However, plasma IL-18BP levels were also significantly 
increased in all 3 patient groups (Figure 1B). This resulted in a calculated free, 
biologically active IL-18 level that was unchanged in dengue and leptospirosis 
patients compared with healthy controls, while patients with enteric fever had 
increased free IL-18 levels despite a simultaneous increase in IL-18BP (Figure 1 
A-C). 
Figure 1. IL-18, IL-18BP, and free, biologically active IL-18 levels in dengue, leptospirosis, enteric 
fever and healthy controls. Plasma levels of (A) total interleukin(IL)-18, (B) IL-18 binding protein (IL-
18BP) and (C) free, biologically active IL-18 in Indonesian adults with dengue fever (n = 95) during the 
febrile (n = 14), critical (n = 77), early recovery (n = 72) and convalescence phase (n = 54); leptospirosis 
(n = 19); enteric fever (n = 6) and in a control group of healthy adult Indonesians (n = 22). The minimum 
detectable concentration was 9.8 pg/mL for total IL-18 and 0.1 ng/mL for IL-18BP. The level of free, bio-
active IL-18 was calculated based on the mass-action law, using a dissociation constant of 400 pM and a 
stoichiometric ratio of 1:1. The dots represent the individual measurements, the horizontal lines 
represent median values, the whiskers represent interquartile ranges. Outliers were left out of the figure 
in: (A) 1 febrile dengue, 1 leptospirosis and 1 enteric fever patient (IL-18 = 2077, 2207 and 1367 pg/mL 
respectively) and in (B) 1 leptospirosis patient (IL-18BP = 441 ng/mL). P values were determined by 
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Mann-Whitney U test for comparison of dengue, leptospirosis and enteric fever patients with the 
healthy control group. A p value < 0.05 was considered significant. The * indicates a p value < 0.05; ** 
<0.01 and *** <0.001.
The critical phase of dengue occurs around defervescence and is the phase 
of dengue in which most severe complications take place . This phase was 
defined as the period within 48 hours after defervescence and before platelet 
counts increased again. Total IL-18, IL-18BP and biologically active IL-18 plasma 
levels did not differ between non-severe and severe dengue (Figure 2 A-C), or 
between patients with and without plasma leakage and/or bleeding in the 
critical phase of dengue (data not shown). In the critical phase of dengue, 
median total IL-18 levels were 218.5 and 163.0 pg/mL (interquartile ranges 
104.5-354.0 and 101.5-258.5 pg/mL), median IL-18BP levels were 14.6 and 
16.7 ng/mL, (interquartile ranges 9.4-22.1 and 12.9-22.8 ng/mL), and median 
biologically active IL-18 levels were 77.4 and 58.1 pg/mL (interquartile ranges 
44.9-158.1 and 37.2-77.3 pg/mL) for severe and non-severe dengue patients, 
respectively. There was a moderate positive correlation between total IL-18 as 
well as IL-18BP levels with ferritin levels in dengue patients (Rs=0.36, p=0.001; 
R
s
= 0.29, p<0.05, respectively). 
Figure 2. IL-18, IL-18BP, and free, biologically active IL-18 levels in non severe versus severe dengue 
cases. Plasma levels of (A) total interleukin(IL)-18, (B) IL-18 binding protein (IL-18BP), (C) free, biologically 
active IL-18 in Indonesian adults with non severe dengue fever (n = 65, n = 4 missing) and severe dengue 
fever (n = 12, n= 3 missing) during the critical phase. The minimum detectable concentration was 9.8 
pg/mL for total IL-18 and 0.1 ng/mL for IL-18BP. The level of free, bio-active IL-18 was calculated based 
on the mass-action law, using a dissociation constant of 400 pM and a stoichiometric ratio of 1:1. The 
dots represent the individual measurements, the horizontal lines represent median values, the whiskers 
represent interquartile ranges. P values were determined by Mann-Whitney U test for comparison of 
dengue, leptospirosis and enteric fever patients with the healthy control group. A p value < 0.05 was 
considered significant. 
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IFN-γ, IFN-α and TNF-α increased, while IL-6, IL-1Ra and IL-1α levels remained 
low during dengue
Plasma levels of IFN-γ, IFN-α and TNF-α were all increased during early dengue 
infection (figure 3 A -C). Remarkably, high TNF-α levels were found in dengue 
patients, while IL-6 remained below the detection limit of 2.4 pg/mL, except 
for 7/13 (54%) patients in the febrile phase (figure 3 D). The same trend was 
observed for IL-1Ra (figure 3E) and IL-1α (data not shown; 156 patients and 
control samples were below the detection limit, therefore no further analysis 
of the remaining samples was performed). 
Figure 3. Cytokine levels in dengue, leptospirosis, enteric fever and healthy controls. Plasma levels of 
(A) interferon(IFN)-γ, (B) IFN-α, (C) tumor necrosis factor(TNF)-α, (D) IL-6 and (E) IL-1 receptor 
antagonist(Ra) in Indonesian adults with dengue fever (n = 95) during the febrile (n = 14), critical (n = 
77), early recovery (n = 72) and convalescence phase (n = 54); leptospirosis (n = 19); enteric fever (n = 6) 
and in a control group of healthy adult Indonesians (n = 22). The minimum detectable concentration 
was 2.4 pg/mL for all cytokines. The dots represent the individual measurements, the horizontal lines 
represent median values, the whiskers represent interquartile ranges. P values were determined by 
Mann-Whitney U test for comparison of dengue, leptospirosis and enteric fever patients with the 
healthy control group. A p value < 0.05 was considered significant. The * indicates a p value < 0.05; ** 
<0.01 and *** <0.001.
Compared to patients with non-severe dengue, patient with severe dengue had 
similar IFN-γ levels (medians 6.3 and 4.4 pg/mL, interquartile ranges 2.4 - 19.1 
and 2.4 - 10.5 pg/mL, respectively), but decreased IFN-α levels (medians 4.6 and 
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11.1 pg/mL, interquartile ranges 2.4 - 10.9 and 6.4 - 27.9 pg/mL, respectively, 
p<0.05) and increased TNF-α levels (medians 14.6 and 9.6 pg/mL, interquartile 
ranges 8.9 – 19.9 and 5.0 – 14.3 pg/mL, respectively, p<0.05) in the critical 
phase. Total IL-18 was moderately associated with TNF-α (R
s
= 0.28, p<0.01) and 
IL-18BP with IFN-α (R
s
=0.29, p<0.01) but not with IFN-γ, whereas biologically 
active IL-18 was not associated with any of the determined cytokines.
Enteric fever patients also had increased IFN-γ, IFN -α and TNF -α plasma levels 
(figure 1 D-F), while leptospirosis was associated with increased IL-6 (Figure 3D) 
and IL-1Ra (Figure 3E). In leptospirosis, IL-18BP positively correlated with TNF-α 
levels (R
s
=0.68, p=0.001) (data not shown). 
DISCUSSION
Three clinical studies documented high IL-18 levels in dengue infected patients 
[10-12]. However, the interpretation of these data is limited by the fact that no 
information on its natural antagonist IL-18BP is given as well. The same applies 
to the in vitro and animal studies that also suggested an important role for IL-
18 in the pathogenesis of dengue [7-9]. In the present study, we document 
high plasma IL-18 levels concurring with increased IL-18BP levels in dengue, 
especially during the febrile and critical phase of dengue and to a lesser extent 
in the recovery phase of dengue. As a result, the calculated levels of circulating 
biologically active IL-18 levels did not increase during any of the phases of 
dengue. Furthermore, IL-18BP and biologically active IL-18 levels were not 
related to dengue severity during any of the phases of dengue infection . Our 
findings therefore suggest that the importance of high IL-18 levels in dengue 
should be put into perspective. 
 The concurrent elevation of IL-18 and IL-18 BP was not specific for dengue 
infection, but also occurred in our cohort of leptospirosis and enteric fever 
patients. Only enteric fever patients ultimately had increased biologically active 
IL-18 levels, although this group was too small to draw any firm conclusions.  
IFN-γ is a central cytokine in the host defense against dengue. IFN- γ production 
can be induced, as shown in a murine dengue model, by the combined action of 
IL-18 and IL-12, while blocking IL-18 activity by administration of recombinant IL-
18BP results in lower IFN-γ, higher TNF-α and IL-6 serum levels and more severe 
disease [8]. In contrast, the present study showed that IFN-γ was increased 
during the febrile phase of dengue, while IL-18 levels were unchanged. Our 
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findings that circulating levels of biologically active IL-18 were not increased 
in dengue does not preclude a role for IL-18 in IFN-γ production, because IL-18 
secreting macrophages are especially located in liver and spleen and levels in 
the peripheral blood may not reflect local IL-18 production. Furthermore, we 
cannot exclude that IL-18 independent IFN-γ production by the adaptive part 
of the immune system, especially specific Th1 memory cells, also plays a role. 
Apart from dengue, IL-18BP levels were also measured previously in patients 
with acute chikungunya infection. IL-18BP levels were higher in acute sera, 
compared to convalescence, but levels in that study were significantly lower 
compared to our data [18]. In patients with sepsis total IL-18, IL-18BP and 
calculated biologically active IL-18 were all increased [19], while the clearly 
elevated IL-18BP levels again did not reach similar levels as we found. These 
studies, together with the current study, indicate that biologically active IL-18 
should be determined when analyzing the role of IL-18 in the pathogenesis of 
diseases.  
A limitation of this study is that patients were admitted relatively late in the 
course of dengue, enteric fever and leptospirosis, probably due to late help-
seeking behavior of the patient and the study- setting in an academic referral 
hospital. We cannot rule out that IL-18BP was induced significantly later than 
IL-18, and that higher biologically active IL-18 levels may have been present 
earlier in the course of dengue. 
In conclusion, in this study we report that increased IL-18 levels concur with 
increased levels of its antagonist IL-18BP, resulting in unchanged biologically 
active IL-18 levels in dengue virus infections. This demonstrates the need for 
both total IL-18 and IL-18BP measurements when studying the role of IL-18 in 
diseases. Increased IL-18 and IL-18BP levels seem not to be specific for dengue 
infection as our data in leptospirosis and enteric fever patients indicate.
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GENERAL DISCUSSION
Dengue virus infection is the most rapidly spreading mosquito-borne viral 
disease in the world and has the highest burden in often resource poor (sub)
tropical countries. Symptomatic dengue patients usually present with a self-
limiting febrile illness, called dengue fever. However, a proportion of dengue 
patients develops severe complications around the time of defervescence, 
which is also known as the critical phase of dengue. Dengue-associated plasma 
leakage is the most frequent and the most feared complication, because it 
may suddenly progress to life-threatening hypovolemic shock and because it 
can cause respiratory distress [1, 2]. Severe bleeding and organ failure are less 
common features of severe dengue. Thrombocytopenia is a hallmark of dengue 
infection and platelet count nadir coincides with the critical phase. Dengue 
infection is frequently difficult to differentiate from other thrombocytopenic 
febrile illnesses, such as leptospirosis and enteric fever.
The first studies described in this thesis focus on the clinical aspects of plasma 
leakage detection (chapter 2) and the differential diagnosis of dengue (chapter 
3). In the other chapters, we explored how changes in the function of platelets 
(chapters 4, 5 and 6), endothelium (chapters 6 and 7) and the host immune 
response (chapter 8) may contribute to the pathogenesis of dengue-associated 
plasma leakage.
Plasma leakage detection by serial ultrasonography: implications for 
dengue research and clinical practice
Identifying the patients at risk for progression to severe dengue is important, 
but at the same time challenging. Much effort has been put in the identification 
of biomarkers that can reliably identify these patients, but so far, no biomarker 
has been proven useful clinically. Directly detecting plasma leakage before 
shock develops is an alternative approach. Although dengue-associated 
plasma leakage is historically considered a hallmark of severe dengue, some 
studies demonstrated the presence of non-symptomatic (subclinical) plasma 
leakage in the early stages of severe dengue infection [3] or in non-severe 
dengue infection [4, 5]. The WHO guidelines for dengue recommend several 
methods to detect plasma leakage: i) serial hematocrit values; ii) visualization 
of pleural effusion and/or ascites by ultrasonography or chest X-rays; iii) by 
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clinical observation of signs of shock and respiratory distress due to pleural 
effusions [6]. Unfortunately, single hematocrit values are difficult to interpreted 
due to individual variations, the absence of pre-illness values and the influence 
of intravenous fluid replacement and bleeding. Significant changes in serial 
hematocrit values are often documented in late stages and therefore of limited 
clinical value as a predictive tool. The use of chest X-rays is limited by high costs, 
restricted availability and the fact that ascites is not detected. 
Nowadays, more affordable handheld ultrasonography devices are available. In 
chapter 2 we determined the natural course of plasma leakage in Indonesian 
adults with dengue, by using daily handheld bedside ultrasonography 
performed by a trained study physician instead of a radiologist. We found that 
subclinical pleural effusion and/or ascites was frequently present at the time 
of hospital admission, which proved to have a positive predictive value of 35% 
and a negative predictive value of 90% for the development of severe dengue. 
Moreover, gallbladder wall thickening often preceded pleural effusions and/
or ascites and the thickness was related to the severity of dengue. Findings of 
the handheld ultrasonography were consistent with findings of conventional 
ultrasonography performed by a radiologist. Hematocrit turned out to be 
a poor indicator of plasma leakage and severe dengue, even when serial 
measurements were performed. 
The previous (1997) and current (2009) WHO dengue guidelines depend largely 
on the presence of plasma leakage to define severe dengue [6-9], and differences 
in the sensitivity of the methods that are used to detect plasma leakage have 
impact on the heterogeneity of study populations of dengue patients. This 
makes it difficult to compare and interpret dengue studies, in particular the 
studies that address the pathogenesis of severe dengue. Additionally, the 
timing and frequency of plasma leakage screening is important; cross-sectional 
screening can miss the plasma leakage that develops later in the course of the 
disease, as our study of serial ultrasonography confirmed. Bedside ultrasound 
devices are therefore not only useful for daily practice, but may be a valuable 
tool for studies as well.
We conclude that serial bedside handheld ultrasonography can help to predict 
which dengue patients are at risk for developing severe plasma leakage by 
detecting subclinical plasma leakage, which is often preceded by thickening 
of the gallbladder wall. The use of more affordable handheld ultrasonography 
devices hold promise for implementation in more resource poor endemic 
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settings, especially since they can be used non-radiologists after a short 
training. A limitation of this study is that patients presented relatively late in 
our referral hospital and therefore plasma leakage could already be detected 
at admission in many patients. It would be useful to study the predictive 
value of serial ultrasonography for severe dengue in non-referral hospitals 
and primary health care centers as well. Moreover, it would be relevant to see 
whether ultrasonography findings of plasma leakage - including gallbladder 
wall thickening - can contribute in the differentiation of dengue from other 
febrile thrombocytopenic illnesses, which is still a challenge as outlined in the 
next section. 
Differentiating dengue from other endemic febrile thrombocytopenic 
diseases
Dengue virus infection has become one of the most common causes of 
undifferentiated fever characterized by thrombocytopenia in tropical settings 
[10-12]. The diagnosis is often complicated by the fact that dengue shares 
many clinical features with other undifferentiated febrile illnesses such as 
leptospirosis and enteric fever [13-15]. Timely differentiation between these 
infections is important as their management differs and early interventions 
may prevent severe illness and death. In recent years, rapid diagnostic tests 
have been developed, but these tests suffer from a limited sensitivity in highly 
endemic regions [16-19]. Hemocytometry, including differential counts, may 
point towards specific infections, however these commonly used parameters 
do not differentiate reliably enough to guide clinical decision making [20-24]. 
In chapter 3 we explored whether hematological parameters, as measured by 
a relatively new generation of automated hematology analyzers, are useful 
to differentiate between dengue, leptospirosis and enteric fever in Bandung, 
Indonesia. Since hematology analyzers are often already routinely used in 
dengue-endemic areas, these parameters hold promise to be implemented 
in clinical practice. Especially determination of the activation state of different 
types of leukocytes was useful in differentiating these infections. We found that 
dengue could be differentiated from leptospirosis by an increased percentage 
of cells in the atypical lymphocyte flagging area (AUC 0.87; 95%CI 0.70-1.03), 
an increased percentage of high fluorescence lymphocytes (AUC 0.89; 95%CI 
0.78-0.99) and an increased percentage of immature platelet fraction (AUC 0.81; 
95%CI 0.65-0.97), while leptospirosis was characterized by a higher percentage 
39796 Michels, Meta.indd   134 28-03-16   12:38
General discussion and summary
135
9
of immature granulocytes (AUC 0.86; 95%CI 0.71-1.02). The combination of 
low percentage of cells in the atypical lymphocyte area, low percentage high 
fluorescence lymphocytes and low percentage of immature granulocytes 
supported a diagnosis of enteric fever, although the number of confirmed 
cases was limited. 
This study offered a first indication on the clinical usefulness of the latest 
generation hematology analyzers in differentiating between dengue and other 
infections. It formed the basis for a large ongoing study in febrile patients in 
Bandung in which a diagnostic algorithm is made using hematology analyzers. 
The study described in this thesis also identified some challenges for large 
diagnostic fever studies. First, the diagnosis of dengue may be complicated. 
According to the WHO dengue guidelines, laboratory confirmation of dengue 
can be made by nucleic acid detection, virus isolation, antigen testing in clinical 
specimens and by serological tests (IgM positivity alone – which is considered a 
probable dengue case -, seroconversion or a 4-fold IgG titer increase in paired 
samples)[6]. In West-Java, dengue is hyper-endemic and most of the adult 
patients suffered from secondary dengue infections. This implies a shorter 
window of PCR positivity (approximately one third of the patients had a positive 
PCR in our adult cohort) and probably also of the NS1 (dengue antigen) rapid 
test due to faster virus clearance from the blood. Additionally, in secondary 
infections the IgM titer response is often absent or weak. Moreover, we found 
that the IgG titers were often very high at presentation, reaching values that 
are highly suggestive for a secondary infection in the first serum sample during 
the acute phase. This means that the criterion of a 4-fold IgG titer increase in 
paired samples could often not be witnessed. Another concern is that rapid 
tests for IgM and IgM ELISAs for dengue and other endemic illnesses such as 
leptospirosis suffer from cross-reactivity. Apart from dengue, it is sometimes 
also difficult to confirm the diagnosis of leptospirosis and enteric fever. Blood 
cultures have a limited sensitivity to diagnose enteric fever, which may be 
further compromised by the frequent use of antibiotics before presentation 
to the hospital. The more sensitive bone marrow cultures are rarely performed 
as it is an invasive painful procedure. The golden standard for leptospirosis 
diagnosis is the microscopic agglutination (MAT) method, which suffers from a 
significant range of technical problems and can only be performed in reference 
laboratories. Moreover, both MAT as well as IgM-based leptospirosis rapid tests 
have a limited sensitivity in the acute phase sera [25]. 
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So, while serial handheld ultrasonography performed by non-radiologists may 
be used to better identify dengue patients at risk to develop severe disease, 
new hematological parameters as measured by new generation hematology 
analyzers may be applied to better differentiate dengue from other endemic 
thrombocytopenic febrile illnesses. Although both methods should be 
validated in other settings as well, the main strength of these studies is that 
they describe methods that may also be affordable and available in most 
dengue-endemic areas.
Role of platelets, endothelium en host immune response in dengue-
associated plasma leakage
The endothelial battlefield during dengue virus infections
Dengue-associated plasma leakage is characterized by a transient increase 
of vascular permeability without morphological damage to the capillary 
endothelium [26]. The underlying mechanisms are complex and have not 
been fully elucidated yet. Many factors may play a role and influence each 
other, including virus related factors, host immune response, platelet count 
and function and endothelial function (figure 1). Furthermore, differences in 
host genetics may account for a predisposition for severe dengue-associated 
plasma leakage. However, all these proposed players on the endothelial 
battlefield – except platelet count nadir - have in common that their presence 
does not coincide with the timing of severe plasma leakage. 
Thrombocytopenia and platelet function during dengue
In recent years, the role of platelets in dengue-associated plasma leakage has 
gained increased interest [27-31]. Platelets constitutively release trophogens 
that stabilize the endothelial barrier function, such as angiopoietin-1 (Ang-1) 
and sphingosine-1-phosphate (S1P). Sufficient numbers of functional platelets 
are not only required for adequate hemostasis, but also for preservation of 
endothelial integrity, especially during inflammation [32]. On the other hand, 
platelets contain vaso-active mediators that increase endothelial permeability, 
such as serotonin, vascular endothelial growth factor A (VEGF-A) and IL-1β. 
Vaso-active mediators can be released upon platelet activation by fusion of 
intra-platelets granules with the outer platelet membrane or in the form of 
micro-particles. 
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Dengue-associated thrombocytopenia likely originates from a combination 
of decreased platelet production due to infection of megakaryocytes and 
cytokine-related bone marrow suppression, and increased platelet clearance. 
Multiple factors play a role in the latter, including platelet activation, 
complement-mediated platelet lysis, antibody-mediated platelet destruction, 
platelet phagocytosis, platelet apoptosis and interaction of platelets with 
other cells such as leukocytes and endothelium [33]. Based on the rationale 
that platelet counts inversely correlate with bleeding risk in patients with 
hypoproliferative bone marrow disorders [34], prophylactic platelet transfusions 
are given in this patient category. In contrast, for dengue patients with severe 
thrombocytopenia the scarcely available data suggest that prophylactic 
platelet transfusions are of limited value in preventing bleeding. Platelet 
transfusion is costly and may have severe side-effects [35, 36]. Therefore, WHO 
dengue guidelines do not advocate platelet transfusions in the absence of 
(suspected) severe bleeding, even at platelet counts below 10 x 109 cells/ L [6]. 
In practice however, clinicians seem to have a heterogonous approach towards 
prophylactic platelet transfusions [37]. 
The fact that petechiae and bleeding complications during dengue frequently 
occur with platelet counts well above the threshold for spontaneous bleeding, 
suggests that dengue is also associated with functional platelet defects. 
Studies using platelet aggregometry indeed showed reduced aggregation in 
dengue patients [38-40], but these methods are less reliable in conditions with 
thrombocytopenia. Although data concerning platelet (dys)function during 
dengue are scarce, platelet activation is known to occur [41, 42]. Dengue virus-
induced platelet activation promotes plasma leakage by activation of the 
NLRP3 inflammasome inside platelets leading to shedding of IL-β rich micro-
particles that can induce hyperpermeability [31]. Platelets are anucleate cells 
and therefore have a limited capacity to restore the vaso-active mediators that 
are released upon platelet activation, making them prone for depletion and 
altered functioning. In chapter 4 we explored the hypothesis that ongoing 
platelet activation leads to platelet depletion of vaso-active mediators and to 
platelet dysfunction, thereby promoting vascular permeability and bleeding. 
Using a novel flow cytometry based assay, we confirmed earlier findings that 
platelet activation occurs in dengue infection. Additionally, ex vivo platelet 
activation with a strong platelet agonist (TRAP) resulted in a reduced expression 
of the activated fibrinogen receptor, P-selectin and CD63. A reduced expression 
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of the active conformation of the fibrinogen receptor upon platelet stimulation 
may inhibit the fibrinogen binding that is necessary for platelet aggregation, 
which may contribute to bleeding complications during dengue. We also 
found a significant association of platelet activation and dysfunction with 
plasma leakage. Whether the reduced expression of platelet activation markers 
following TRAP stimulation indicates an extensive ‘exhausted’ state of the 
platelets remains uncertain after these experiments. A recent report studying 
platelet function by similar methods in Hanta virus infection – another viral 
hemorrhagic disease- showed increased platelet activation markers in vivo and 
reduced platelet activation markers upon ex vivo platelet stimulation. However, 
these platelets retained their ability to enhance the level of fibrinogen binding 
via autocrine ADP-mediated stimulation, which argues against an important 
degree of platelet exhaustion [43]. 
The P-selectin expressed on activated platelets can bind to the P-selectin 
glycoprotein ligand-1 (PSGL-1) on leukocytes and is the main molecular basis 
for the formation of platelet-leukocyte complexes. In fact, both platelet-
monocyt (PMC) and platelet-neutrophil complexes (PNC) are considered to be 
very sensitive markers for platelet activation, since aggregations are already 
formed at a low degree of P-selectin expression on the platelet surface. It is 
therefore striking that we found increased platelet P-selectin expression in 
combination with decreased numbers of PMCs and PNCs. The PMC/ PNCs were 
strongly related to the platelet counts in our patients and we speculate that the 
degree of thrombocytopenia may also determine the number of PMC and PNC. 
Our findings of decreased PMC/ PNCs are in contrast with data obtained from a 
cohort of patients with mild dengue [44] and to an experimental primate model 
of dengue infection [45]. In these studies, platelets were identified by P-selectin 
expression, whereas we used CD42b to identify the platelets in circulating 
PMC/PNCs. However, P-selectin is not only expressed by activated platelets but 
also by endothelial cells, while CD42b is expressed on platelets only, including 
platelets that are not activated. Possibly, not only platelet-derived but also 
endothelial derived microparticles interact with monocytes, explaining the 
difference between our results and other studies, as endothelial cell activation 
is indeed a well known feature of dengue virus infection.  Platelet-leukocyte 
complexes are more than an indicator of platelet activation. P-selectin binding 
to PSGL-1 alters leukocyte functions and as such alters immune responses and 
leukocyte infiltration in inflamed tissues, which can both contribute to vascular 
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hyperpermeability [46-49]. Also apoptotic platelets aggregate with monocytes 
during dengue infection and alter specific cytokine responses that may 
contribute to the pathogenesis [50]. Furthermore, these apoptotic platelets 
are cleared from the circulation by macrophages [51], which contributes to 
thrombocytopenia and to further plasma leakage. 
Platelets are the main vehicle for intravascular transport of the vascular 
permeability inducer serotonin. We found that platelets contain increased 
serotonin levels during the critical phase of dengue, while serotonin plasma 
levels remained the same. The increased serotonin content of platelets may 
be due to the effects of thrombocytopenia and the upregulation of the 
serotonin transporter (SERT) on platelets, as has been described previously in 
association with activation of the fibrinogen receptor [52]. Due to the dynamic 
regulation of SERT on platelet membranes, plasma levels of serotonin can be 
tightly regulated and the intra-platelet serotonin content may show different 
kinetics than other vascular mediators in platelets concerning depletion due 
to platelet activation. So, platelets have the potential to act as a two-edged 
sword regarding vascular permeability, since they contain both anti- and pro-
permeability mediators, of which the storage and release are at least partly 
regulated by different pathways. 
A limitation of this study is that flow cytometry does not provide information on 
cells that are no longer in the circulation. Therefore, we also determined soluble 
markers for platelet activation, and found that soluble P-selectin (sCD62P) and 
platelet factor 4 were decreased during the critical phase of dengue, while the 
chemokine RANTES (Regulated on Activation, Normal T cell Expressed and 
Secreted) showed no differences at all. RANTES is powerful chemo-attractant 
for inflammatory cells and is deposited on inflamed endothelium by activated 
platelets [53] and platelet microparticles [54]. These data of soluble platelet-
derived factors are difficult to interpreted in dengue, since the levels of these 
soluble factors are likely to depend on the platelets counts [55], which rapidly 
fall and rise during dengue. Moreover, sCD62P is secreted by both activated 
platelets and endothelium, and RANTES can be secreted by many cell types, 
including endothelial cells, activated T-cells and macrophages. 
A particular strength of this study is that many precautions were taken to avoid 
in vitro platelet activation, including the use of CTAD vacutainers (sodium 
citrate, theophylline, adenosine and dipyramidol), blood drawing methods 
resulting in minimum shear stress of platelets and rapid processing of the 
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blood. These precautions were also taken to determine changes in the amount 
of vaso-active mediators in platelets which are described below. 
Plasma levels of vaso-active mediators affecting endothelial permeability
Platelets contain and release vaso-active mediators, such as S1P and Ang-1. We 
studied these mediators during dengue infections as they are known to protect 
the endothelial barrier. In chapter 5 we describe that plasma concentrations 
of S1P and its chaperone apolipoprotein M (ApoM), which is predominantly 
present on HDL particles, are decreased in dengue. This reduction in plasma S1P 
levels was associated with plasma leakage, but, in contrast to our hypothesis 
of platelet depletion and exhaustion, the supernatant of platelet rich plasma 
contained similar S1P levels compared to platelet poor plasma in all phases of 
dengue infection as well as in healthy controls, suggesting that platelets were 
not the dominant source of S1P. Moreover, there was no correlation of plasma 
S1P with soluble and membrane markers of platelet activation. This argues 
against an important role for platelets in the altered plasma S1P concentrations 
during dengue. The decreased HDL and ApoM levels that we observed may 
underlie decreased plasma S1P during dengue. In chapter 6 we report that 
Ang-1 levels are decreased in dengue infection, and are accompanied by an 
increase of Ang-2. Ang-1 is stored in platelets and maintains vascular integrity, 
while the endothelium-derived Ang-2 promotes vascular leakage. This Ang-1/ 
Ang-2 imbalance was associated with markers of plasma leakage in a cohort of 
Indonesian children with severe dengue. Plasma Ang-1 and Ang-2 act through 
the Tie-2 receptor, which is not expressed on post-capillary venules [56]. These 
venules are an important site for plasma leakage. In this context, it should be 
mentioned that the anti-permeability effect of Ang-1 can be mimicked by S1P 
via activation of the S1P-producing enzyme SphK1 and that the endothelial 
barrier stabilizing effect of S1P is thus not restricted to the occurrence of Tie-2, 
suggesting a more universal function of S1P on endothelial barrier integrity 
compared to Ang-1 [57]. 
Drugs interfering with vascular permeability, such as Ang-1, S1P and FTY720-P 
(Fingolimod; an S1P analogue) are already used for other clinical indications 
and are potential candidates for counteracting dengue-induced endothelial 
hyperpermeability. In vitro, endothelial hyperpermeability due to infection 
with pathogenic Hanta virus was blocked by Ang-1, S1P and antibodies to 
the VEGF receptor (VEGFR2) [58].  Animal studies aiming to intervene in the 
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Tie-2/ Angiopoietin axis showed that a drug-like Tie2 receptor agonist was 
able to counteract microvascular endothelial barrier dysfunction and reduced 
mortality in a murine sepsis model [59]. Further studies intervening in these 
angiogenic factors in an animal model that recapitulates human dengue 
infection would be useful to explore potential therapeutic targets in dengue 
infection. Unfortunately, current animal models have not succeeded yet in 
carefully mimicking human dengue virus infection and particularly plasma 
leakage is not present in the existing models [60]. Besides the challenges 
of developing an accurate animal model of dengue infection, the interplay 
between different angiogenic factors should be kept in mind when therapeutic 
interventions are explored. For example, the action of angiopoietins depends 
on the concomitant levels of VEGF-A, which in turn depend on the levels of 
its receptors. Reports on VEGF-A levels in dengue infection show conflicting 
results [61-64], which may be attributed to differences in the timing of sample 
collection in the course of dengue infection, as well as inconsistencies in 
method of sample collection (e.g type of anticoagulant; whether serum, plasma 
or whole blood was used) and sample processing [65]. Also angiopoietin 
and sphingolipid effects on endothelial permeability are related, since Ang-
1 mediated endothelial permeability is regulated by a key enzyme in S1P 
metabolism, as mentioned above [57]. These examples suggest that new 
therapies aimed to reduce the endothelial hyperpermeability in dengue 
should probably target different vaso-active mediators simultaneously. Finally, 
vaso-active mediators may also influence dengue pathogenesis in other ways. 
For example, S1P has important effects on immune cell migration, release of 
inflammatory mediators, phagocytosis and cell death [66, 67], which should be 
considered when therapeutics that interfere with S1P metabolism and/or its 
S1P1-receptor are tested as a specific treatment for dengue. 
In chapter 7, we explored the possible role of the vaso-active hormones 
adrenomedullin and vasopressin, by determining their more stable pro-
hormones mid-regional pro-adrenomedullin (MR-proADM) and copeptin, 
respectively in the cohort of children with severe dengue. Adrenomedullin 
and vasopressin are vaso-active hormones that exert specific hemodynamic 
effects and have received attention in recent years as biomarkers for sepsis. 
Adrenomedullin is predominantly released by the endothelium, acts as a 
potent vasodilator and has natriuretic effects [68-70]. Other properties of 
adrenomedullin include a reduction in endothelial permeability [71, 72], 
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bactericidal effects [3] and down-regulation of pro-inflammatory cytokines 
[73]. Vasopressin (also known as the antidiuretic hormone) is released 
from the hypothalamus and has potent antidiuretic and vasoconstrictive 
effects. MR-proADM levels were increased in children with severe dengue 
compared to controls and correlated with the severity of plasma leakage. 
Copeptin concentrations showed no significant changes as compared to 
controls. Possibly, adrenomedullin has a functional role in limiting endothelial 
hyperpermeability during severe dengue and this pilot study may be used as a 
start to study the role of adrenomedullin in the pathogenesis of severe dengue. 
For future studies, the inclusion of both severe and non-severe dengue cases 
are recommended, to see whether differences in MR-proADM levels exist. 
Studies in patients with SIRS and sepsis showed only marginal differences in 
MR-proADM levels between these 2 groups [74], which possible indicates that 
levels of this (pro-hormone) also alters during cases of less severe inflammation 
or vasomotor response. 
A role for IL-18 in severe dengue? 
Finally, the timing of severe complications around defervescence triggered 
us to explore the role of the pro-inflammatory, but non-pyrogenous cytokine 
interleukin (IL)-18. IL-18 is known to induce IFN- γ, which is crucial for dengue 
host response. Increased IL-18 levels were reported in 3 human dengue studies, 
but levels of its natural inhibitor IL-18 binding protein (IL-18BP) were not 
reported. In a murine dengue model, the combined action of IL-18 and IL-12 
induced IFN-γ, while blocking IL-18 activity by administration of recombinant 
IL-18BP results in lower IFN-γ, higher TNF-α and IL-6 serum levels and more 
severe disease [75]. In chapter 8 we describe increased levels of both IL-18 and 
IL-18BP, resulting in unchanged levels of the biologically active IL-18 during 
dengue. Furthermore, IL-18BP and biologically active IL-18 levels were not 
related to dengue severity. Additionally, the increase in IL-18 and IL-18BP was 
not specific for dengue, as similar increases were observed in patients with 
leptospirosis and enteric fever. 
We found that IFN-γ was increased during the febrile phase of dengue, while 
free IL-18 levels were unchanged, which does not preclude a role for IL-18 in 
IFN-γ production, because IL-18 secreting macrophages are especially located 
in liver and spleen and levels in the peripheral blood may not reflect local IL-
18 production. Furthermore, we cannot exclude that IL-18 independent IFN-γ 
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production by the adaptive part of the immune system, especially specific Th1 
memory cells, also plays a role. A limitation of this study is that patients were 
admitted relatively late in the course of dengue, enteric fever and leptospirosis. 
We cannot rule out that IL-18BP was induced significantly later than IL-18, 
and that higher biologically active IL-18 levels may have been present earlier 
in the course of dengue. Based on this study there is no rationale in further 
investigating whether interfering with the IL-18/ IL-18BP axis would benefit 
dengue patients, unless studies performed earlier in the course of dengue will 
show increased free IL-18 levels and an association with severity of disease. 
Figure 1. summarizes how the different players on the endothelial battlefield 
may interact and can lead to plasma leakage during dengue virus infections. In 
the legenda the specifc actors that are subject of the studies in this thesis are 
described in more detail.
Figure 1. The endothelial battlefield: Interactions between dengue virus, immune cells, platelets and 
endothelial cells that can promote hyperpermeability during dengue virus infection. 
Dengue virus (DENV) infects and activates (yellow lightning symbol) innate immune cells such as 
dendritic cells, monocytes/ macrophages and mast cells. This results in viremia, circulation of DENV 
antigens including nonstructural protein 1 (NS1; blue dots), antibodies against DENV antigens 
including NS1 and cytokines/ chemokines (red dots) that may directly or indirectly increase endothelial 
permeability. Activation of adaptive immune cells including memory T-lymphocytes with low affinity 
for the present infecting DENV serotype, but with high affinity for a previously encountered DENV 
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serotype, can further contribute to a cytokine storm that promotes endothelial permeability. Also 
circulating DENV-antibodies with little neutralizing capacity for the present DENV serotype, can 
promote viral replication by enhancing infection antigen presenting cells via increased uptake of DENV/ 
antibody complexes. Several studies determined cytokine profiles during dengue infection. However, a 
clear consistent relationship between cytokine levels and the timing of severe plasma leakage around 
defervescence has not been demonstrated yet. This can at least partly be attributed to differences 
between studies regarding sampling methods and timing, as well as differences in plasma leakage 
detection methods. IL-18 is a pro-inflammatory cytokine that is mainly derived from macrophages and 
does not induce fever. In chapter 8 we describe unchanged biologically active IL-18 levels due to a 
concomitant increase of both IL-18 and its natural antagonist IL-18 binding protein, and we observed 
no association of these levels with plasma leakage.
So far, it has not been shown that DENV infection and replication of ECs occur in vivo. Anti-NS1 
antibodies can act as auto-antibodies which activate and target non-infected ECs and platelets, with 
subsequent release of vaso-active mediators that promote endothelial permeability (orange dots), such 
as angiopoietin-2 (Ang-2). Complement activation was demonstrated in patients with severe dengue, 
but the exact mechanism of activation and its role in the pathogenesis is still unknown. NS1 seems to 
be an important trigger for complement activation via binding of antibodies to NS1 present on other 
cells. Additionally, binding of NS1 to sulphated glycosaminoglycans may alter the electric charge of the 
glycocalyx layer on ECs, further favoring plasma leakage. 
Platelets normally help to maintain vascular integrity by releasing vaso-active mediators which 
inhibit vascular endothelial permeability (green dots), such as sphingosine-1-phosphate (S1P) and 
angiopoietin-1 (Ang-1). Sufficient numbers of functional platelets are especially required in conditions 
of inflammation to prevent endothelial hyperpermeability. Platelets are activated in dengue infection 
as we confirmed in chapter 4, but whether this results from direct infection of platelets and/or 
megakaryocytes, antibody-mediated platelet activation, cytokines and/or platelet-cell interactions is 
partly unknown. Platelet activation may result in release of stored pro-inflammatory microparticles or 
cytokines (such as IL-1β) and other vaso-active mediators (such as serotonin, VEGF) that can promote 
EC hyperpermeability. We found that serotonin contents of platelets were increased during dengue 
infection and inversely associated with platelet counts, while plasma levels of serotonin remained the 
same (chapter 4). 
Apoptotic platelets interact with and alter the signaling of monocytes after phagocytosis. Platelet 
activation also facilitates the formation platelet monocyte and neutrophil complexes, which can 
further increase the pro-inflammatory cytokine storm. In our cohort of adult dengue patients 
circulating platelet-monocyte and platelet-neutrophil numbers were decreased during the period of 
thrombocytopenia, despite the presence of platelet activation (chapter 4). 
The origin of dengue-associated thrombocytopenia is thought to be multifactorial with decreased 
production due to cytokine-induced bone-marrow suppression and possibly direct infection of 
megakaryocytes; increased platelet activation and destruction by direct interaction with DENV 
(antigens) and/or its antibodies and/or stimulation by cytokines; apoptosis; and complex formation with 
endothelial cells and leukocytes. Thrombocytopenia and platelet dysfunction may further compromise 
EC integrity. In ex vivo platelet stimulation assays we found that platelet function was altered (chapter 4). 
Plasma levels of the vasculoprotective platelet-derived Ang-1 were decreased during dengue infection 
while levels of the endothelium derived vascular pro-permeability mediator Ang-2 were increased 
(chapter 6). Moreover, vasculo-protective S1P plasma levels were decreased during dengue infection. 
These decreased plasma S1P levels were not associated with a decreased content of S1P in platelets, but 
may be due to decreased levels of its main carrier apolipoprotein M (chapter 5). 
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FUTURE PERSPECTIVES
Important challenges remain in the combat against dengue. Currently 
no licensed vaccine exists and dengue vector control efforts have not 
succeeded yet in reducing the incidence. As long as dengue infection cannot 
be prevented, new methods to timely diagnose and differentiate dengue 
from other febrile illnesses are urgently needed. Naturally, these methods 
should be suitable for implementation in resource poor endemic areas. Serial 
handheld ultrasonography performed by trained clinicians as described in 
this thesis, may be useful to detect patients at risk for circulatory failure before 
shock develops. To further investigate this, ultrasonography studies should 
be repeated in primary health care settings en non-referral hospitals, where 
patients are more likely to present before shock develops. Also children should 
be included in such studies, since they tend to progress more rapidly to shock 
than adults. Evaluation for gallbladder wall thickening may not only yield an 
early predictor for severe dengue, but can also be evaluated for its capacity to 
differentiate dengue from other febrile illnesses. New parameters determined 
by hematology analyzers that are already used in routine dengue care may 
aid to differentiate dengue from other illnesses, as described in this thesis. 
Currently a larger study is being performed to further investigate this. Next, 
it would be useful to investigate whether an algorithm using a combination 
of readily available clinical, laboratory and/or ultrasonography findings can 
be developed to accurately differentiate dengue from other illnesses and to 
predict severe dengue in order to guide clinical decision making. 
Further advances in animal models resembling human dengue pathology are 
needed to increase our understanding of the pathogenesis and to test the 
efficacy and side-effects of specific interventions including administration 
of vaso-active mediators (or analogues) such as S1P and Ang-1 in vivo. 
Also interventions that target platelet function during dengue deserve 
more attention in future research, and should not only focus on bleeding 
complications, but especially on plasma leakage. 
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SUMMARY 
Dengue has become the most important arthropod-borne viral infection in the 
(sub)tropics. Patients with symptomatic dengue virus infection usually develop 
a mild, self-limiting, febrile illness, which is often difficult to distinguish from 
other endemic febrile illnesses during the early stages. Around the time of 
defervescence, a subset of dengue infections progress to a life-threatening 
condition with severe plasma leakage leading to shock and/ or respiratory 
distress. The underlying pathogenesis of severe dengue-associated plasma 
leakage is complex and incompletely understood. Dengue virus related factors, 
host immune response, platelet counts and function and genetic host factors 
all seem to directly or indirectly play a role in the pathogenesis of plasma 
leakage (see figure 1 in this chapter). Severe hemorrhage and/ or organ failure 
are other - less common - manifestations of severe dengue. It is currently not 
possible to accurately predict who is at risk for severe dengue and should be 
closely monitored. To date, no specific therapy or vaccine exists for dengue 
virus infection.
The studies in this thesis were performed in Bandung (in adults with severe and 
non-severe dengue) and in Semarang (in children with severe dengue), both 
located in Java, Indonesia.
In chapter 2 we determined the predictive diagnostic value for severe dengue 
of asymptomatic (subclinical) plasma leakage by performing serial, daily, 
bedside ultrasonography in adults with dengue. This study demonstrated that 
asymptomatic plasma leakage in the form of ascites and/or pleural effusion 
frequently occurs in dengue infection, in contrast to the historical concept 
that plasma leakage is a hallmark of severe dengue which develops around 
defervescence. Ascites and/or pleural effusion was often preceded by a 
thickening of the gallbladder wall, which may be used as an early marker for 
plasma leakage. Over one third of the patients with ascites and/or pleural effusion 
at hospital admission developed circulatory failure with or without respiratory 
distress at some time-point (positive predictive value 35%), whereas the 
negative predictive value was 90%. Findings of the handheld ultrasonography 
were consistent with findings of conventional ultrasonography performed by a 
radiologist, which will facilitate implementation in clinical practice in endemic 
settings. Although hematocrit is still mentioned in the WHO guidelines as a 
marker for plasma leakage, it turned out to be a poor indicator.
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In chapter 3 we identified new hematological parameters, as measured by 
Sysmex XE-5000 automated hematology analyzer, that can help to differentiate 
between dengue, leptospirosis and enteric fever. Especially determination of 
the activation state of different types of leukocytes was useful in differentiating 
these infections. This study offered a first indication on the clinical usefulness of 
the latest generation hematology analyzers in differentiating between dengue 
and other infections. It formed the basis for a large ongoing study in febrile 
patients in Bandung in which a diagnostic algorithm is made using hematology 
analyzers.
Patients with dengue have a bleeding tendency that also occurs with relatively 
high platelet counts. Increasing evidence supports the role of platelets in 
preservation of endothelial integrity. In the following chapters, we explored 
the association of changes in platelet physiology and platelet-derived proteins 
in dengue associated plasma leakage. In chapter 4 we explored the hypothesis 
that ongoing platelet activation leads to platelet dysfunction, thereby possibly 
promoting vascular permeability. Using a novel flow cytometry-based assay, 
we confirmed that dengue is associated with platelet activation and secondary 
platelet dysfunction (thrombocytopathy). This may contribute to bleeding as 
well as plasma leakage. 
Chapter 5 describes that plasma concentrations of the endothelial protective 
molecule sphingosine-1-phosphate (S1P) are decreased during dengue and 
that these decreased levels are associated with plasma leakage. Platelets contain 
high concentrations of S1P, but our findings show that thrombocytopenia 
and platelet exhaustion are not responsible for the reduced  plasma S1P 
concentrations. Rather, the reduction in lipoproteins, including  apolipoprotein 
M (ApoM), was responsible for this finding, directly relating lipoproteins to 
plasma leakage. 
In chapter 6 we report that plasma levels of angiopoietin (Ang)-1, a protein 
stored in platelets, are decreased in dengue infection, and are accompanied by 
an increase of Ang-2, findings that both favor endothelial hyperpermeability. 
This Ang-1/ Ang-2 imbalance was associated with markers of plasma leakage 
in a cohort of Indonesian children with severe dengue. 
In chapter 7 we explored the possible role of the vaso-active hormones 
adrenomedullin and vasopressin, by determining their more stable pro-
hormones mid-regional pro-adrenomedullin (MR-proADM) and copeptin, 
respectively in the cohort of children with severe dengue. MR-proADM levels 
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were increased in children with severe dengue compared to controls and 
correlated with the severity of plasma leakage. Copeptin concentrations 
showed no significant changes as compared to controls. 
In chapter 8 we described increased levels of both interleukin(IL)-18 and IL-18 
binding protein(BP), resulting in unchanged levels of the biologically active IL-
18 during dengue. IL-18BP and biologically active IL-18 levels were not related 
to dengue severity. Additionally, the increase in IL-18 and IL-18BP was not 
specific for dengue, as was shown leptospirosis and enteric fever patients. 
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NEDERLANDSE SAMENVATTING
Dengue is uitgegroeid tot de belangrijkste virale infectie in de (sub)tropen die 
door muggen wordt overgedragen. Patiënten met symptomatische dengue virus 
infectie ontwikkelen meestal een milde koortsepisode die in de vroege stadia 
vaak moeilijk te onderscheiden is van andere endemische ziekten. Vaak herstelt 
de patiënt snel na de koortsepisode, maar sommige patiënten ontwikkelen 
ernstige complicaties rond de tijd dat de koorts verdwijnt. De meest gevreesde 
complicatie is ernstige plasma lekkage, omdat dit in korte tijd kan leiden tot 
shock en/of ademhalingsproblemen. De onderliggende pathogenese van 
dengue-geassocieerde plasma lekkage is complex en wordt nog onvoldoende 
begrepen. Factoren die een rol kunnen spelen bij het ontstaan van plasma 
lekkage zijn gerelateerd aan het virus zelf, de afweerrespons van de gastheer, 
de aantallen en functie van bloedplaatjes, de functie van het endotheelcellen 
en de interacties tussen deze factoren. Ernstige bloedingen en/of orgaan 
falen zijn manifestaties van ernstige dengue die minder vaak voorkomen. 
Het is nog niet mogelijk om nauwkeurig te voorspellen welke dengue 
patiënt een verhoogd risico heeft op ernstige dengue en daarom intensiever 
geobserveerd moet worden in het ziekenhuis. Ook bestaat er nog geen 
specifieke behandeling of een  geregistreerd vaccin tegen dengue virus infectie. 
De studies in dit proefschrift werden uitgevoerd in Bandung (bij volwassenen 
met ernstige en niet-ernstige dengue) en in Semarang (bij kinderen met 
ernstige dengue), beide op Java, Indonesië.
In hoofdstuk 2 beschreven we een onderzoek naar de voorspellende 
diagnostische waarde van niet-symptomatische (subklinische) plasma lekkage 
voor het ontstaan van ernstige dengue. Artsen kregen een korte training in 
het gebruik van een klein echoapparaat en onderzochten daarmee dagelijks 
aan het bed van de volwassen dengue patiënten of er sprake was van plasma 
lekkage. Deze studie toonde aan dat subklinische plasma lekkage in de vorm 
van ascites en/of pleurale effusie vaak voorkomt tijdens een dengue infectie. 
Dit is in tegenstelling tot het historische concept dat plasma lekkage met name 
een kenmerk is van ernstige dengue en alleen optreedt rond de tijd dat de 
koorts verdwijnt. Ascites en/of pleurale effusie werden vaak voorafgegaan 
door een verdikking van de galblaaswand en dit kan wellicht worden gebruikt 
als een vroeg teken van plasma lekkage. Meer dan een derde van de patiënten 
die zich presenteerden met ascites en/of pleurale effusie op het moment van 
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ziekenhuisopname, ontwikkelde shock met of zonder ademhalingsproblemen 
op een bepaald tijdpunt (positieve voorspellende waarde 35%), terwijl de 
negatieve voorspellende waarde 90% was. Bevindingen van de echografie 
met het kleine echoapparaat waren consistent met de bevindingen van 
conventionele echografie uitgevoerd door een radioloog. Echografie door een 
radioloog wordt echter nauwelijks toegepast in de klinische praktijk vanwege 
de beperkte beschikbaarheid en de kosten. Hoewel hematocriet nog steeds in 
de richtlijnen van de WHO als een marker voor plasma lekkage wordt genoemd, 
bleek het een slechte indicator te zijn. 
In hoofdstuk 3 rapporteerden we over nieuwe hematologische parameters, 
gemeten door een Sysmex XE-5000 hematologie analyzer, die kunnen helpen 
om te differentiëren tussen dengue, leptospirosis en buiktyfus. Vooral bepaling 
van de activeringstoestand van verschillende soorten leukocyten bleek nuttig 
bij het differentiëren tussen deze infecties. Deze studie gaf een eerste indicatie 
over de klinische bruikbaarheid van de nieuwste generatie hematologie 
analyzer in het onderscheid tussen dengue en andere infecties. Dit vormde 
de basis voor een grote lopende studie bij patiënten met koorts in Bandung, 
Indonesië, waarbij een diagnostisch algoritme wordt gemaakt met behulp van 
hematologie parameters.
Patiënten met dengue hebben een verhoogde bloedingsneiging, ook bij 
relatief hoge bloedplaatjes aantallen. Toenemend bewijs ondersteunt de rol 
van bloedplaatjes in het behoud van endotheel integriteit. In de volgende 
hoofdstukken onderzochten we de associatie van veranderingen in de functie 
van bloedplaatjes en veranderingen in plasma concentraties van stoffen die 
invloed hebben op de endotheel integriteit met het optreden van plasma lekkage 
tijdens dengue. In hoofdstuk 4 verkenden we de hypothese dat aanhoudende 
activering van bloedplaatjes leidt tot een veranderde bloedplaatjes functie 
hetgeen vasculaire permeabiliteit kan bevorderen. Door middel van een nieuwe 
op flow cytometrie gebaseerde bepaling bevestigden we dat dengue wordt 
geassocieerd met bloedplaatjes activatie en secundaire bloedplaatjes disfunctie 
(trombocytopathie). Dit kan bijdragen tot bloedingen en plasma lekkage. 
In Hoofdstuk 5 beschreven we dat plasmaconcentraties van het endotheel 
beschermende molecuul sphingosine-1-fosfaat (S1P) zijn verlaagd tijdens 
dengue en dat deze verlaagde concentraties geassocieerd zijn met plasma 
lekkage. Bloedplaatjes bevatten hoge concentraties van S1P, maar onze 
bevindingen tonen aan dat trombocytopenie en bloedplaatjes uitputting niet 
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verantwoordelijk zijn voor de verminderde plasma S1P concentraties. Het is 
waarschijnlijker dat verlaging van lipoproteïnen concentraties, waaronder 
apolipoproteïne M (ApoM), verantwoordelijk was voor deze bevinding. 
Apolipoproteine M is een belangrijke transporter van S1P en Apo M plasma 
concentraties kunnen hierdoor S1P plasma concentraties en plasma lekkage 
beïnvloeden.
In hoofdstuk 6 vermeldden wij dat plasma concentraties van angiopoietine 
(Ang)-1 - een eiwit opgeslagen in bloedplaatjes - afgenomen zijn tijdens 
dengue infectie. De lagere Ang-1 concentraties gaan gepaard met een toename 
van Ang-2, bevindingen die beide de endotheel permeabiliteit bevorderen. 
Dit verstoorde Ang-1 / Ang-2 evenwicht werd geassocieerd met markers van 
plasma lekkage in een cohort van Indonesische kinderen met ernstige dengue. 
In hoofdstuk 7 onderzochten we de mogelijke rol van de vaso-actieve 
hormonen adrenomedulline en vasopressine, door het bepalen van 
hun stabielere pro-hormonen mid-regionaal pro-adrenomedulline (MR-
proADM) en copeptin, respectievelijk in een cohort van kinderen met 
ernstige dengue. MR-proADM concentraties waren verhoogd bij kinderen 
met ernstige dengue vergeleken met gezonde controles en correleerden 
met de ernst van plasmalekkage. Copeptin concentraties toonde 
geen significante veranderingen ten opzichte van gezonde controles. 
In hoofdstuk 8 beschreven we interleukine (IL) -18 concentraties gedurende de 
verschillende fasen van dengue infectie. IL-18 is een pro-inflammatoir cytokine 
dat in tegenstelling tot de meeste pro-inflammatoire cytokinen geen koorts 
geeft. Onze hypothese was dat verhoogde IL-18 concentraties een verklaring 
zouden kunnen zijn voor de specifieke timing van complicaties, namelijk rond 
de tijd dat de koorts verdwijnt. Wij vonden verhoogde IL-18 concentraties, 
maar ook verhoogde IL-18 bindend eiwit concentraties, hetgeen resulteerde 
in onveranderde concentraties van biologisch actieve IL-18 tijdens de dengue. 
IL-18 bindend eiwit en biologisch actieve IL-18 concentraties waren niet 
gerelateerd aan de ernst van dengue infectie. Daarnaast was de toename van 
IL-18 en IL-18 bindend eiwit is niet specifiek voor dengue, maar trad dit ook op 
bij leptospirosis en buiktyfus patiënten.
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Het onderzoek in dit proefschrift is het resultaat van de inspanningen van velen 
en ik wil alle mensen bedanken die me de afgelopen jaren direct of indirect 
hebben geholpen. 
Allereerst wil ik de patiënten en familieleden die toestemming gaven voor 
deelname aan onze studies bedanken voor hun vertrouwen en medewerking. 
Veel dank ben ik verschuldigd aan mijn promotoren en copromotoren:
Professor dr. A.J.A.M. van der Ven, beste André, na mijn wetenschappelijke 
stage bij je gedaan te hebben, bood je me de kans om dit promotieonderzoek 
te doen. Ik kende je inmiddels al als een enorm energieke en optimistische 
begeleider met veel originele ideeën en hypothesen. Ik wil je bedanken voor 
de fijne samenwerking, voor het vertrouwen en de ruimte die je me hebt 
gegeven om dit onderzoek te doen.
Professor dr. Ph.G. de Groot, beste Flip, ondanks dat ik regelmatig langere 
perioden afwezig was, kon ik altijd bij je terecht voor je expertise op het gebied 
van bloedplaatjes en het uitvoeren van experimenten in het laboratorium 
Klinische chemie en hematologie van het UMCU. Dank hiervoor!
Doctor Q. de Mast, beste Quirijn, ik heb ontzettend veel gehad aan je kennis 
en ervaring die je altijd op een aanstekelijk enthousiaste manier weet over te 
brengen. Dank voor al je inspanningen en het goede gezelschap in binnen- en 
buitenland! 
The dengue study in Bandung would not have been possible without my 
copromotor from Indonesia, dr. B. Alisjahbana. Dear Bachti, I probably noticed 
only a fraction of all the efforts you made to ensure that our study would 
succeed. From the start I felt welcome in the dengue research team and I am 
very grateful that I had the opportunity to work with you and with the other 
team members. I am looking forward to see what future studies from the 
Bandung- Nijmegen collaboration will bring. Terima kasih banyak! 
Graag wil ik de manuscriptcommissie bestaande uit prof. dr. I. Joosten, prof. dr. 
P. Pickkers en prof. dr. J.M. Smit bedanken voor het lezen en beoordelen van 
het manuscript. 
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Alle co-auteurs bedankt ik voor hun bijdragen aan de verschillende 
hoofdstukken.
In Bandung I had the pleasure to work in great team and I thank all of the 
members for this collaboration. The study doctors Intan, Mita and Sylvia: thank 
you for your hard work, weekends included, and for the fun times we spent 
together after work. The laboratory analysts Yani, Fitri and Teni: it was great 
working with you all in the lab. You were always very committed and eager 
to learn new techniques. Despite frequently occurring technical problems, 
we ultimately found a solution for everything… Thank you for the many nice 
evenings with dinners, movies and trips in the surroundings; I really enjoyed 
spending time with you and I hope to see you all again. 
Doctor Agnes, dr. Amaylia, dr. Rudi, dr. Irra, and dr. Delita: thank you all for your 
hospitality and your great company during my stay in Bandung. 
De samenwerking met de onderzoekers en analisten van de afdeling Klinische 
Chemie en Hematologie van het UMCU was altijd bijzonder prettig en de 
technieken die ik er heb geleerd zijn onmisbaar geweest voor dit proefschrift, 
dank hiervoor! 
Professor Mihai Netea en prof. Leo Joosten van de afdeling experimentele 
interne geneeskunde van het Radboudumc; bedankt voor jullie feedback en 
adviezen. De vaste ‘crew’ van het laboratorium - Liesbeth, Trees, Helga, Heidi, 
Cor, Anneke, Ineke, Johanna en Magda -  en wisselende populatie onderzoekers/ 
promovendi in het laboratorium; bedankt voor de samenwerking en discussies 
door de jaren heen. 
Lisa van de Wijer en Ellen de Boer, bedankt dat jullie als enthousiaste studenten 
meewerkten aan het onderzoek. 
De gang van het Nijmegen Institute for International Health wordt gebruikt 
door vele inspirerende en fijne collega’s. Mijn werkkamergenoten Monique 
Keuter en Henri van Asten bedank ik voor de vele leuke gesprekken en de 
gezellige intermezzo’s. Henri , ook bedankt voor je hulp bij ICT perikelen en 
statistiek vraagstukken. Reinout van Crevel, bedankt voor de praktische tips 
voor het doen van onderzoek in Bandung. Mieke Daalderop, Carla  IJsenbrandt 
en Maureen Wijnhoven bedankt voor jullie veelzijdige ondersteuning. Alle 
collega’s van de PRIOR kamer bedankt voor de gezelligheid! Susanne van 
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Santen, leuk dat het nog steeds lukt om elkaar regelmatig te zien ondanks volle 
agenda’s. Hinta Meijerink, bedankt voor de vele gezellige avonden in Nijmegen 
en Bandung, en voor het ontcijferen van de belangrijkste ankot routes in 
Bandung , de vele heerlijke Indonesische etentjes en andere leuke momenten. 
Ik ben benieuwd waar op de wereld je allemaal nog terecht gaat komen. 
Ajeng Tunjungputri, na het nieuws dat we toch niet in Semarang zouden gaan 
samenwerken, ben je gelukkig naar Nijmegen gekomen en heb ik je alsnog 
leren kennen. Veel succes met het laatste deel van je onderzoek.
Mijn opleiders in het Radboudumc  -prof. Jos van der Meer, prof. Paul Stuyt, prof. 
Jacqueline de Graaf, prof. Jan Smit, dr. Chantal Bleeker –Rovers -  wil ik bedanken 
voor hun begeleiding bij de opleiding tot internist en voor de mogelijkheid die 
ik heb gekregen om de opleiding te combineren met onderzoek. Ik heb goede 
herinneringen aan mijn tijd in Nijmegen!
Gerard Michels en Ghislaine Waltman, bedankt dat jullie mijn paranimf willen zijn! 
Beste Gerard, toch mooi dat jij je nu in míjn proefschrift gaat verdiepen (toch?). 
Ik was in ieder geval blij dat ik je tijdens een autorit vanuit Frankrijk nog heb 
kunnen uithoren over de inhoud van jouw ingewikkelde proefschrift, voordat 
ik je paranimf mocht zijn. Beste Ghislaine, tijdens onze onderzoeksprojecten in 
Bandung zijn we bevriend geraakt, en ik vind het ontzettend leuk dat we nog 
steeds contact hebben ondanks je intensieve studieprogramma. En wie had 
gedacht dat je na je afstuderen nog geneeskunde zou gaan studeren (nou ja ik 
misschien, een beetje ).
Zonder de hulp van mijn lieve moeder had het nóg veel langer geduurd 
voordat dit proefschrift af was geweest; bedankt voor de vele keren oppassen! 
Ook mijn andere (schoon)familieleden en vrienden wil ik bedanken voor hun 
steun en interesse. Toch, de belangrijkste dingen in het leven zijn niet goed te 
verwoorden binnen het kader van een dankwoord in een proefschrift.   Wat 
jullie voor me betekenen gaat natuurlijk veel verder dan het bovenstaande en 
behoeft hopelijk hier geen toelichting. 
Gerben, wat een geluk hebben wij met elkaar en onze lieve jongens! Ik kijk 
erg uit naar een ‘full house’ in Zeist en nog veel meer mooie momenten in de 
toekomst.
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CURRICULUM VITAE
Meta Michels werd geboren op 26 oktober 1978 in Utrecht. In 1997 deed zij 
eindexamen atheneum aan het Heerbeeck College in Best. Na gestart te zijn 
met de studie psychologie volgde zij 2 jaar de opleiding fysiotherapie en werd 
zij uiteindelijk in 2000 ingeloot voor de studie geneeskunde aan de Radboud 
Universiteit in Nijmegen.  Na haar co-schappen in het Sumve District Designated 
Hospital in Tanzania en een wetenschappelijke stage onder leiding van prof. dr. 
A. J. A. M. van der Ven, begon zij in 2007 met haar opleiding tot internist in het 
Jeroen Bosch ziekenhuis (opleider dr. P. M. Netten). In 2009 startte zij met het 
onderzoek dat uiteindelijk heeft geresulteerd in dit proefschrift. Dit onderzoek 
vond plaats in Nederland en Indonesië en werd afgewisseld met de opleiding 
tot internist in het Radboudumc in Nijmegen (opleider prof. dr. J. W. M van der 
Meer en later prof. dr. J. de Graaf ). Sinds 2016 is zij bezig met haar opleiding 
tot internist in het aandachtsgebied infectieziekten in het Universitair Medisch 
Centrum Utrecht (opleider prof. dr. I. M. Hoepelman).
Ze is getrouwd met Gerben van Boekel en ze hebben 2 kinderen, Abel (2013) 
en Jonas (2014). 
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